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STELLINGEN 
1. "Validatie" en "calibratie" van voedingsinname-metingen moeten per definitie 
worden beschouwd als vormen van statistische modellering, berustend op de 
aanname dat verschillende methoden eenzelfde verschijnsel meten, maar 
onafhankelijke fouten hebben. 
(dit proefschrift) 
2. Validiteit en precisie kunnen het best worden gezien als kenmerken van een 
verzameling metingen, en niet van de gebruikte meetmethode. 
(dit proefschrift) 
3. Bland & Airman's categorische verwerping (Lancet,1986;i:307-10) van de 
correlatie-coëfficiënt als maat voor validiteit of reproduceerbaarheid (of een 
combinatie van beide) is onterecht. 
4. Het onderzoeken van epidemiologische verbanden tussen innameniveaus van 
individuele nutriënten of voedingsmiddelen en chronische ziekten leidt 
gemakkelijk tot overinterpretaties die zouden kunnen worden vermeden als de 
voedings-' blootstelling" meer integraal werd beschreven als een 
multi-dimensionaal consumptiepatroon. 
5. De recente uitkomsten van de finse kanker-preventie trial met ß -caroteen en 
a-tocopherol (New England Journal of Medicine, 1994;330:1029-35) suggereren 
dat men voor chemopreventie beter wat vaker naar de groenteboer kan gaan dan 
naar de apotheek. 
6. De recent ingevoerde registratie van epidemiologen in Nederland suggereert een 
gebrek aan vertrouwen dat (collega) werkgevers van epidemiologisch 
onderzoekers zelf een curriculum vitae kunnen beoordelen. 
7. De sociale rechtvaardigheid van een wettelijk gegarandeerd minimum inkomen is 
aangetast als men werkzoekenden niet op afzienbare termijn een baan kan bieden. 
8. De sterke toename van aantal skiliften in franse Alpen doet vermoeden dat, onder 
het motto "vooruitgang is alleen vooruitgang als die wordt gedeeld door iedereen", 
de wereld langzaam wordt omgetoverd in een gigantisch gemechaniseerd 
pretpark. 
9. Des chercheurs qui cherchent, on en trouve; des chercheurs qui trouvent, on en 
cherche, (generaal de Gaulle) 
10. Te beoordelen naar hun gedrag in het stadsverkeer hebben de fransen met de haan 
als nationaal symbool geen slechte keus gemaakt. 
11. De aankondiging van een verhoging van het budget voor de vroege opsporing van 
mammacarcinoom (Volkskrant, 1-9-94) valt op aardige wijze samen met de 
recente benoeming van mevrouw Borst als minister voor Volksgezondheid, 
Welzijn en Sport. 
Stellingen behorend bij het proefschrift 'Efficiency aspects of design and analysis of 
prospective studies on diet, nutrition and cancer', van Rudolf Kaaks. Wageningen, 7 oktober 
1994. 
Abstract 
This thesis presents and analyzes methodological approaches to improve the 
design and analysis of prospective cohort studies on the relations between 
diet, nutritional status and cancer. The first chapters discuss methods to 
optimize the measurement of the individuals' habitual dietary intakes, 
focussing on the use and design of sub-studies for the "validation" or 
"calibration" of baseline dietary questionnaire assessments. The power of 
prospective studies can be improved by maximizing the variation in true 
dietary intake levels actually distinguished - or "predicted" - by 
questionnaire assessments. This can be achieved by designing an optimal 
questionnaire method, using a preliminary validity study to evaluate its 
performance. An additional possibility is to broaden the range of dietary 
exposures by conducting multiple cohort studies in populations with 
different dietary habits. A main objective is to precisely estimate the 
magnitude of the predicted variation of intake levels, to account for the 
effect of measurement error as well as of the real variation in exposure, in 
the evaluation of the power or sample size requirements of a cohort study, 
and in the estimation of relative risks describing diet-disease relations. 
The predicted variation is estimated most efficiently by means of a 
"calibration" sub-study, which differs from validity studies in that it 
requires only a single (unbiased) reference measurement per person (e.g., 
based on a 24-hour recall), in a representative sub-sample of cohort 
members. In multi-cohort projects, calibration studies are essential to 
improve the between-cohort comparability of relative risk estimates, and to 
increase the power of a statistical test for the presence of a diet-disease 
association based on a pooled summary estimate. A simplified method is 
proposed for the estimation of sample size requirements of dietary 
calibration studies. When the exposure assessments are based on a 
biochemical marker, a most efficient design is to store biological specimens 
in a biobank, and to postpone laboratory analyses until cases with disease 
have been identified. Nevertheless, the number of scientific hypotheses 
potentially of interest is usually much larger than can be tested with 
limited amounts of biological specimens available. The last chapter of this 
thesis discusses the use of a sequential study design, to allow the 
evaluation of a maximum number of different hypotheses at the expense of as 
little biological material as possible. 
The research described in this thesis was carried out at the International 
Agency for Research on Cancer (Lyon, France) as part of the EPIC project, 
supported by a grant from the Europe Against Cancer Programme of the 
Commission of European Communities 
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Background 
Over the past 20 or 30 years, important developments have been made in 
epidemiological research on the relation between diet and cancer. Following 
international correlation studies (1-3), and studies on migrants (4,5), 
which indicated that diet and nutrition-related life style may be important 
determinants of cancer risk, epidemiological research shifted towards 
studies where the basic units of observation were individuals rather than 
entire populations. During the 1970s, most of these were of a case-control 
design, focusing mainly on cancers of the stomach, colorectum, and breast. 
During the 1980s, the number of case-control studies increased, and were 
gradually oriented to a larger variety of cancer sites, including the upper 
aerodigestive tract (larynx, oesophagus), endometrium, ovary, prostate and 
lung (6). This period was also characterized by the development of more 
modern concepts and methods for "nutritional epidemiology", as evidenced by 
the (still relatively recent) publication of two standard textbooks in this 
field (7,8). Particular attention was given to the development of 
appropriate methods for the assessment of individuals' habitual diet, 
especially food frequency questionnaires (7,9), and to the use of 
methodological sub-studies to evaluate the validity and reproducibility of 
the dietary questionnaire assessments (10,11). Finally, a number of large, 
well-designed prospective cohort studies were started, in which diet was 
measured by means of carefully selected and "validated", questionnaire 
instruments (12-14). Then, at the end of the 80s, the idea of developing 
multi-cohort projects was conceived. The first of these was the European 
Prospective Investigation on Cancer and Nutrition (EPIC), a multi-centre 
cohort study currently being conducted in collaboration with 17 research 
centres in seven European countries, and which is coordinated by the 
International Agency for Research on Cancer at Lyon (15). Following a 
similar rationale, another multi-centre (and multi-ethnic) project is being 
planned in areas around Pacific basin, including Hawaii, Califoria, 
Singapore and possibly Japan (16). 
The main reasons for conducting prospective cohort studies, rather than 
using a case-control design, are that in the latter the estimated 
association between diet and disease risk may be prone to bias. Selection 
biases may occur if controls and cases do not originate from the same 
population base (17). Another type of bias is due to differences between 
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cases and controls in the recall of their previous dietary habits (18). In 
prospective studies, the diet-disease relationship is investigated following 
the natural time sequence between the exposure, assessed at baseline when 
the subjects enrol in the study, and the subsequent occurrence of disease 
during a period of follow up. It is unlikely that assessments of habitual 
dietary intake will be differently biased among participants who eventually 
develop a given disease, as compared to those who remain in good health. 
Moreover, prospective cohort studies provide a well described population 
base for making comparisons between the measured exposures of cases, and of 
disease-free control subjects. Thus, selection bias is also unlikely to form 
a serious problem in this type of study, unless for some reason losses in 
follow up are associated with the level of dietary intake assessments. 
An important remaining problem, also in prospective cohort studies, is 
that there should be sufficient statistical power to test for the presence 
(or absence) of specific diet-disease associations. In conjunction, it is 
desirable to obtain relative risk estimates with a sufficient level of 
precision, as measured by the width of their confidence intervals. Within a 
limited geographical (or cultural) area, there may be relatively little 
between-individual variation in habitual dietary intake, as compared to the 
variation that exists between mean intake levels in different countries. For 
example, the mean fat intake at a population level varies from as little as 
11 percent of daily energy intake for some developing countries, to more 
than 43 percent in the United States, whereas within the United States as a 
single country the between-individual variation in fat intake was estimated 
to be between 30 and 45 percent of total energy (19). Due to this relative 
homogeneity of dietary habits within a single country, true relative risks 
between subjects with either "high" or "low" intake levels of a given food 
or nutrient will tend to be much weaker. In addition, there is the problem 
that relative risks tend to be under-estimated due to the attenuating 
effects of random errors in the dietary exposure measurements, so that the 
statistical power to test for the presence of a diet-disease association is 
even further decreased (20). Therefore, relatively large numbers of cases 
with the disease of interest will be required for a cohort study to reach a 
reasonable level of power and precision. 
Although the total cancer burden is high in economically more developed 
countries, there are many different forms of cancer, and incidence rates of 
each of these separately are usually relatively low. Therefore, prospective 
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cohort studies must in general be very large, including several tens of 
thousands of individuals, for a sufficient number of cases with a specific 
form of disease to develop during a follow up period of no more than 10 to 
15 years. Consequently, the costs of such prospective studies can be very 
high. It is thus fundamental to use an efficient study design which, for a 
given investment of time and resources, makes the study as informative as 
possible. The main criteria to judge the amount of information obtained in a 
study are: 
a. the power of statistical tests for the presence of specific diet-
disease associations; 
b. the validity and precision with which the magnitude of such 
associations can be estimated (e.g., in the form of relative risks); 
and 
c. the number of different scientific hypotheses that can be evaluated. 
Major aspects of the design of a prospective study are related to the choice 
of the study population, as characterized by the expected cumulative 
incidence of disease (within a given follow-up period), the presence of a 
reliable mechanism for follow-up (e.g., a cancer registry), or factors which 
may facilitate contacting the study subjects (e.g., participation in a local 
screening programme). Once a choice has been made for the type of study 
population, the efficiency of the design of a prospective cohort study can 
be optimized by maximizing the accuracy of the exposure measurements, and by 
determining the sample size at which the cohort will have sufficient 
statistical power. The estimated sample size requirements, as well as 
financial resources available, are then key elements for deciding how many 
different types of exposure information can be collected from each 
participant (e.g., apart from the main questionnaire(s) on dietary habits, 
additional questionnaires can be included, for instance on physical 
activity, or biological samples can be collected for the assessment of 
various biochemical markers). 
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Scope of this thesis 
This thesis addresses a number of methodological issues related to the 
efficiency of the design and conduct of prospective cohort studies. The 
first chapters (chapters 2 to 5) discuss methods for optimizing the 
assessment of the habitual, long-term dietary intake of individuals 
participating in a prospective cohort study. More specifically, these 
chapters focus on the use and design of sub-studies with additional 
reference measurements, for "validation" or "calibration" of baseline 
questionnaire assessments of dietary intake level. Chapter 6, on the other 
hand, addresses the aspect of optimizing the number of specific study 
hypotheses that can be evaluated when exposure assessments are based on a 
biochemical marker measured in blood, or other tissue samples. 
i. "Validation" and "calibration" of dietary intake assessments 
As mentioned above, the power and precision of a cohort study on diet 
depend, among other things, on the heterogeneity in dietary intake levels 
within a given study population, as well as on the accuracy with which this 
variation in intake level is measured at baseline. Therefore, before 
starting the main epidemiological study, it is important to verify whether 
the baseline dietary intake assessments - usually obtained by means of a 
structured food frequency, or dietary history type of questionnaire (9,10) -
make sufficient distinctions between the high or low intake levels of 
different individuals. For this purpose, it is usually proposed to conduct a 
smaller sub-study, in which the accuracy of questionnaire assessments is 
evaluated by comparison with 'reference' measurements that are assumed to 
provide a more accurate measure of the individuals' true habitual intake 
levels (7). In the first instance, such sub-studies can be used during the 
development (21) or selection (22-24) of an optimal dietary questionnaire 
instrument, even before the main cohort study is started. Chapter 2 of this 
thesis presents a mathematical model for the definition of different types 
of error in dietary exposure measurements. This chapter then reviews, in 
terms of latent variable models, the essential requirements for the design 
and analysis of dietary validity studies, aimed at estimating the 
correlation between questionnaire assessments and the true, habitual dietary 
intake levels of individuals. 
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Apart from selecting an optimal questionnaire instrument, further reasons 
for collecting additional reference measurements are that: 
1. at the start of a prospective cohort study, this allows a more precise 
estimation of the expected statistical power, or sample size 
requirements of the cohort, taking account of the inaccuracy of certain 
dietary intake assessments; and 
2. at the analysis stage, this will allow the estimation of relative risk 
estimates with a correction for biases due to errors in the baseline 
dietary exposure assessments. Indeed, we are interested in disease risk 
as a function of true dietary intake levels rather than of measured 
levels of intake. With only a single, baseline measurement of dietary 
exposure (usually obtained by means of a questionnaire), the 
quantitative relation between true intake level and disease risk cannot 
be estimated. 
In previous epidemiological studies, the additional reference measurements 
needed to meet these two objectives have been usually collected within a 
preliminary validity study. Prospective cohort studies, however, also offer 
the possibility of collecting reference measurements as an integral part of 
the overall dietary exposure assessment at baseline, on at least a 
representative sample of study participants. This possibility is discussed 
in Chapter 3, which proposes an efficient alternative to dietary validity 
studies, based on the concept of "calibration" of the baseline dietary 
questionnaire assessments. 
Another possible approach to improve the correlation between measured and 
true dietary exposure values, and to increase the power and precision of a 
prospective cohort study while keeping its sample size constant, is to 
broaden the range of true dietary exposure levels covered. This may be 
achieved by conducting studies in different geographical areas (as in the 
EPIC project (15)), or by including different ethnic sub-groups which are 
known to have different food consumption habits (this is the rationale for 
the Pacific Area Multi-Ethnic project (16)). Advantages of the multi-cohort 
study design, as compared to "ecological" studies based on aggregate (i.e., 
group level) information about exposure and disease incidence, are discussed 
in Chapter 4. A complication in the multi-cohort design, however, is that, 
within different cohorts, questionnaire assessments of dietary exposure may 
not have the same degree of accuracy for classification of individuals by 
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their habitual dietary intake levels, whereas mean intake levels may also be 
over- or underestimated by unequal amounts. A solution to this problem is 
presented in Chapter 4, proposing the "calibration" approach to combine the 
findings of different cohorts in a manner that reflects the accuracy of the 
questionnaire assessments, and to adjust for differences in systematic over-
or underestimation of mean intakes at a level. 
Within this context, it is important that calibration sub-studies should 
themselves be large enough to reach a minimum level of precision, without on 
the other hand overinvesting in this component of exposure assessment. The 
issue of optimal sample size requirements for dietary calibration studies is 
addressed in Chapter 5. 
ii. Design aspects when exposure measurements are based on biochemical 
markers 
Another important advantage of prospective cohort studies is the possibility 
to use exposure assessments based on biochemical markers, measured in urine 
or blood, or in tissue specimens such as nails and fat tissue biopsies. 
Since in prospective studies the biological specimen can be collected before 
the clinical manifestation of disease, it is unlikely that the presence of a 
tumour, or related metabolic effects such as cancer cachexia, will have 
influenced the levels of biochemical marker. Observed associations between 
biochemical markers and disease risk can thus be interpreted more reliably 
as reflecting a causal relation, between the level of a given type of 
exposure and the development of a disease (and not vice versa). It should 
not be forgotten, in the current development of "biochemical" epidemiology, 
that the time sequence between exposure and disease is one of the 
fundamental conditions for interpretation of an epidemiological association 
as a potentially causal one (25). Markers which of may be of interest in 
studies on diet and cancer include: 
- markers of dietary intake and nutritional status (e.g. plasma levels of 
vitamins, triglycerides, or lipoproteins; fatty acid composition of fat 
tissue biopsies, selenium levels in toenails) (26-28), 
- markers of hormonal status and metabolism (e.g., plasma levels of 
specific steroid hormones, or sex-hormone binding globulin) (29), 
- markers of susceptibility (e.g., genetic or phenotypic polymorphisms of 
enzymes which may play a role in the activation or inactivation of 
(pre-) carcinogens (30)), 
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- markers of DNA damage (e.g., oxidative damage of DNA (31,32). 
Efficient approaches to exposure measurements by means of biochemical 
markers differ from those where exposure assessments are obtained by means 
of a questionnaire, because: 
1. it would be too expensive to measure all biochemical markers 
potentially of interest at baseline for all individuals; and 
2. the types of marker of interest will vary according to the prevailing 
biological hypotheses for the type of cancer under investigation. 
It is therefore usually more efficient to store biological specimens in a 
biological bank, and to delay the second step of the exposure assessment 
(the laboratory analysis) until a later date, when it will be known which 
individuals have developed a given type of disease, and which will be 
selected as suitable control subjects. Nevertheless, there remains the 
problem that the number of biological hypotheses potentially of interest 
will generally exceed the number of biochemical parameters that can actually 
be assessed with the limited volume of biological specimens for cases and 
suitable controls. For instance, in the EPIC project (15), a total of only 
14 millilitres of blood fractions (plasma, serum, buffy coat and red blood 
cells) are kept for each individual, in the form of 28 smaller (0.5 ml.) 
aliquots. Therefore, after the creation of a biological bank, an additional 
aspect related to increasing the efficiency of exposure assessment is how to 
optimize the number of different hypotheses that can be evaluated with a 
limited biological material. This aspect is addressed in Chapter 6, which 
proposes the use of a sequential test procedure to distinguish between 
promising new hypotheses, which may be worth further investigation, and less 
promising ones. 
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Abstract 
The validity and precision of questionnaire assessments of the habitual 
intake of individuals are usually evaluated by comparison with reference 
measurements that are supposed to provide a best possible substitute for the 
individuals' true intake values. In the present paper, a measurement error 
model is presented, defining different types of error - random or 
systematic, and within or between individuals - that may occur in dietary 
intake measurements. It is then discussed how simple latent variable models 
(structural equation models) can be used to estimate the average magnitude 
of these various types of error. So far, approaches described for the 
analysis of dietary validity studies were all based on the assumption that 
the random errors of repeat reference measurements, taken by the same method 
on different occasions, are uncorrelated, so that the average of a 
sufficiently large number of repeat reference measurements will provide an 
accurate ranking of individuals by true intake level. In the present paper 
it is described how, by additional comparison with a third type of 
measurement such as a biochemical marker, the validity of dietary 
questionnaire measurements can be evaluated even in situations where the 
random errors of repeat reference measurements cannot be assumed to be 
independent. 
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Introduction 
The validity and precision of measurements of diet obtained with dietary 
questionnaires are usually studied by evaluating their concordance with 
"reference" measurements, which are supposed to provide the best possible 
substitute for the true habitual intake value of every single subject 
participating in a dietary validity study (1-3). The two classic measures of 
concordance most commonly used in such validity studies are the correlation 
coefficient, and the difference between group means. The first measure is 
seen as an index of the accuracy with which questionnaire assessments can 
rank individuals by dietary intake level, while the second is used to 
express the average tendency of individuals to over- or under-estimate their 
dietary intake. 
In most studies on the validity of dietary questionnaire assessments, the 
reference measurements have been based on weighed food records (2), but 
24-hour recalls have also been used (2,4). Usually, such measurements of 
daily intake are repeated for multiple days, with the objective of obtaining 
a precise estimate of the individual level of the usual daily nutrient 
intake value. In early validity studies it was often assumed that the 
average of one or two weeks of daily intake recording provided accurate 
measurement of long-term nutrient intake. On this assumption, the 
correlation between questionnaire assessments and reference measurements 
should precisely reflect the accuracy of the questionnaire assessments for 
ranking individuals by habitual intake level. More recently it was shown 
that a larger number of recording days may be required, and that the 
correlation of questionnaire with reference measurements might underestimate 
the correlation with true intake levels if the reference measurements are 
subject to random error (e.g., if the reference measurements are based on 
only one week of food records) (5-8). Methods were proposed to correct for 
the underestimation of correlation and regresssion coefficients 
("attenuation" bias) due to within-subject random errors in the reference 
measurements (6,9). Freedman and colleagues (10) extended these methods by 
also incorporating an adjustment for the over- or under-estimation of 
correlation and regression coefficients that may result from a covariance 
between random errors of questionnaire and reference measurements taken too 
close in time. 
So far, the various approaches described for the analysis of dietary 
validity studies were all based on the assumption that the average of repeat 
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reference measurements will provide an accurate ranking by true intake level 
provided that the number of repeat measurements is large enough. In 
practice, however, this may not be the case. For instance, by comparing 
weighed food records with precise measurements of energy expenditure 
obtained by the "doubly labeled water" method (11,12), it has been shown 
that individuals can differ in their tendency to systematically under-report 
energy intake. One may expect that 24-hour recalls would result in an even 
greater systematic under-reporting, since a major source of error will be 
the subjects' tendency to forget which foods they actually consumed during 
the previous day. In addition, one would expect that greater systematic 
errors will be made in the description of portion sizes (2). Individuals 
might therefore systematically differ in their over- or under-reporting of 
intake. If this is the case, the random errors of repeat reference 
measurements, taken by the same method on different occasions, will be 
correlated, and repetition of daily intake estimates will fail to provide a 
fully accurate classification of individuals by true intake level. 
In the present paper, we shall present a measurement error model, 
defining different types of error - random and systematic, within or between 
individuals (13) - that may occur in dietary intake measurements. Ve shall 
then review, in terms of structural equation models, various procedures for 
the estimation of the average magnitude of the different types of error, and 
show how simple SAS programmes (using the procedure "CALIS") can be used for 
computations. Basic assumptions underlying the analysis of dietary validity 
studies will be discussed. It will be shown that, by additional comparison 
with a third type of measurement such as a biochemical marker, unbiased 
estimates of the average magnitude of the different errors can be obtained 
even when the random errors of repeat reference measurements are correlated. 
A measurement error model 
Suppose that for different individuals within a dietary study one seeks to 
measure the usual intake of a given nutrient. If, for a given individual i, 
a measurement X is made of his or her true intake T, one can write : 
X. = T. + y. 
l l 'l 
E(Yi) = B. 
Var(y.) = „J(1 
where y. is the "error", B. is the bias, and o . is the variance of the 
within-subject random error (13), which is the random error for repeat 
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measurements taken by the same method on the same individual. B. has 
previously been called the within-subject systematic error (13), or subject-
specific bias (2,3), and differs from zero if, on repeat occasions, the 
individual tends consistently to over- or underestimate intake. 
Within a population of I individuals, the magnitude of the bias B. and 
2 
of the variance o . may vary from one subject to another. On average, 
Y» i 2 
however, the variance of within-subject random error will be equal to o , 
2 the expected individual variance in the population. The average variance o 
will be assumed to be the same at all values of true intake, T. 
The bias may, to a certain extent, be functionally related to T. We shall 
assume that this functional relation is linear: 
B = a + bT + 6 
where E(S) = 0, Var(6) = o^ , and Cov(6,T) = 0. 
According to this linear model, the expected over- or underestimation for 
each individual can be decomposed into a multiplicative component bT, which 
depends on the individual's true dietary intake, and a constant additive 
component a. The term 6 represents the residual part of the subject-specific 
bias, which cannot be accurately predicted from the linear relation with T. 
2 
We shall therefore refer to 6 as "random" bias. Also the variance o. will be 
assumed to be equal for all values of T. 
We can now write the following model to measure the intake for an 
individual i belonging to the given study population : 
J.± = T± + (a + bTt) + 6± + Yt = a + ßT± + E± , 
Here, the measurement X. is the sum of the expected measurement, conditional 
on the individual's true intake, 
E(X|T.) = T. + (a + bT.) = a + ßT. , 
plus a total random error £.. The total random error is itself the sum of 
Y-, the within-subject random error, and of 6., the unpredictable part of 
the individual's bias. The distinction between the total random error 
components Y and 5 is of importance since, when X measurements are repeated 
on the same individuals, the random biases 6. will be reproduced. As a 
consequence, the total random errors £ of the repeat measurements will be 
correlated unless all 6. = 0. The average variance of the total random error 
is given by 
Var(£) = Var(X|T) = o* + o2y = a2£ . 
The coefficient a indicates the average tendency to over- or under-estimate 
intake by a constant amount, and ß indicates the tendency to over- or under-
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estimate intake by an amount which is proportional to the level of the true 
intake. 
"Validity" is commonly defined as the absence of bias, whereas 
"precision" is usually defined to be equivalent to a high reproducibility of 
measurements (2). Thus, if the objective is to measure the intake of 
individuals, validity corresponds in model terms with the absence not only 
of constant and proportional biases (i.e., oc=0, ß=1.0), but also of random 
2 
biases (i.e., o.=0). A high reproducibility then corresponds to a small 
variance of within-subject random errors. It should be kept in mind that the 
2 2 parameters in the estimated measurement model (a, ß, a,, and o ) may not 
only depend on the type of measuring instrument but also on the population 
being investigated, and therefore should not be taken as universal 
parameters specific for the measuring instrument used. 
If the values of the parameters a and ß were known, one could correct the 
X-measurements for "systematic" biases by: 1) substracting an amount a to 
correct for the average additive bias, and 2) subsequent division by ß to 
correct for the average multiplicative bias. The relation between the 
corrected measurements and true intake then becomes: 
Xi* = (^-«J/ß = Ti + £i* ' w h e r e ei* = £ i / ß ' 
This correction can be seen as a scale adjustment, re-expressing the 
X-measurements in the measurement units of the true intake. The coefficients 
a and ß can therefore also be referred to as scaling factors. Also the 
random errors e. undergo rescaling, to yield standardized random errors £. . 
The correlation between the measurements X and true intake T depends on the 
variance of the standardized random errors relative to the variance of the 
9 9 9 
true intake being measured, as : p™ =!/>/( 1 + a /(ß o„) ). 
Estimation of the error parameters 
Suppose one seeks to measure habitual, long-term dietary intake of 
individuals, using a dietary questionnaire, which is related to true intake 
as : 
Q = a Q + ß Q T + £ Q [ 1 ] . 
An evaluation of the accuracy (i.e., validity plus precision) of the 
questionnaire measurements implies that the magnitude of the unknown error 
2 
parameters a-, ß„ and a _ should be estimated. Ideally such estimates would 
be obtained by comparing the individuals' questionnaire assessments with the 
Validation of questionnaire assessments 27 
corresponding true intake values. However, the true intake values will never 
be known, but must rather be seen as values of a latent variable (14). It is 
thus only possible to compare the questionaire assessments with "reference" 
measurements R, which are related to the same latent variable but which may 
also contain some error : 
R = Og + ßR T + £R [2]. 
Throughout this paper, we shall assume that the latent, true intake variable 
2 
T has a normal distribution, with mean uT and variance o™, and that also all 
random measurement errors (e) are normally distributed (with mean 0 and 
2 
variance o„, as defined earlier in the section on the measurement error 
£ 
model). It follows that also the observed measurements Q and R will have a 
normal distribution. Since the expected measurements E(Q|T) and E(R|T) are 
both assumed be linearly related to the same latent variable T, under the 
assumption of joint multi-variate normality of the R,Q,T distribution there 
must also be a linear relation between the two types of expected 
measurement: 
E(Q|T) = cc£ + ß£ E(R|T) [3], 
where oci = a_ - ß-o^/ßj. , and ßi. = ßn/ßR- For the remainder of this paper it 
will be assumed that reference measurements can be found without any 
constant or proportional bias (i.e., ou=0, and ß_=1.0), so that a» = a_, and 
The combination of equations [1], [2] and [3] describes the so called 
"structural" relation (15,16) that one theoretically expects to observe 
between the measurements of Q and R. The equations are therefore said to 
define a structural equations model. In the following sections we shall 
discuss the possibility of estimating the unknown parameter values in the 
structural equations model, depending on the number and type of additional 
measurements available. The parameter estimates can in principle be computed 
by finding optimal correspondence between the theoretical, multivariate 
normal distribution of Q,R,X as predicted by the structural equations model 
(where X stands for any additional measurement involved in the comparison) 
and the distribution of measurements actually observed. Given our assumption 
that true and measured intake values are normally distributed, the 
theoretical and observed multivariate distributions are fully characterized 
by their first and second moments, that is, by their (theoretical or 
observed) means, variances and covariances. The parameter values can thus be 
estimated by fitting the theoretical moments predicted by the structural 
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equations model to the observed moments estimated from actual measurements 
in a population sample (14-16). Version 6 of the SÂS package for statistical 
analysis (17) provides a programme for the analysis of structural equations 
models, the "CALIS" procedure, to obtain maximum likelihood estimates of the 
parameter values and their confidence intervals. In the Appendix, CALIS 
programmes are given that were used for the computations of the numerical 
examples 2 and 3 in this text. In this paper we shall focus on situations 
where, with additional assumptions, the number of error parameters to be 
estimated is equal to the number of sample moments. For these situations, 
explicit forms of the maximum likelihood estimators can be obtained, by 
simply equating the sample means, variances and covariances to their values 
predicted by the model. These estimators have been more extensively 
discussed by Barnett (18), by Jaech (19), and by Dunn (20). 
Method 1. Comparison with a single reference measurement 
The simplest possible comparison is that between the questionnaire 
assessment and a single reference measurement. As an example of a reference 
measurement - often used in dietary validity studies - one may think of a 
mean intake estimate calculated from a series of weighed food records. We 
shall assume that random errors of the questionnaire assessments and of the 
reference measurements are uncorrelated. Given this assumption, and given 
the structural equations model defined by equations [l]-[3], the pairs of R-
and Q-measurements can be considered as a sample of observations from a bi-
variate normal distribution, of which the means, variances and covariance 
can be expressed in the various error parameters of interest (see Table 
l.A). As the minimal set of sufficient statistics we have the sample moments 
of the observed R,Q-distribution. Equating the sample moments to the 
predicted moments of the theoretical, bivariate normal distribution yields 
five estimating equations, which however are expressed in six unknown 
parameters : 
(4.a) uT = R 
"2 2 2 
(4.b) oT = SR - o£R 
(4-C> Pq = SQ,R ' <SR - <4> 
(4.d) ;Q = Q - S [ S Q R / (SR - o2£R) ] 
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(*'e) °sQ = SQ - SQ,R 1SQ,R I (SR " «4>1 
2 2 Here, R, Q , S„ and S« represent the observed sample means and variances 
of the R- and Q-measurements, respectively, while S-
 D is their sample 
covariance. 
Only u_ can be uniquely determined from these estimating equations, as 
the mean of the reference measurements (equation 4.a). By contrast, the 
2 2 
estimates of o™ , oc0 , ßn , and o _ (equations 4.b-4.e) depend on the value 
of o„, , and can thus only be determined if this value is known. However, 
the variance of the reference measurement, o „, cannot be estimated from the 
equations 4.a-4.e unless the value of at least one of the parameters o_ , 
2 
oc0 , ß 0 , and o _ can be assumed to be known a priori. Since there are more 
unknown parameters than estimating equations, more than one set of parameter 
estimates can be found for which the predicted moments are equal to the 
sample moments actually observed. Thus, all model parameters cannot be 
estimated with the given study design, unless additional (external) 
information is available on the value of at least one parameter. The model 
is then unidentifiable. Some traditional approaches ignore this 
identifiability problem, by assuming that the R-measurements equal the 
2 2 
individuals' true intake values, that is, o _ = 0. Substituting 0 for a _ in 
equations 4.b-4.e, the usual formulas for linear regression analysis follow. 
2 
For instance ß_ would be estimated as S0 R/S R, which is the slope of Q 
regressed on R. The estimates of oc0 and o _ are in this case equal to the 
intercept of the regression line, and the variance of the residual errors of 
the regression analysis. 
Example 1 
In a Swedish dietary validity study (21), the usual daily intake of vitamin 
C was assessed by a dietary questionnaire in a population sample of 107 
subjects (men and women combined). The questionnaire assessments were 
compared with reference measurements, based on the average of two three-day 
weighed food records. Table 1 shows the estimated sample moments for the Q-, 
and R-measurements (which had been transformed to improve normality of their 
distributions (22,23)). The second part of Table 1 shows the error parameter 
estimates obtained from the equations 4.a-4.e, assuming that the reference 
measurements had a (close to) perfect correlation with true intake values 
2 (i.e., assuming that o _ = 0). 
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Table 1. Predicted and observed moments, and error parameter estimates for 
Q-, and R-measurements of vitamin C intake. 
Predicted Moments 
Covariance Matrix Means 
R 
Q 
2 2 
' o 
2 
°T + °£R 
ßQ oT 
a2 2 _,_ 2 
ßQ °T + °£Q aQ + ßQ UT 
Observed Moments 
Covariance Matrix Means 
R 
Q 
Sg =2.00 
SQ,R » X-42 SQ = 3.32 
R = 6.29 
Q = 9.68 
Measurements were transformed to improve normality, using "Box-Cox" (23) 
power transformations (i.e., using X = (X -1)/A, where A_=0.3, and 
XR=0.2) 
Parameter Estimates 
UT = 6.29 (6.02,6.56) o£ = 2.00 (0.81,2.11) 
°£R = ° 
aQ - 5.20 (3.88,6.52) ß = 0.71 (0.51,0.91) ô2^ = 2.31(1.69,2.93) 
(between parentheses are 95 percent confidence intervals) 
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The estimated scaling factors for the questionnaire indicated the 
presence of a constant bias (a„ = 5.20), as well as some proportional bias 
(ß. = 0.71). The estimated correlation between questionnaire assessments and 
the "latent" true intake could be computed as pQT = 1 / 7(1 + oQ/(ß0 o_)) = 
1 / 7(1 + 2.31/(0.71 2.00) = 0.55 . Note, however, that in this particular 
case the correlation could also have been estimated directly as that between 
2 
the Q and the R-measurements, p0R, since it was assumed that a _ = 0. 
The assumption of a perfect correlation between the reference 
measurements and the underlying true intake is rather a strong one, and the 
2 
validity of this assumption may be quite doubtful. If in reality o,_ * 0, 
CK 
the failure to take account of random error in the R-measurements had biased 
our estimates of each of the error parameters. For instance, the estimate of 
2 2 2 ßQ was then biased by a factor o_,/(oT+o R ) , which is known as the 
"attenuation" bias (6,9). Likewise, <xn and on were then over-estimated. 
Therefore, rather than relying on assumptions about the magnitude of the 
2 
variance o _, further analyses were performed in order to try to estimate 
this error variance from additional information. 
Method 2. Comparison with repeat reference measurements. 
In dietary validity studies it has become common practice to use as a 
reference measurement an average intake estimate computed from a series of 
repeat recordings of daily intake (i.e., repeated weighed food records or 
2 
24-hour recalls). Therefore, rather than simply assuming that o _ = 0, one 
might also try to solve the identifiability problem by considering repeat 
daily recordings as separate measurements. In the validity study on vitamin 
C intake, for instance, the reference measurement could be considered as an 
average of two measurements, R, and R2, each based on a three-day food 
record. Predicted moments of the Q,Rj,R2 distribution are given in Table 
2. A, still assuming that for both R-measurements random errors are 
independent of those of Q. By equating these to the observed sample moments, 
six equations expressed in seven unknown parameters are obtained: 
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(5.a) uT = % (Rl+R2) 
<5.b) oT = S ^ ^ - o6R 
(5.C) pQ - 1b(SQfRi+ SQ>Ri) / (S R i i R 2-<4) 
(5.d) ;Q = Q - [ *(SQfRi+ SQ>Ri) / (S R i > R r 4 ) ] %(R1+R2) 
(5.e) ;2£Q = S2 - [ *(SQfRi+ S Q R 2) ] 2 / (S R I J R 2 - o2R) 
( 5 . f ) Ô2£R = M S 2 i + s R 2 ) - s R i > R 2 + o 2 R 
Rather than by assuming that the reference measurements do not have any 
2 
random error at all (i.e., o _ =0), one may now estimate all error 
parameters on the more relaxed assumption that the random errors of repeat 
2 
reference measurements are independent (i.e., Oj.D = 0). Given this 
2 2 2 2 
additional assumption, we can write : o „ = o-R + o _ = o R. The total 
random error variance o
 R can thus be estimated from the repeat measurements 
R. and R,, as the variance of the within-subject random error (equation 
2 "2 5.f). The coefficient ß 0 can now be determined as ß_ = S0 H/(S0 - o R ) . This 
is identical to the slope of Q regressed on R, with correction for the 
2 2 2 
attenuation bias, S„/(SR-o R ) , due to within-subject random error. Estimates 
of <xn and o _ are then identical to the intercept and to the variance of 
residual errors of this corrected regression line. 
One could argue that, in spite of the different nature of the Q- and the 
Rj-measurements, their random errors might not be entirely independent if 
both measurements are taken very close in time. Freedman et al refined the 
estimation procedure with repeat reference measurements described above, to 
take into account a possible covariance between the random errors of the Q-
and R,-measurements (10). The errors of R2- and Q-measurements were still 
assumed to be independent, however, as these measurements were taken at a 
greater distance in time. The predicted moments are given in Table 2.B. 
Equating these to the observed sample moments yields the following 
estimating equations: 
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Table 2.A. Predicted and observed moments, and error parameter estimates, 
for Q-, and R-measurements (R,, and R2) of vitamin C intake. 
Predicted Moments 
Covariance Matrix Means 
2 2 
°T + °£R 
2 ßQ oT 
°T + °£R 
ßQ oT 
a2 2 2 
ßQ °T + °£Q otQ+ßQUT 
Observed Moments 
Covariance Matrix 
» 1 
s2 
R, ,R2 
SQ,R, 
= 2.53 
= 1.47 
= 1.36 
R2 
S2 
SQ,R2 
2.55 
1.50 SQ = 3.32 
Means 
R! = 6.15 
R2 = 6.25 
Q = 9.68 
Measurements were transformed to improve normality, using "Box-Cox" (23) 
power transformations (i.e., using X = (X -1)A, where X_ = 0.3, 
and X_ = X, 0.2). 
Parameter Estimates 
UT = 6.20 (5.93,6.46) 
°ER = 1*07 (O-79-1-37) 
âQ = 3.64 (1.70,5.58) 
Ô2 = 1.47 (0.91,2.03) 
ßQ = 0.97 (0.66,1.28) Ô2Q 1.93 (1.26,2.60) 
(between parentheses are 95 percent confidence intervals) 
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(6.a) pT = % (R,+R2) 
(6.b) 4 = S ^ ^ - o*R 
<6'c> P Q = S Q , R 2 7 (SR1>R2-°6R) 
(6.d) ; Q = Q - [ SQ>R2 / (SRi>R2-o2R) ] %(R1+R2) 
<6-e) ;2£Q = S Q - I SQ,R2 ? ' Ih^R, - 'Il 
<6-f> 4-^4, + SR2> - S R l f R 2 + 0 M 
<6-S) °£R1)£Q = SQ,Rl - SQ,R2 
Again, these equations can be solved under the additional assumption that 
2 
36R= the random errors of repeat reference measurements are uncorrelated (o._=0). 
Example 2 
The sample moments of the observed Q,Rj,R2 distribution in the vitamin C 
data are given in Table 2.A. The second part of Table 2.A shows the 
estimates for each of the error parameter estimates, according to first 
model where o _. _ was assumed to be equal to 0. Comparison of these 
estimates with those of example 1 shows that in the first analysis 
parameters were biased by attenuation, due to within-subject random error in 
the reference measurements. Correction for such bias in this second analysis 
resulted in lower estimates of the constant scaling bias (e.g., ocn = 3.64) 
2 
and of the random error variance (o _ = 1.93). Proportional scaling bias no 
longer appeared to be present (ßQ = 0.98). The correlation between the 
questionnaire measurements and the latent variable was estimated to be equal 
to p Q T = 1 / -/(l + 1.92/(0.972 1.47) ) = 0.65. 
Parameter estimates according to the model of Freedman et al are given in 
Table 2.B. The covariance between the random errors of R, and Q appeared to 
be very small, and was even slightly negative (°£R1 £n = " 0.13). 
Consequently, estimated parameter values were almost identical to those in 
Table 2.A. 
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Table 2.B. Predicted moments , and error parameter estimates for Q-, and 
R-measurements (R,, and R2) of vitamin C intake, following 
Freedman's model. 
Predicted Moments 
Covariance 
»i 
2 2 
2 . 2 , 
°T {+ "6R) 
2 
ßQ °T + °£R1 ,£Q 
Matrix 
R2 
2 2 
°T + °£R2 
ßQ oT 
Q 
Q2 2 2 
ßQ °T + °£Q 
Means 
<xQ + ß Q p T 
Parameter Estimates 
UT = 6.20 (5.93,6.46) 
'2 
o£ = 1.47 (0.91,2.02) 
o£R = 1.08 (0.79,1.37) o£R £Q = -0.13 (-0.55,0.29) 
a = 3.35 (1.15,5.55) ßQ = 1.02 (0.66,1.37) o£Q = 1.79 (0.95,2.63) 
(between parentheses are 95 percent confidence intervals) 
Observed moments were the same as in Table 2.A. 
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2 
The assumption that o,R = 0 means that the full set of error parameters 
can be estimated without bias, but only if the reference measurement is 
repeated at least once. This is a more relaxed assumption than that in 
2 
Example 1, where it was necessary to assume that o
 R=0; that is, the 
correlation between measured and true intake values was assumed to be 
perfect even for a single R-measurement. However, there may also be doubts 
about the validity of this more relaxed assumption. If in reality o._ * 0, 
all parameter estimates except that of u-, would be biased. For instance, ß_ 
is estimated as %(SQ _, + S_ R2)/sRi R2 (equation 5.c). Filling in the 
predicted moments from Table 2. A, it can be easily seen that the expected 
2 2 2 
value of this ßn-estimate would be equal to ß_o_,/(o_+oclJ), where the factor 
2 2 2 i f i i o K 
oT/(o_,+OoH) expresses a residual attenuation bias. 
Method 3. Comparison with a reference measurement plus a third type of 
measurement 
Barnett (18) showed that the problem of identifiability of error parameters 
can also be solved by comparing the questionnaire assessments with at least 
two different types of measurement. Instead of taking duplicate reference 
measurements by a similar method, for instance based on weighed food records 
or 24-hour recalls, one may also obtain a third measurement using a very 
different method such as a biochemical marker (M). The assumption that the 
random errors c are independent for each pair of measurements is then more 
likely to be valid. Predicted moments of the Q,R,M -distribution are given 
in Table 3. Equating these to the observed sample moments yields nine 
estimating equations, expressed in an equal number of unknown parameters. 
The parameters can therefore all be estimated without additional 
assumptions: 
(7.a) ÛT = R 
(7.b) <4 = (S Q R S M R) / S Q M 
( 7 . c ) <xQ = Q - ( S Q M R) / S M R 
( 7 . d ) ^ = M - ( S Q ) M 6 ) / S Q R 
( 7 . e ) ßQ • S Q f „ / S M j R 
< 7 - f > K = S Q , M / S R , Q 
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(7.g) oJR - sj - ( S Q R S„fR) / S Q M 
(7.h) ;2£Q - sj - ( SQfM S Q R ) / S M R 
(7.1) < 4 - sj - ( S M R SQf„ ) / S Q R 
It is worth noting that we can now estimate the variance of the total 
2 
random error of the R-measurements, o _, which includes the variance of 
random biases o._. This underlines that it is not essential that the 
reference measurements provide a fully accurate estimate of the individuals' 
2 
ranking by true intake level. Even when the total random error variance o _ 
is relatively large, all error parameters are expected to be estimated 
without bias. It should be kept in mind, however, that the estimates will 
then also have relatively wide confidence intervals unless the dietary 
validity study is based on a very large number of individuals. 
The biomarker assessment, M, can be seen as merely an "instrumental" 
variable (15,16), which makes it possible to estimate the "true" regression 
of the Q- on the R-measurements with adjustment for all attenuation bias due 
to the total random error in the reference measurements. In other words, the 
biomarker assessment allows to estimate the relation between the 
Q-assessments and the latent variable, expressed in the measurement units of 
R. It should be noted that it is not necessary to know the quantitative, 
functional relation between the M-measurements and true intake T. In fact, 
any third H can be used as an instrumental variable as long as it has a 
linear relationship with the underlying latent variable, and random errors 
that are independent of those of R and Q. For many biomarkers of dietary 
intake, such as the blood concentration of a particular vitamin, or the 
fatty acid composition of a tissue biopsy, the quantitative relation to 
absolute intakes is quite unclear. Still, such markers can provide ideal 
instrumental measurements since they can have good correlations with true 
intake levels (24-26). Theoretically, one could even envisage the use of 
body mass index or total energy expenditure as potential instrumental 
measurements if their relation with the underlying true intake factor is 
strong enough. However, one would expect a low correlation between the 
instrumental measurement and the latent variable to result in relatively 
large confidence intervals, even though parameter estimates would still be 
expected to be unbiased. 
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Table 3. Predicted and observed moments, and error parameter estimates for 
Q-, R-, and M-measurements of vitamin C intake. 
Predicted Moments 
R 
Q 
M 
R 
Q 
M 
R 
2 
o_ + o 
ßQ oT 
l*M ° T 
R 
s2 
bR 
SQ,R 
SM,R 
Covariance Matrix 
Q M 
2 
£R 
02 2 2 
ßQ °T + °£Q 
ß Q ßM ° T ßM ° T + ° £ M 
Observed Moments 
Covariance Matrix 
Q M 
= 2.00 
= 1.42 S2 = 3.32 
= 5.63 S_ „ = 5.48 S2 = 39.87 Q,M M 
Means 
PT 
aQ + VT 
"M + ßMUT 
Means 
R = 6.29 
Q = 9.68 
M = 17.70 
All measurements were transformed to improve normality, using "Box-Cox" 
(23) power transformations (i.e., using X = (X -1)/X, where XQ=0.3, 
XR=0.2, and XM=0.7). 
Parameter Estimates 
UT = 6.29 (6.02,6.56) o2, = 1.46 (0.81,2.11) 
°£R = °'54 (°-12>0-96) 
aQ = 3.57 (1.44,5.68) 
ctjj = -6.57 (-14.49,1.35) 
ßQ = 0.97 (0.63,1.31) o^Q = 1.92 (1.30,2.58) 
ßM = 3.86 (2.61,5.11) ô2 = 18.2 (10.5,25.8) KM £M 
(between parentheses are 95 percent confidence intervals) 
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Example 3 
In the validity study on vitamin C intake, a third estimate of the validity 
of the questionnaire assessment of vitamin C intake was obtained by 
comparison with the overall average of R-measurements, and a biochemical 
marker, M, which was an average of six different measurements of vitamin C 
concentration in blood serum. The moments of the observed Q,R,M distribution 
and estimates of the error parameters are given in Table 3. 
Interestingly, the estimates from the third analysis were virtually 
identical to those in Tables 2. A and 2.B, indicating that in fact there was 
already no residual attenuation bias left using method 2. In this final 
analysis, the total random error variance for a reference measurement based 
2 
on a six-day food record was estimated to be equal to o _ = 0.54. This is 
exactly half of the variance of the within-subject random error for a 
2 
three-day record, estimated in the previous analysis (o
 R = 1.08; see Table 
2.A). We therefore concluded that indeed a„,=0. This particular data example 
thus seems to confirm the common assumption that day-to-day variations in 
the individuals' true intake are virtually the only source of random error, 
when repeat weighed records are used for the assessment of usual, long-term 
intake. 
Precision of the parameter estimates 
Although parameter estimates were almost identical in Tables 2.A and 3 
2 
(since apparently oSn=u)> and in spite of the fact that in Example 3 the 
overall information per subject had been increased by adding the M-
measurements, confidence intervals were larger for the estimates obtained by 
method 3. This can be explained by the fact that using method 3 a larger 
number of parameters has to be estimated. 
According to the estimates of Table 3, the correlation between M and T 
equalled 1/7(1+18.2/(3.86 *1.46) = 0.74. The question arose whether, if this 
correlation had been even stronger, method 3 could have given more efficient 
estimates than method 2. This was investigated by a simple simulation, 
modifying the value of the sample variance of M-measurements into 22.73 
instead of the value of 39.87 that was truly observed. This modification 
left all parameter estimates of Table 3 unaffected, except that o „ was now 
estimated to be equal to zero, indicating a perfect correlation between M 
and T. In addition, confidence intervals of various parameter estimates had 
become narrower, and were also slightly narrower than for the estimates 
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obtained by method 2. For instance, ßn was estimated to be equal to 
0.97+0.25, against 0.97±0.31 in Table 2. 
In all examples shown, the confidence intervals were rather large, 
indicating that validation studies should be based on a larger number of 
observations. For the parameter estimates obtained from equations 7.a-7.i, 
closed form formulas for the estimation of confidence intervals have been 
given by Barnett (18). Such formulas indicate how random errors in each of 
the measurements affect the precision of the parameter estimates, and may 
thus be helpful in determining sample size requirements for dietary validity 
studies, in terms of the total number of individuals to be included, or of 
numbers of repeat assessments to be taken on each individual. Discussion of 
such design options is, however, beyond the scope of this paper. 
Discussion 
We have discussed the estimation of the magnitude of measurement error in 
assessments of the habitual dietary intake of individuals in terms of 
structural equation models, which belong to the more general class of latent 
variable models (14,20). We have shown that, to estimate accurately the 
scale of error in dietary questionnaire assessments, these must be compared 
with at least two additional measurements. The first - which we constantly 
refer to as the "reference" measurement - is by definition unbiased at a 
group level, conditional on the true intake value (i.e., OCT.=0 and ß_=1.0). 
The second additional measurement should at least provide another 
independent estimate of the individuals' ranking by intake level, and can 
either be based on a repeated reference measurement (assuming that the 
errors of repeat reference measurements are uncorrelated) or on a third 
method such as a biochemical marker. 
A major requirement for validity studies is that a comparison be made 
between measurements that do not tend to have similar errors for the same 
individuals (i.e., the errors are independent). Any correlation between 
these measurements will then be due only to the fact that they relate to the 
same latent variable. If errors cannot be assumed to be independent, it will 
no longer be clear whether a correlation between measurements exists because 
they each really measure the same thing, or merely because the errors are 
correlated. Mathematically, this will be expressed as a problem of 
identifiability: if it is suspected that errors are correlated, the 
Validation of questionnaire assessments 41 
structural equations model should also incorporate parameters for the 
covariances between errors. As a consequence, there will then be more 
parameters to be estimated than there are sample moments. Even if it is 
possible to test for the independence of the errors of some measurements, 
such a test will always have to rely on the assumption of independent errors 
for other measurements that were taken for the same individuals. For 
instance, parameters in the model of Freedman et al. would become 
unidentifiable if one does not assume that the errors of the Q-measurements 
are independent of those of at least one of the two R-measurements. A 
validity study must therefore always rely on the assumption that, for at 
least a certain number of measurements, errors are uncorrelated. The 
decision on which methods can be considered different enough to have 
independent errors will depend on the researcher's understanding of the 
nature of each method used, and their potential sources of error. In this 
paper we assumed that there may be three main categories of methods for 
which random errors will be independent, namely: 1) dietary questionnaires 
to obtain an immediate estimate of usual food consumption, 2) methods based 
on the recording of actual food consumption on one or more randomly selected 
days, and 3) biochemical markers of dietary intake. 
The procedures discussed in this paper to estimate error parameters and 
their confidence intervals are valid on the assumption that the 
distributions of true, as well as measured, intake are normal, and that 
associations between different measurements are linear. In practice, 
distributions of dietary intake measurements are often positively skewed, 
approaching log-normality (23,27). Scatterplots often show a widening 
pattern with increasing values of intake measurements, suggesting that such 
log-normality may be due to a larger variance of random error in the larger 
values of each type of measurement. We used "Box-Cox" power transformations 
to correct for the positive skewness of dietary intake measurements (22,23). 
It is believed that, while the overall distributions of measurements will be 
normalized as a result of such transformations, at the same time the random 
errors will become more homoscedastic. It may remain unclear however, how 
transformations separately influence the distributions of the latent 
variable and of the random errors, and how they might affect the assumption 
of linearity of relations between different types of measurement. Since 
random error is generally a predominant source of variation, scatterplots 
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can provide only limited information about the shape of the structural 
relation between measurements. 
The various parameter estimates given in this paper can be useful during 
the planning phase of epidemiological studies on diet in relation to 
disease. Validity studies will allow the evaluation and selection of an 
optimal dietary questionnaire for the assessment of dietary exposures of 
interest, before it is applied in a large-scale study. The questionnaire's 
capacity to rank individuals by true intake level is described by the ratio 
2 2 
o
 0/o_, while estimates of ou and ßn will indicate whether the questionnaire 
measurements contain constant or proportional scaling bias. In addition, 
2 
knowledge of the variance of the true intake distribution, o_, may be an 
essential element in the determination of sample size requirements for 
cohort studies (28). 
At the stage of analysis of the epidemiological study results, the 
estimated error model parameters could in principle also be used to adjust 
point and interval estimates of relative risk for biases due to error in 
dietary questionnaire assessments of exposure (29,30). A correction factor 
2 2 2 (o„+o
 0)/oT would be needed to adjust a logistic regression coefficient for 
attenuation bias, while a multiplication by ßn would adjust for over- or 
under-estimation of relative risk due to the proportional scaling bias in 
the questionnaire measurements. However, in order to make these adjustments 
2 2 it is not really necessary to first obtain estimates of ß_, o _, and o» 
separately. Rosner et al (30) have described how the overall correction 
2 2 2 factor ß0(o_+o 0)/o_ can also be estimated as the reciprocal of the slope of 
a linear regression of a single reference measurement R on the dietary 
exposure assessments (assuming that E(R|T) = T). A validity study, based on 
more than one additional intake measurement, is not needed therefore for the 
sole purpose of adjusting relative risk estimates. In fact, it is then the 
measurement of disease status which plays the role of a third measurement 
related to the latent intake variable. 
We conclude that, even in the absence of truly valid reference 
measurements, it is possible to evaluate the validity of dietary intake 
assessments using latent variable models. However, for sufficient precision, 
validity studies should be based on larger numbers of observations than has 
been usually the case, while the robustness of the estimation procedures 
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relying on assumptions of normality may also need further evaluation. 
APPENDIX; SAS Calis programs used. 
/* Data input from Table 1 
data vite(type = 
input 
cards; 
n . 107 
mean . 6 
cov Rl 2 
cov R2 1 
cov Q 1. 
type $ 
107 107 
.15 6.25 
.53 . . 
.47 2.55 
36 1.50 : 
cov); 
name $ 
9.68 
. 
!.32 ; 
..a 
Rl 
*/ 
R2 Q; 
/* Computations for Table 2.a */ 
proc calis ucov aug stderr data = cite; 
lineqs Rl = meanR intercep + fT + eRl, 
R2 = meanR intercep + fT + eR2, 
Q = meanR intercep + betaQ fT + eQ; 
parameters alphaQ; 
meanQ = alphaQ + betaQ*meanR; 
std eRl = veR, 
eR2 = veR, 
eQ = veQ, 
fT = vT; 
run; 
/* Computations for Table 2.b */ 
proc calis ucov aug stderr data = cite; 
lineqs Rl = meanR intercep + fT + eRl, 
R2 = meanR intercep + fT + eR2, 
Q = meanR intercep + betaQ fT + eQ; 
parameters alphaQ; 
meanQ = alphaQ + betaQ*meanR; 
std eRl = veRl, 
eR2 = veR2, 
eQ = veQ, 
fT = vT; 
cov eRl eQ = cov:; 
run; 
/* Data input from Table 3 */ 
data vitc(type = cov); 
input _type_ $ _name_ $ R Q M; 
cards; 
n . 107 107 107 
mean . 6.29 9.68 17.70 
cov Rl 2.00 . . 
cov R2 1.42 3.32 . 
cov Q 5.63 5.48 39.87 
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/* Computations for Table 3 */ 
proc calis ucov aug stderr data = cite; 
lineqs R = meanR intercep + fT + eR, 
Q = meanQ intercep + betaQ fT + eQ, 
M = meanM intercep + betaM fT + eM; 
parameters alphaQ alphaM; 
meanQ = alphaQ + betaQ*meanR; 
meanM = alphaM + betaM*meanR; 
std eR = veR, 
eQ = veQ, 
eM = veM, 
fT = vT; 
run; 
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Chapter 3 
"Validation" and "calibration" of dietary intake assessments 
in prospective cohort studies. 
This chapter has been submitted for publication, by the authors R. Kaaks, E. Riboli, and 
W.A. van Staveren. 
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Abstract 
To evaluate the accuracy of dietary intake measurements in prospective 
cohort studies on diet, it has been proposed that sub-studies be conducted 
in order to: 1) correct relative risk estimates for biases due measurement 
error, and 2) account for statistical power losses when estimating the 
sample size requirements of the cohort. Usually, the sub-study takes the 
form of a "validity" study, based on a small group of volunteers, using 
multiple days of food intake records per subject as reference measurements. 
In this paper it is shown that, when relative risks are estimated for 
scaled, absolute intake differences rather than for quantile categories, a 
"calibration" study based on only a single day's food intake record (but on 
a larger number of subjects), can provide sufficient information as a 
reference measurement. A major advantage of calibration studies is that they 
can be conducted more easily on a representative sample of cohort 
participants. In addition, it is shown that, for a given number of daily 
intake records collected, a calibration study is statistically most 
efficient when it includes a maximum number of subjects, with only a single 
intake record each. 
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Introduction 
A major limitation of epidemiologic research on diet in relation to chronic 
diseases such as cancer is the difficulty of obtaining accurate measurements 
of individuals' habitual, long-term intake levels of foods and nutrients. 
Correlations between dietary questionnaire measurements and true, long-term 
intake values are generally estimated to be lower than 0.7 (1,2), which 
implies that at least half of the variation in intake measurements is due to 
random errors. As a result of these relatively low correlations, relative 
risks indicating a relation between dietary intake patterns and the 
occurrence of disease tend to be underestimated, and the probability of 
observing a real, statistically significant relation is reduced (3,4). To 
estimate the magnitude of these effects, it has been recommended that 
epidemiologic investigations, and in particular prospective cohort studies, 
should incorporate sub-studies to evaluate the accuracy of dietary 
questionnaire measurements (5). 
In the past, sub-studies on the accuracy of dietary questionnaire 
measurements have mostly taken the form of validity studies, based on a 
small group of 100 to 200 volunteers, using daily food intake records as 
reference measurements (1,2). Repeated records are taken for each subject to 
improve the precision of the validity study, and to estimate the correlation 
between the questionnaire measurements and the individuals' true habitual 
intake values (with adjustment for attenuation biases due to random errors 
in the reference measurements) (6,7). This correlation coefficient is then 
taken as the main criterion to evaluate, before starting the main 
epidemiologic study, whether a newly developed questionnaire instrument 
measures habitual diet sufficiently accurately or whether sections of it 
should be improved for specific food groups or nutrients. If more than one 
type of questionnaire is tested, a validity study can be used to select the 
version which yields the most accurate measurements (2,3). The estimated 
correlation coefficient is often used also for the subsequent planning and 
analysis of the main cohort study in order to: 
a) account for inaccuracy of dietary intake measurements when estimating 
the statistical power or sample size requirements for the main 
epidemiologic study (3,8); and 
b) adjust for attenuation biases in relative risk estimates, which are 
usually expressed for quantiles (mostly quartiles, or quintiles) of 
the intake distribution (3,4). 
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A problem with dietary validity studies is that keeping dietary intake 
records for many days is a considerable burden. Probably only subjects who 
are particularly interested in diet and who are motivated to respond 
accurately to the questionnaires will agree to take part. It therefore seems 
likely that the correlation between questionnaire measurements and true 
intake values in the validity study is stronger than in the overall study 
population. There is consequently a risk of overestimating the statistical 
power of the main epidemiologic study and underestimating the attenuation 
biases in relative risk estimates. This hypothesis is supported by recent 
results from the New York University Women's Health Study (9) where the 
reproducibility of dietary questionnaire measurements was better among 
participants who later agreed to fill out the questionnaire for a third 
time, than among those who did not (10). 
In the present paper we review the requirements for sub-studies on the 
accuracy of dietary questionnaire measurements, focusing on the use of such 
studies for objectives a) and b) above. It will be shown that, if relative 
risks are estimated for scaled, quantitative differences in intake level 
rather than for quantiles of the population distribution of intake levels, 
both objectives can be met by a calibration study, based on the "linear 
approximation" method described by Rosner et al. (11). The advantage of this 
approach is that such calibration studies require only a single day's intake 
record per subject as a reference measurement, and may therefore be 
conducted more easily on a representative sub-sample of the study 
population. A theoretical example is given to illustrate that a calibration 
sub-study can be conducted ideally during the initial ("pilot") phase of a 
prospective cohort study. 
Effects of dietary measurement errors: bias and statistical power 
Bias: Suppose that within a given study cohort the relation between the 
incidence rate of a given disease (e.g., a specific form of cancer), and the 
habitual intake T of a dietary factor (e.g. a particular nutrient) is given 
by: 
log(disease rate at intake level T) = constant + 6T [1]. 
In this exponential risk model, commonly adopted in the analysis of 
individual-based epidemiologic studies, the slope parameter 9 is the 
logarithm of the relative risk of disease for a unit difference in intake T. 
The slope parameter can be estimated for instance by logistic regression, 
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using a case-control study nested within the cohort (12), or by a Poisson 
type of regression if the analysis is based on the total number of person 
years observed in the cohort (13). We shall assume that the relation between 
questionnaire measurements of the intake level of a given nutrient and the 
individuals' true habitual intake levels is correctly described by a linear 
measurement error model: 
Q=CC Q + P Q T + £ Q [2]. 
In this model, which is discussed in more detail elsewhere (7), the 
coefficients ot_ and ßn represent constant and proportional scaling biases, 
which occur, respectively, if individuals tend to over- or underestimate 
intake by some constant amount, or by an amount proportional to the true 
intake value itself. The term e0 indicates a random error which, at a group 
level, and conditional on the true intake level T being measured, has zero 
2 
mean and variance o
 n- Using questionnaire measurements Q instead of true 
intake values T, the expected log relative risk estimate will be equal to 
E[ê*] = X6 , where X =
 PQT/ßQ [3]. 
This estimate will thus be biased by a factor X, which is the inverse of the 
2 
proportional scaling factor ß0, multiplied by an attenuation factor pn_, 
which is the square of the correlation between measured and true intake 
values. 
Statistical pover: In conjunction with the attenuation of relative risk 
estimates, an imperfect correlation p0_ leads to a loss of statistical power 
for a test of association between the dietary intake factor and disease 
risk. If we assume that the population distribution of the true intake 
2 
values is Normal - with mean n_ and variance o~ - and that the rate of 
disease incidence is low (as is the case for most specific types of cancer), 
the power of a test of the null hypothesis IL.:9=0 is approximately equal to 
that of a t-test on a mean intake difference between cases and controls 
(14,15). Thus, for a case-control study nested within the cohort, in which 
dietary questionnaire measurements of an expected number of D cases are 
compared to those of j times as many controls, the statistical power can be 
derived as 
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power 
eV°T yD . 
I V(j+i)/j 
Za/2 [*]• 
Here Z ._ denotes the 100(l-a/2) centile of the standard normal 
distribution, and $(U) is the probability that a standard normal variate is 
smaller than U (16). Likewise, the number of cases required to reach a 
minimal statistical power 1-ß (where ß here denotes the probability of a 
type II error) can be derived as: 
2 
(j+l)/j 
Zg/2+Zß 
epQT°T 
Note that in a full cohort analysis there will be many more controls than 
cases, so that the factor (j+l)/j approaches 1.0. 
In reality, the size of a newly planned cohort study can be determined 
to a large degree by pragmatic considerations. For example, it may be 
possible to conduct the cohort study within an existing programme originally 
designed for a different purpose, such as breast cancer screening or blood 
donation (17), but which provides an economical infrastructure for data 
collection and follow-up. In this type of situation, where the expected 
number of cases is determined beforehand by the given cohort size and the 
planned duration of follow-up, equation 4 can be used to evaluate whether 
the power to detect a diet-disease association will be high enough to make 
the study worthwhile. Alternatively, there may be situations where the size 
of the cohort can be extended to increase the study power. Equation 5 can 
then be used to calculate the number of cases required to reach a minimum 
study power. In either case, we must specify a realistic value for the 
product 9p_TaT, which is composed of three unknown parameters: 9, the 
logarithm of the relative risk for one unit difference in intake level; o-, 
the standard deviation of the true intake distribution; and p0T, the 
correlation between questionnaire measurements and true intake levels. This 
product measures the strength of the association between disease risk and 
the questionnaire measurements of intake, as is illustrated by the fact that 
it relates to an expected odds ratio of disease between given quantiles of 
the measured intake distribution (see appendix in Kaaks et al. (18)). 
Given our primary interest in obtaining an unbiased estimate of the log 
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relative risk 8, a natural approach to specifying the product 6pQToT is to 
define first a minimum value for the log relative risk, 8_, that would be 
considered of etiologic or public health relevance. This 8_-value can be 
defined, for instance, for a given absolute intake difference that is known 
to exist between subgroups of a given population (15). Alternatively, the 
8_-value may be based on an a priori estimate, obtained for instance from 
international correlation studies, as has been illustrated for studies on 
fat intake in relation to cancers of the colon or breast (15,19). Having 
defined the 9_-value, we need an estimate of the magnitude of the remaining 
product PnT°T- This smaller product represents the amount of between-person 
variation in true intake levels that is accurately distinguished - or 
2 
"predicted" - by the dietary questionnaire measurements; that is, (POT°T) 
Var(E[T|Q]). 
In the following paragraphs we shall discuss how to estimate not only the 
2 
bias factor X but also the predicted intake variance (p0_o_) using the 
information from additional, unbiased reference measurements, obtained in a 
sub-sample of cohort participants. 
CALIBRATION STUDIES; estimating the bias factor, and the predicted 
variation in true intake level 
Intuitively it can be easily seen that the bias factor X in equation 3 
should be similar to the slope of true intake values T regressed on the 
questionnaire measurements Q. This led Rosner et al. (11) to describe the 
following method, known as "linear approximation", to adjust for this bias 
in log relative risk estimates. In a representative sub-sample of cohort 
participants, additional "reference" measurements are taken which, at a 
group level, can be assumed to be free of scaling bias (i.e., a_=0, and 
ß_=1.0), and whose errors can be assumed to be independent of those of the 
baseline questionnaire measurements. The linear approximation method then 
consists of: 1) estimation of a crude log relative risk estimate 8 , for 
instance by logistic regression; 2) estimation of the bias factor X as the 
slope of a normal linear regression of reference measurements R on 
questionnaire measurements Q; and 3) estimation of a corrected log relative 
risk estimate as 9=6 /A. This approach can also be seen as a linear 
rescaling of the questionnaire measurements by a factor X (that is, using 
transformed measurements Q'=XQ), so that an unbiased estimate of the log 
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relative risk is obtained by regression of disease status (as a binary 
outcome variable) on the rescaled measurements. We shall therefore refer to 
this approach as a "calibration" procedure, and the bias factor X as a 
"calibration factor". 
The variance of the "calibrated" questionnaire measurements will be equal 
2 2 
to Var(Q') = X Var(Q) = (p0_oT) (Appendix A), and thus provides an estimate 
of the amount of between-subject variation in true intake level that is 
predicted by the baseline questionnaire measurements (i.e., Var(Q') is an 
estimate of Var(E[T|Q]) ). On the basis of this predicted variation, an 
estimate can be obtained of the log relative risk e, and the null hypothesis 
of "no diet-disease association" (Hn:9=0) can be tested. Thus, if the 
calibration study is conducted early in the recruitment phase of a 
prospective cohort study (e.g., as part of an overall feasibility study), 
the estimate of the predicted intake variance can be used to calculate the 
sample size requirements of the cohort. 
The reference measurements may be obtained for instance by means of 
weighed food records, or 24-hour recalls. It is important to note that 
random errors in the reference measurements (£„) are not expected to cause 
bias in the X-estimate (attenuation bias depends only on random error in the 
predictor variable, that is, in the questionnaire measurements). Reference 
measurements can therefore be based on only a single day's intake record per 
subject, even though this may be relatively unreliable as a measurement of 
an individual's long-term, habitual intake level. For the calibration to be 
precise, however, a sufficient total number of daily intake records should 
be obtained in the entire sub-study, either by increasing the number of 
study participants, or by taking repeat records for each participant. In 
dietary validity studies it is common practice to obtain multiple daily 
intake records per individual. For a calibration study conducted on a sub-
sample of participants in a cohort study, however, it can be shown that, for 
a given total number of intake records collected, estimates of X and of the 
predicted variance Var(E[T|Q]) will be most precise when the calibration 
study is based on a maximum number of individuals, with only a single intake 
record each (Appendix B). For example, instead of collecting 14 days of 
weighed food records from 100 subjects, a calibration study will be 
statistically more efficient if it includes 1400 subjects with only a single 
record each. 
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VALIDITY STUDIES: estimating the correlation between questionnaire 
measurements and true intake values 
Although a single reference measurement per individual (e.g., based on a 
single food record, or a single 24-hour recall) can provide sufficient 
information to estimate the calibration factor X as well as the predicted 
intake variance Var(E[T|Q]), this information will not be sufficient for 
2 2 
separate estimation of the parameters pn_, ß_, and o_. It will thus be 
impossible to determine whether bias in relative risk estimates is mainly 
the result of random dietary measurement errors (i.e., a low correlation 
Pn_), or of proportional scaling bias as well. Likewise, it will not be 
possible to evaluate whether a small predicted intake variance is mainly the 
result of a low correlation between questionnaire measurements and true 
intake values, or whether it reflects a small between-subject variation in 
true intake level. In other words, the loss of statistical power due to 
random measurement error cannot be estimated. 
2 
Studies that do allow a separate estimation of the parameters pnT, ßn, 
and o™ can be referred to as "validity" studies, as they permit a 
distinction between variation in the questionnaire measurements that 
reflects true intake differences, and variation which is due to random 
errors. As discussed in detail elsewhere (7), a major requirement for 
validity studies is that the questionnaire measurements must be compared 
with a minimum of two additional intake measurements, at least one of which 
should be a reference measurement (R) without scaling bias (i.e., R=T+e_), 
whereas the other can be either a repeat reference measurement (R?), or a 
biochemical marker of intake. It is also vital that all three measurements 
have mutually independent random errors. In the past, dietary validity 
studies have most often been based on a comparison with k repeat reference 
measurements, R. (i=l, ,k), each obtained by means of a weighed food 
record or a 24-hour diet recall. Then, assuming a zero covariance between 
the errors of repeat reference measurements, we can obtain the following 
estimates: 
oT
2
 = Cov(Ri,Rj) [6.a], 
p Q T = Cov(Q,R)/Vr[Var(Q)Cov(Ri,Rj)] [6.b], 
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ßQ = Cov(Q,R)/Cov(R.,Rj) [6.c], 
k 
where R = ER. is the average of the k repeat reference measurements of 
i=l 1 
each given individual, and Cov(R.,R.) is the mean covariance between 
repeat reference measurements. 
2 
The estimate of the true intake variance o~ (equation 6.a) is equivalent to 
the estimated between-subject variance of reference measurements as usually 
obtained in an analysis of variance using individuals as a grouping factor. 
Likewise, the estimates of the correlation p0_ (equation 6.b), and of the 
proportional scaling bias ßn (equation 6.c), are equivalent to those which 
can be obtained by linear correlation and regression analysis with 
adjustment for attenuation biases due to random error in the reference 
measurements (2). 
Once separate estimates of the correlation p0„ and of the proportional 
scaling bias ßn are obtained from a validity study, they can be used to 
adjust crude log relative risk estimates for, respectively, attenuation bias 
and scaling bias. However, the combination of these two corrections is 
equivalent to a "calibration" adjustment, where the calibration factor is 
estimated as the slope of the individuals' mean reference measurements (R) 
regressed on questionnaire measurements. This can be easily seen from 
equations [6.b] and [6.c], since: 
p^T x l/ßQ = Cov(Q,R)/Var(Q) = X. 
Likewise, it can be seen that using separate estimates of the true intake 
2 2 
variance o_ and of the correlation p0_ for power calculations (based on 
equation 4) is equivalent to using an estimate of the variance of the 
predicted intake distribution, Var(E[T|Q]) = (p o_) , which can also be 
obtained directly by the same calibration approach. Thus, when relative 
risks are expressed for scaled, absolute intake differences, there seems to 
be no advantage in obtaining separate estimates of ßn and pnT to adjust for 
bias, nor is there any advantage in separately estimating p_T and o_ for 
power calculations. 
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An example 
Suppose we wish to investigate whether fat intake as a percent of total 
energy is associated with breast cancer risk, to confirm observations made 
in international correlation studies. For this purpose, we plan a 
prospective cohort study, to be nested within a population-based breast 
cancer screening programme. Each year, about 12,000 women aged between 50 
and 65 visit the screening centre. Every four years, the women are invited 
for another visit. Thus, within four years, we could recruit a maximum of 
about 48,000 women in the cohort study. Suppose also that, in this 
hypothetical population, the expected cumulative incidence of breast cancer 
is about 200 cases per 10,000 women, after 10 years of follow-up. 
For the measurement of dietary intake levels, a self-administered food 
frequency questionnaire is adopted, which had been previously validated for 
another on diabetes and cardiovascular disease. Since it is not clear how 
well the questionnaire will perform in the breast cancer screening 
population, and to evaluate whether enough variation in fat intake can be 
measured for the cohort study to reach the required statistical power, it is 
decided to conduct a one-year pilot study with about 1500 women. Additional 
objectives of the pilot study are to develop the logistics of the cohort 
study, and to determine whether the study would not seriously interfere with 
the normal running of the screening programme. From each study subject, a 
single reference measurement of dietary intake is obtained using a 24-hour 
recall interview. Using these pilot study data, the bias factor X is 
estimated to be equal to 0.38. The estimated standard deviation of the 
predicted fat intake distribution is estimated to be 4.2 percent of energy 
intake (see Table 1). 
International correlation studies have reported that, in countries where 
the diet contains 44 percent calories from fat, breast cancer rates are 
about 1.5 times higher than in countries where the average fat intake equals 
32 percent of energy (20). Assuming that this reflects the true increase in 
disease risk per percent increase in energy from fat and that, at the level 
of individuals, the true dose-response relation is exponential, an a priori 
estimate of the log relative risk can be obtained as 9_ = log(1.5)/(44-32) = 
0.034. Thus, using equation 5, the number of cases required for a full 
cohort analysis (with many more controls than cases) with 0.90 power and 
0.05 significance level will be equal to (1.960+1.282)2/(0.034x4.2)2 = 515. 
This number of cases can be reached after following up a cohort of about 
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Table 1. Measured and predicted distributions of fat intake as a percent of 
total energy, as estimated in a (pilot) calibration study. 
À. Questionnaire measurements: 
mean = y = 37.2 
standard deviation = on = 11.0 
B. Reference measurements: 
mean = uR = 38.5 
standard deviation = o„ = 19.0 
Correlation between questionnaire, and reference measurements: 
PQR = °-22 
Slope of reference measurements regressed on questionnaire measurements 
X = 0.38 
C. Predicted intake distribution: 
estimated mean = u_ =38.5 
estimated standard deviation = Xon = 4.2 
26.000 women for an average of 10 years. Suppose that during the pilot phase 
about 80 percent of participants in the screening programme agreed to take 
part in the cohort study. Then, assuming a similar participation rate during 
the remaining recruitment phase, a sufficiently large cohort could be formed 
in less than three years. 
Discussion 
For the efficient planning of prospective cohort studies where diet is the 
principle exposure factor of interest, it is essential to estimate which is 
the minimum study size needed to reach a sufficient level of statistical 
power. The estimated sample size requirements, together with the financial 
resources available, are the key elements to evaluate which detail of 
exposure information can be obtained from each study participant (e.g., 
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including the collection of biologic specimens, or not). Given the true 
magnitude of increase in disease risk for a standard unit difference in 
intake level, the power of a cohort study depends on the amount of variation 
in true intake level that is predicted by the dietary questionnaire 
measurements collected at baseline. In this paper we have discussed how this 
predicted variation in intake level can be estimated by a simple calibration 
approach, using additional reference measurements collected in a sub-sample 
of cohort participants. The same approach can be used to correct for biases 
in relative risk estimates. The bias factor (X) is then equal to the ratio 
of the predicted variance of the true intake level, divided by the variance 
of the baseline questionnaire measurements. 
As compared to the traditional design of dietary validity studies, a 
major advantage of the calibration approach is that it requires only a 
single day's intake record per individual as a reference measurement. 
Calibration studies can therefore be conducted more easily on a truly 
representative sub-sample of the study population. Preliminary experience in 
the European Prospective Investigation into Cancer and Nutrition (EPIC) (17) 
indicates that almost all study participants will cooperate in 24-hour 
recall, if this is taken immediately when they present themselves for 
recruitment in the cohort study. 
The proposed calibration approach requires several assumptions: 
1) a well defined form of dose-response relation between intake level 
and incidence rates of disease, 
2) normality of the true, as well as of the measured intake 
distributions, and 
3) absence of scaling bias in the reference measurements. 
In this paper, we have assumed an exponential type of dose-response. This 
is a standard model for the analysis of case-control or cohort studies 
(12,13), which justifies its a priori assumption for statistical power 
calculations (15,21). Nevertheless, some investigators have based their 
power calculations on a somewhat different type of risk model. For example, 
Walker and Blettner (3) and Freudenheim et al. (23) assumed a linear 
increase in the relative risk (not of its logarithm ! ) over a series of 
ordered intake categories, defined by quantiles of the measured intake 
distribution. Freedman et al. (8) used a similar model, but defined intake 
categories by quantitative cut-points, on a known (reference) scale, rather 
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than quantiles. The assumption of a linear trend in relative risk is 
incompatible with the combination of a normal exposure distribution and a 
linear logistic model, but differences between these models may be small as 
long as relative risks are low (as is the case in most studies on diet). 
When the cohort study has reached the analysis stage, it can of course be 
investigated whether a form of dose response provides a better fit of the 
statistical model to the data observed. Alternatively, a less parametric 
approach, which is often followed in nutritional epidemiology, is to 
estimate relative risks for discrete, ordered intake categories, without a 
priori specification of the form of dose-response. Data from a calibration 
study can then still be used to estimate the corresponding true mean intake 
levels within each category. The latter approach is well illustrated by a 
study on blood pressure in relation to stroke and coronary heart disease 
(24). 
The second assumption implies that not only the individuals' true 
habitual intake values but also random measurement errors are normally 
distributed, and that the variance of errors is independent of the level of 
intake measurements. In practice, this requirement may not always be met. 
Dietary intake measurements often follow an approximately log-normal 
distribution, because of larger error variance at higher intake levels. 
Mathematical transformations can be used to normalize the distribution, and 
to obtain more constant error variances (25,26). Such transformations, 
however, also modify the form of dose-response between intake measurements 
and disease risk, and this should be accounted for in power calculations, or 
in the estimation of biases in relative risk estimates. This issue requires 
further investigation. In the meanwhile, it should be realized that 
normality of the exposure measurements is not only a necessary assumption 
for the proposed calibration approach, but also for previous methods where 
the probabilities of misclassification between intake categories are 
computed from the estimated correlation between measured and true intake 
values (3,8,23). 
The third assumption - absence of scaling biases in the reference 
measurements - is more specifically required for a valid application of the 
calibration approach, and puts heavier constraints on the choice of a 
reference method. For most nutrients, and for food groups, weighed food 
records or 24-hour recalls (if well conducted) are generally taken to be the 
optimal methods for measuring mean intake levels of a study population, or 
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sub-groups (27,28), although the validity of these measurements may be 
difficult to demonstrate in the absence of objective measures of true intake 
suitable for use among free-living individuals. Only for a few nutrients, 
such as protein, is it possible to use a biochemical marker with a well 
known quantitative relation to absolute daily intake levels (29,30). An 
apparent advantage of relative risks estimated for quantile categories of 
intake distribution is that such estimates are independent of the scale on 
which intake levels are measured. Depending on the variation in intake level 
within the population, however, a given true increase in disease risk for a 
standard unit difference in intake level may correspond to different levels 
of diet-disease association as expressed in relative risks between 
quantiles. As indicated also by Freedman et al. (8), methods for power 
calculations based on the a priori assumption of a given relative risk 
between quantiles (3,23) ignore the amount of variation in intake level 
present in the study population, and therefore whether the starting 
assumptions themselves are reasonable. This, in our view, is a greater 
potential disadvantage than possible under- or overestimation of the 
predicted intake variance (and thus of statistical power and sample size 
requirements) which may occur if there is some scaling bias in the reference 
measurements. 
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Appendix A: Variance of the predicted intake distribution. 
If X is the slope of the linear regression of reference measurements on 
2 
questionnaire measurements, with an expected value of X=p0_/ß_, and var(Q) 
is the variance of baseline questionnaire measurements, then the variance of 
the predicted intake distribution will have an expected value of 
Var(E[T|Q]) = X2 Var(Q) 
= [PQT/ßQ]2 Var(Q) 
4 
2 ^0°T' 2 2 
= 1/PQ — ^ — KVi» + °CQ1 
(ßQoT) + 0£Q 
ft2 „ 4 
PQ °T _ 2 2 
" ,. ,2 2 " PQT °T (ßQoT) + o£Q 
Appendix B: The relative precision of X-estiraates. 
The variance of the calibration factor estimated in a calibration study of 
Nxk participants with a single reference measurement each, is given by 
Var(X)1 = [(l-p2T)o2 + o2R]/NkVar(Q) 
2 2 2 
= [(1-PQT) + o>]/Nk , where a> = °£R/°T-
Likewise, the variance of the calibration factor estimated in a calibration 
study of N individuals, with a k reference measurements each, is given by 
Var(X)k = [(l-p2T) + (o/k]/NVar(Q) 
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The ratio of the two variances equals: 
Var(X)k k [ (1-PQT) + »/k ] 
Var(\)1 (1-PJX) + <" 
2 
It can be seen from this equation that, for all (l-pnT)>0, the variance 
ratio Var(X), /Var(X). will be greater than or equal to 1.0. Thus, for a 
given total number of reference measurements N, the optimal design of a 
calibration study nested within a cohort is that with a maximum number of N 
participants, with only one reference measurement each. 
Chapter 4 
Adjustments f or bias due to errors in exposure assessments 
in multi-centre cohort studies on diet and cancer: 
a calibration approach. 
This chapter has been published by the authors R. Kaaks, M. Plummer, E. Riboli, J. Estève, 
and WA. van Staveren, in the American Journal of Clinical Nutrition (special supplement) 
1994;S9:245S-50S. The text has been slightly adapted, however, for a more uniform notation 
of statistical eqations across the chapters of this thesis. 
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Abstract 
An advantage of multi-centre cohort studies on diet and cancer is that these 
may include populations over a wide range of dietary exposure. With some 
simplifying assumptions, the information from such multi-centre studies may 
be divided into: 
1. Estimated relationships within each of the separate cohorts, between 
individual-level measurements of dietary exposure and disease 
outcome, and 
2. An estimated between-cohort relationship, between the mean intake 
measurements and mean incidence rates. 
Errors in the dietary exposure measurements may lead to different amounts of 
bias in each of these estimated relationships, in particular when dietary 
questionnaire methods cannot easily be standardized. A calibration approach 
can be used to adjust for such differences in bias. If sufficiently precise, 
such calibration will improve the relative weighting of within- , as well as 
between-cohort components of evidence for a diet-disease association. 
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Introduction 
International correlation studies have shown strong associations between 
cancer incidence and the per capita intake of specific dietary factors (1). 
A well known example is the correlation between fat intake and breast cancer 
incidence. However, because of the possibility of serious uncontrolled 
confounding, international correlation studies are usually regarded as 
providing only limited evidence for a causal exposure-disease relationship 
(2-3). Efforts and resources were therefore focused on studies in which 
individuals are the units of observation, in the attempt to investigate 
specific diet-disease relations within populations that are more homogeneous 
with respect to potential confounding factors (but also with respect to the 
dietary exposure of interest). An additional methodological advantage of 
such individual-based studies is that confounding could be adjusted for at 
the subject level. So far, however, the overall evidence derived from case-
control and cohort studies remains inconclusive for many dietary intake 
factors, some studies showing a significant association while others do not 
(4) (e.g., total fat intake and breast cancer risk). Inconsistencies between 
study results could of course be explained by a real absence of relationship 
between, the dietary factor and disease risk, within some of the populations 
studied. An alternative interpretation would be that, on average, studies at 
the subject level lack the statistical power to detect specific diet-disease 
associations consistently. 
A lack of power in case-control or cohort studies on diet and cancer, 
mostly conducted within limited geographical areas, might be explained to a 
large extent by the relatively small variations in dietary exposure levels 
(5). It is reasonable to suppose that true associations between dietary 
intake factors and cancer risk (if any) are usually relatively weak, with 
relative risks probably not higher than 4 or 5 for the highest versus the 
lowest quintile level of intake. Since estimated relative risks are mostly 
attenuated due to random errors in measurements of exposure, observed diet-
disease associations will be even weaker (6,7). 
The increase in statistical power that may be obtained within a single 
study, either by increasing the total sample size, or by improving the 
precision of the dietary exposure assessments, is often limited for 
practical or logistical reasons. An additional possibility for improving the 
statistical power, however, is to increase the overall heterogeneity of the 
dietary exposure studied, combining the data of multiple studies conducted 
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in populations with different dietary habits. This was a major underlying 
rationale for the planning of the European Prospective Investigation into 
Cancer and Nutrition (EPIC) (8), a collaborative project of multiple cohort 
studies coordinated by the International Agency for Research on Cancer. In 
this project, data will be collected on diet and potential confounding or 
interacting factors such as smoking, physical activity, reproductive 
history, or drug use. In addition, blood samples will be collected and 
stored in a biological bank. The study will include about 400,000 middle 
aged men and women in seven European countries (United Kingdom, Netherlands, 
Germany, France, Italy, Spain and Greece). 
A complicating factor in multi-centre studies such as the EPIC project, 
is that it may be impossible to use identical dietary assessment methods in 
each centre. Between countries, food consumption patterns may be as 
different as the various languages spoken. Since dietary questionnaires 
should always be adapted to local food habits, they may differ in the number 
and detail of questions concerning specific foods consumed. Also logistic 
reasons may preclude the use of identical assessment methodologies. In the 
EPIC project for instance, it was decided for reasons of compliance to use 
an interview-administered dietary history questionnaire in southern Italy 
and Spain. In France, however, most contacts with the subjects will be by 
mail, necessitating the use of a self-administered (and self-explanatory) 
food frequency questionnaire. 
In this paper we shall describe how, with some simplifying assumptions, 
the information from multi-centre cohort studies may be considered in two 
parts: 
1. A within-cohort relationship, between intake measurements and 
disease outcome at the level of individuals, and 
2. A between-cohort relationship, between the mean intake measurements 
and overall incidence rates in the various cohorts. 
The estimations of both types of relationship, within and between cohorts, 
may be biased to different extents as a result of errors in the dietary 
exposure measurement. This paper discusses the possibility of adjusting for 
such biases, following a calibration approach. The calibration will improve 
the relative weighting of the various components of evidence for a diet-
disease association, coming from between-subject comparisons within 
different cohorts, as well as from between-cohort comparisons. 
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I. Combining cohort-specific relative risk estimates 
A model 
Consider a collaborative multi-centre investigation of j different 
cohorts, studying the relation between a given dietary intake factor (e.g., 
daily fat intake) and the subsequent probability of developing a given 
disease. Baseline dietary exposure measurements Q are obtained by means of a 
structured questionnaire. After follow up, in each cohort i (i=l, ,j) a 
number of disease cases will be detected, whose dietary intake assessments 
can then be compared with those of a subset of disease-free individuals. It 
is then usually assumed that within each cohort there is a linear relation 
between the logarithm of the disease incidence rate, <|f, and a true 
underlying exposure T (which may for instance be defined as the average 
daily fat intake during a given period): 
• 4 = log(rate) in cohort i - ^ + e. (T - T ^ 
(ignoring, for the sake of simplicity, the effects of confounding or 
interaction factors). The slopes of these log-linear relations, 9., are 
equal to the logarithm of the relative risk of disease for one unit 
difference in intake, within a given cohort. The values of 6. can be 
estimated for instance by a Poisson type of regression. Alternatively, if 
the disease incidences are low, but reasonably stable during the period of 
follow-up, a nested case-control design may be used, and logistic regression 
may be used to estimate each of these cohort-specific slope parameters (9). 
Whatever statistical method is used, a crude estimate of log-relative risk, 
0 , will be obtained, where the asterisk indicates that the estimate may be 
biased because it is based on a comparison of questionnaire assessments 
instead of the true exposure values. Under the mild condition that the 
exposure distribution is close to normal, and especially under circumstances 
that the cases are compared to a much larger number of controls, the 
variance of the e.*~estimate will be approximately equal to (10): 
Var(êt*) — JIJ 
d± Var^Q) 
where dj is the number of cases, and Var.(Q) is the variance of the 
questionnaire measurements of exposure. 
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Increasing the sample size by combining relative risk estimates across 
cohorts 
Following a meta-analytic approach, the 6. 'estimates from different cohorts 
can be combined into an average value 8„ , summarizing the relations 
observed within cohorts between exposure measurements and the log incidence 
rate. Weighting each estimate by the inverse of its variance, this pooled 
estimate is computed as: 
j 
E d. Var (Q) e * 
i=l x x x 
e w* - : t 2 i ' 
D vârw(Q) 
where D is the total number of cases of all cohorts combined, and 
1 j 
Var (Q) = E d Var (Q), 
w
 D i=l x x 
is the average within-cohort variance of the questionnaire measurements of 
exposure (weighted by the numbers of cases in each cohort). The pooled 
estimate 9„ is equivalent to that obtained by, for instance, logistic 
regression on the data of all cohorts combined, with stratification by 
cohort. Its variance equals: 
1 
Var(6w*) [3]. 
D vâry(Q) 
Clearly, due to an increase in the number of cases ( D > d. ), this variance 
will be smaller than that for any of the cohort-specific 6 'estimates. 
Thus, if the 8 .estimates are approximately equal, indicating a similar 
trend of dose-response in all cohorts, the efficiency of testing for the 
presence or absence of a diet-disease association will be improved. This is 
an obvious advantage of multi-centre studies, whether of a case-control or 
of a cohort design. 
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Comparability of cohort-specific relative risk estimates 
When combining relative risk estimates into an average summary value, the 
underlying assumption is that each study provides an estimate of a unique 
underlying dose-response relationship, which is similar in each of the study 
populations. Between cohorts, results will then corroborate one another. In 
practice, however, the study populations of the various cohorts may be quite 
heterogeneous with regard to the prevalence of additional risk factors. This 
may cause some between-cohort variation in relative risk estimates, because: 
1. to varying degrees, relative risks may be biased due to confounding, 
and 
2. to a different extent, interacting factors may modify the 
susceptibility to the exposure factor studied (effect modification). 
As far as possible, adjustment should be made for confounding by 
measuring confounders on all individuals in the study, and stratifying the 
analysis. When in all cohorts individuals are classified into similar strata 
of age, sex or other potential confounding factors, populations are within 
such strata more likely to be homogeneous across cohorts. This decreases the 
likelihood that within similar strata of confounding factors relative risk 
estimates are differently biased. Classification of individuals into similar 
strata of confounding factors obviously requires that in each study 
identical information should be available, not only for the exposure, but 
also for potential confounding factors. This is a major argument in favour 
of carefully designed, collaborative multi-centre studies. 
The presence of effect modification merely reflects the fact that the 
relative risk associated with a given type of exposure depends on additional 
individual characteristics which are unevenly distributed over the various 
study populations. The assumption that each study provides an estimate of a 
unique underlying dose response relationship is then violated to at least 
some degree, and it may not be possible to compute a meaningful summary 
estimate of relative risk (11); that is, between cohorts study results may 
not be "combinable" (12). This problem of "combinability" may at least 
partly be solved if biologically plausible effect modifiers (e.g. smoking, 
menopausal status, other dietary factors) can be identified at the subject 
level. If, for example, smoking appears to be a strong effect modifier, 
betveen-cohort heterogeneity of results may be explained by differences in 
smoking prevalence. Results can then be combined across cohorts, but within 
categories of tobacco consumption. This would require that also information 
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about potential modifiers be collected in a standard manner in all 
collaborating centres. 
Biases due to errors in the exposure measurements 
Biases due to errors in the dietary exposure measurements may form an 
additional source of between-cohort variation in relative risk estimates. 
This may be particularly true if it is impossible to use identical dietary 
assessment methods. 
He shall assume that for each cohort the relation between measured and 
true intakes can be approximately described by a linear measurement error 
model, which is discussed in more detail elsewhere (13): 
Q - Qt = ß Q 1 (T - Tt + eQ) . 
According to this model, bias in the mean intake measurement, at the group 
level, is given by the difference QJ-TI- The ß-coefficient expresses a 
proportional scaling bias, which occurs if measurement errors are correlated 
with the true intake values being measured (i.e., when the tendency to over-
or under-estimate is different for subjects with a high intake than for 
subjects with a low intake). The term tn represents an independent, 
2 
standardized random error, with mean zero and variance a
 n. The ratio of the 
2 
error variance to the variance of the true exposure (o„) determines the 
correlation between measured and true intakes within a given cohort: 
'QT,i 
y 1
 + o2Q/02 
hi-
lf the measurement error model correctly describes the relation between 
measured and true intake values, crude estimates of log relative risk (8 ) 
will be biased by a factor X which, within a given cohort i, will have an 
expected value of: 
1
 2 
Xi = ~1 pQT,i [51> 
ßQi 
Thus, the bias in the log relative risk estimate will be equal to the 
inverse of the scaling factor ß_, multiplied by an attenuation factor which 
is equal to the square of the correlation between measured and true intakes, 
2 PQ». It can easily be shown that X is equal also to the slope of a linear 
regression of true on measured intake values. 
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Comparisons between dietary validity studies suggest that the correlation 
between measured and true intake values can for the same nutrient be as 
different as 0.4 or 0.7, depending on the questionnaire method used and on 
the study population (14,15). Therefore, X-values may vary and, even if true 
relative risks are approximately equal in all cohorts, their estimates may 
appear to be different. Between-cohort differences in the scaling factor ßQ 
may add further variability to the estimated relative risk values. 
Adjustment for differences in bias due to errors in the exposure 
measurements; a calibration approach 
In order to improve their between-cohort comparability, crude relative risks 
should be corrected for biases due to measurement error. A convenient 
approach for making such corrections has been described by Rosner et al, and 
is referred to as the "linear approximation method" (16). This approach 
requires that for at least a representative subsample of individuals, there 
should be an unbiased reference measurement, R = T + eR, in addition to the 
baseline questionnaire assessments (Q). The random errors of the R- and Q-
measurements (e_ and £Q, respectively) should be independent. In practice, 
the reference measurements might for instance be obtained by means of a 
weighed food record, or using a quantitative biomarker of nutrient intake 
(if the marker can be reliably translated into an absolute, daily intake 
value). The bias factor X can then be estimated in the subsample by normal 
least squares regression of R- on Q-measurements. Corrected estimates of 
** " (log) relative risk are then computed as 6 - 6 A . The correction method can 
also be seen as a regression of disease outcome on "calibrated" dietary 
questionnaire measurements, which have first been rescaled so that the 
resulting 8-estimate will be unbiased. Ve shall therefore also refer to this 
type of correction as a "calibration". 
The variance of the corrected estimates is given as (16): 
i . 'e* 
VarfBj) - — 2 Var(et*) + -T^- VarfX^ [6]. 
Xi Xi 
This equation shows that the variance of each corrected 8-estimate will also 
depend on the precision with which the bias factor X is estimated. Here, we 
shall for simplicity assume that the calibration subsample is large enough 
to obtain Xestimates with negligible imprecision (i.e., Var(X.) « 0). The 
variance of the corrected eestimate then approximately reduces to: 
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Var(8i) = VartSj) = ; [7], 
X.2 d. Var.(E[T|Q]) 
, where 
Var(E[T|Q]) = p 2 T a2 [8] 
is equal to the variance of intake predicted by the Q-measurements (i.e., 
the part of the variance of true intake values T, which is explained in a 
regression of true intake values on questionaire measurements Q; see Chapter 
3, Appendix A). 
In this ideal case of perfect calibration, relative risk estimates in 
each cohort can be accurately adjusted for biases due to errors in exposure 
measurements. It will thus be possible to to evaluate more accurately 
whether between-cohort relative risk estimates are in agreement (and 
"combinable"). Accurate calibration will also result in a more efficient 
weighting of cohort-specific evidence, when computing an average summary 
estimate of relative risk. This can be easily seen, since substitution of 
Var^EITlQ]) for Var^Q) in equation [2] yields: 
j 
£ d. Var.(E[T|Q]) 8. 
i=l x x x 
8W _ ; 19]. 
D vârw(E[T|Q]) 
Thus, lower relative weights will be given to cohorts where there is 
relatively little between-subject variation in true intake values (i.e., 
2 
when the true intake variance o„ is small), or where the dietary exposure is 
relatively poorly measured (i.e., when p__ is low). The improved relative 
weighting of evidence will help optimize the efficiency of a statistical 
test on the presence of a diet-disease association. 
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II. Estimates of relative risk based on between-cohort variation of 
exposure and disease incidence 
The corrected summary estimate 6„ is entirely based on comparisons between 
individuals who belong to the same cohort. An additional estimate of (log) 
relative risk, 9R> can be obtained on the basis of between-cohort 
comparisons of disease incidence and exposure levels. Since for both the 
exposure and incidence the within- and between-cohort components of variance 
are independent, the estimate of 6_ will be complementary to that of &„. 
As for the within-cohort analysis it was assumed that at the subject 
level there was a log-linear dose-response between exposure and disease 
rate, the between-cohort estimate of relative risk should theoretically be 
obtained by linear regression of estimates of the mean log incidence rate in 
each cohort , (iL), on measurements of the mean exposure levels, T.. A 
complication, however, is that the mean log incidence rates ij», are not 
estimable from aggregate level data. (In the literature concerning 
ecological studies, this has received some attention as a problem of model 
specification (17,18)). Nevertheless, at least approximate estimates of 8_ 
can be obtained by linear regression of the logarithm of the average 
incidence rates, Y.=log(d./n.), on measurements of the mean exposures 
(19,20). This estimate will be most precise if each data point is weighted 
proportionally to the precision with which it is estimated. 
The between-cohort estimate 9_ may be biased if mean exposure 
measurements Q. are over- or under-estimated to varying degrees. This may be 
a problem, in particular when the dietary questionnaire methods cannot 
easily be standardized. One may then choose to obtain an alternative 
estimate of the mean exposure in only a subsample of each cohort, using an 
additional dietary assessment method for which standardization poses fewer 
problems. Again, measurements may for instance be based on a weighed food 
record or on a biochemical marker. One can thus use the same sub-sample and 
the same reference measurements (R) as for the within-cohort calibration of 
relative risk estimates. It should be noted that the reference measurements 
only need to provide an accurate estimate of the mean exposure at the group 
level; the measurements may be too imprecise to also provide an accurate 
classification of individuals by exposure level. 
As before, we shall assume that the reference measurements are perfectly 
standardized, and that calibration sub-samples are sufficiently large to 
obtain highly accurate estimates of the mean exposure in each cohort. The 
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precision of each data-point (R.,Y.) is then mainly determined by the 
variance of Y., which is equal to 1/dj. Thus, each point will be optimally 
weighted by the number of cases, d., which leads to the following estimate 
for 9_ (see also Rothman (21), pp. 336-9) : 
E
 d lR i Y l - ( E d.R. ) ( E dlYi ) / D C O V B ( T > Y ) 
E diRi2 - f E d ^ ] / D VarB(T) 
Here, Cov_(T,Y) = Cov(E(T|cohort),E(Y|cohort)) is the estimated between-
cohort covariance between the (mean) exposures T. and estimated average 
incidence rates Y. (weighted by the numbers of cases), and Var_(T) = 
Var(E(T|cohort)) is the between-cohort variance of exposure. 
The variance of the 8„ estimate is equal to: 
1 
Var(6B) = [11] 
D VarB(T) 
Combining within- and between-cohort estimates of relative risk. 
If the within- and between-cohort estimates of relative risk are reasonably 
similar, both estimates can in principle also be combined, into anoverall 
summary value 8-. Again, both estimates should be weighted by the inverse of 
their variances. If both estimates were fully corrected for biases due to 
error in the exposure measurements (i.e., after perfect calibration), 8_ 
would be computed as: 
vârw(E[T|Q]) _ VarB(T) 
ê 0 ; ; ê y + ê B [12]. 
vâry(E[T|Q]) + vârB(T) vârw(E[T|Q]) + Varß(T) 
Again, the relative weights are proportional to the relative variances, 
within and between cohorts, of accurately predicted exposure differences. 
If, on average, exposure differences are poorly distinguished within cohorts 
(i.e. when the correlation pQ_, is low), the value of Var„(E[T|Q]) decreases, 
and relatively greater weight will be given to the between-cohort estimate. 
This illustrates that accurate calibration also improves the weighting of 
the vithin-cohort evidence relative to the between-cohort evidence for a 
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diet-disease association. The variance of the overall 6_-estimate is then 
equal to : 
Var(90) = 113]. 
D (vârB(T) + vârw(E[T|Q]) 
This formula shows that, compared to the pooled vithin-cohort estimate 8y, 
the precision of the relative risk estimate can be further increased by also 
taking the betveen-cohort variations in exposure and disease rate into 
account. Thus, if the estimates 6„ and 6R are similar enough to be combined, 
the overall power for testing a single, average dose-response relationship 
will be improved. This is a major potential advantage specifically for 
multi-centre cohort studies. 
Discussion 
A single cohort or case-control study may be unable to detect small 
increases in relative risk, as it can be the case if the heterogeneity of 
exposure within a population is small, or when the association between 
exposure and disease is attenuated by measurement error (or both). This 
potential limitation of case-control or cohort studies has been used as an 
argument in favour of ecological studies (19,22-24), since these include a 
wider range of exposures. However, the disadvantages of ecological studies 
have also received considerable attention in the epidemiological literature 
(2,3,18,25). In principle, a collaborative multi-centre cohort study has the 
ideal design for studying the relationship between dietary intake and 
disease risk, offering all the potential advantages of studies based on 
individual subjects (in particular, the possibility to adjust for 
confounding), while at the same time increasing heterogeneity of the 
exposure. 
With some simplifying assumptions (approximate normality of the exposure 
distributions, as well as the assumption that the logarithm of the average 
incidence rate Y.=log(d./n, ) is a good approximation of the mean log-rate 
iL), the information concerning the exposure-disease relationship can be 
divided into two parts: 
1. A within-cohort relationship, between intake measurements and 
disease outcome at the level of individuals. 
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2. Â between-cohort relationship, between the mean intake measurements 
and overall incidence rates within each of the various cohorts. 
The increased heterogeneity of exposure deriving from a multi-centre design 
is captured by the data at a cohort level, while within cohorts the evidence 
is strengthened by an increased number of cases. A similar partitioning of 
information has been given by Fiantadosi et al. (3), as well as by Elliott 
(26) for the situation where the outcome variable is normally distributed. 
The between-cohort part of the study bears a superficial resemblance to 
an "ecological" study, but is in fact considerably stronger. In true 
ecological studies, there can be basically two causes of bias (18,25): 
a. The population from which exposure data are collected is not 
representative of the population for which incidence data are 
available. 
b. Adjustment cannot be made for known confounders (and effect modifiers) 
before aggregation of the data. Attempts to adjust for confounding 
after aggregation may not be successful. 
A multi-cohort study may also suffer from the first of these problems, if 
there is selection bias in the subsample chosen for standardized exposure 
measurements. In order to avoid selection bias, one should ensure a very 
high compliance with the type of dietary method used to obtain the 
standardized measurements. In the EPIC-project, this was a reason to decide 
that 24-hour recall interviews will be used as a standard method, rather 
than weighed food records. The second problem can be overcome in a similar 
manner as in the analysis of within-cohort relationships, by measuring 
confounders on all individuals in the study and stratifying the analysis. 
Ideally the two forms of evidence - within and between cohorts - should 
corroborate one another and, following a meta-analytical approach, can 
ultimately be combined to yield an overall estimate with greater statistical 
power. The validity of this planned meta-analysis may be increased by 
careful standardization of measurements of exposure and potential 
confounding or interacting factors. Correction for biases due to errors in 
the exposure measurements can be made by a calibration approach, based on 
the linear approximation method previously described by Rosner et al (16). 
This will also improve the weighting of component estimates of relative risk 
(estimated either within cohorts, or from the "ecological", between-cohort 
relation), the weights being proportional to the variances of the predicted 
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intake distributions. Likewise, calibration also leads to a reweighting of 
the overall evidence from within cohorts relative to that from a between-
cohort analysis. For the sake of discussion, we made the simplifying 
assumption that the estimation of calibration parameters (X) were basically 
error-free. Sample size requirements for calibration substudies and 
underlying assumptions regarding the reference measurements will be further 
discussed elsewhere (20). 
Although in principle a collaborative multi-centre cohort study has the 
ideal design for studying the relationship between dietary intake and 
disease risk, some caution is necessary. Residual (or unmeasured) 
confounding may have a different effect on within-cohort relative risk 
estimates than on estimates based on between-cohort comparisons (25). 
Another potential problem, which has not been discussed in this paper, is 
the difficulty of standardizing measurements of the outcome variable. 
Differences in the completeness of registration of cancer cases, or errors 
in the evaluation of the time of follow-up may lead to bias in the between-
cohort analysis. The interpretation of the study may therefore not be clear 
whenever there is a strong divergence between the two forms of evidence. 
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Abstract 
Advantages of multi-centre cohort studies on diet and cancer is that these 
allow the cross-validation of relative risk estimates between different 
study populations. Moreover, more powerful summary estimates of relative 
risk can be obtained by combining cohort-specific results. A complication, 
however, is that in different cohorts relative risk estimates may be biased 
to a different degree as a result of errors in the baseline assessments of 
habitual dietary intake levels. Such divergent biases can be adjusted for by 
means of "calibration" studies, using standardized reference measurements 
obtained in a sub-group of each cohort. These adjustments entail a cost, 
however, in terms of an increase in the confidence interval the relative 
risk estimates. In this paper, we evaluate the possible magnitude of such 
losses in precision, and discuss the approximate sample size requirements of 
dietary calibration studies for adjustments for bias to have a sufficient 
level of accuracy. 
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Introduction 
Single case-control or cohort studies may lack the statistical power to 
detect specific relationships between dietary intake factors and cancer. An 
advantage of conducting parallel studies in multiple populations is that 
this allows a cross-evaluation of the consistency of observed diet-disease 
associations (1). This was one of the reasons for planning the European 
Prospective Investigation on Cancer and Nutrition (EPIC), a project of 
multiple cohort studies on diet and cancer in seven European countries (2). 
An additional advantage of multi-centre cohort studies such as EPIC is that, 
by combining the data of the different cohorts, the overall study power and 
precision of relative risk estimates can be improved. A complication, 
however, is that questionnaire assessments of the individuals' habitual 
dietary intake levels may not have the same level of accuracy in each of the 
cohorts. This may be particularly true if it is impossible to use an 
identical questionnaire in all countries, because of major differences 
between food consumption patterns or language. Thus, in different cohorts 
(countries) relative risk estimates may be biased to a varying degree as a 
result of errors in the dietary exposure assessments, and may not be 
strictly comparable. 
More specifically, suppose that in each study cohort there is a log-
linear relation between the incidence rate of disease and the true intake 
level T of particular nutrient; that is, log (rate) = constant + 6T. In this 
simple model, commonly adopted in the analysis epidemiological data, the 
parameter 6 denotes the logarithm of the relative risk for one unit 
difference in true intake level. In addition, let us assume that within each 
cohort the relation between dietary questionnaire assessments and true 
intake values is well described by a linear measurement error model (3): Q = 
cc_ + ß_T + £Q. Here, the coefficients aQ and ßQ denote constant and 
proportional scaling biases, respectively, and the term en represents a 
2 
random error with mean zero and variance o _. It can then be shown that 
£Q 
estimates of the slope parameter 6, obtained by regression of a (binary) 
disease outcome variable on questionnaire assessments of exposure, will be 
biased by a factor X (4,5), with an expected value of 
x
 1
 2 
X
 - —
 PQT-
ßQ 
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Here, p n T is the correlation between questionnaire assessments and true 
intake values. Differences in the proportional scaling bias ßQ, or in the 
correlation p-., between questionnaire assessments and true intake values, 
will induce different degrees of bias in estimates of the log-relative risk 
parameter 9, as obtained in each of the various cohorts. 
The between-cohort differences in bias can in principle be adjusted for 
if well standardized reference measurements are available for at least a 
sub-sample of participants in each cohort. If this adjustment is accurate, 
it will result in a more optimal weighting of cohort-specific relative risk 
estimates when these are combined into a summary value, the weighting 
factors reflecting the level of accuracy of the dietary intake assessments 
in each cohort (6). The reference measurements may be obtained by a more 
detailed method, such as daily intake records, using a weighing method or 
24-hour diet recalls (7,8). Then, using the method of "linear approximation" 
described by Rosner et al. (4), the bias factor X can in each cohort be 
estimated by normal linear regression of reference measurements on 
questionnaire assessments, and corrected estimates of the log-relative risk 
can be obtained as 8=6 /X (where 6 is the unadjusted estimate). This method 
can also be seen as a rescaling of the baseline questionnaire assessments so 
that, by regression of disease outcome on the rescaled assessments, a 
consistent estimate of the log-relative risk will be obtained (6). Ve shall 
therefore refer to this approach as a "calibration" procedure, and to the 
factor X as the "calibration factor". 
Adjustments of relative risk estimates by calibration will only be 
adequate if, in each cohort, the calibration factor X is estimated with a 
sufficient level of precision. In this paper, we present some mathematical 
simulations to illustrate the possible losses in precision which may result 
from calibration. In the subsequent sections we shall discuss the 
approximate sample size requirements of dietary calibration studies, in 
prospective cohort studies on diet and chronic disease risk. 
Loss of precision due to calibration 
Rosner et al. (4) derived a closed-form expression for the variance for the 
calibrated estimate of the log-relative risk (6=6*/X), taking account of the 
imprecision in the estimation of the calibration factor X. Ve shall assume 
that the exposure distribution is close to normal, with mean u™ and variance 
2 
o _, and that the cases are compared to a much larger number of disease-free 
Sample size of calibration studies 85 
control subjects as in the case of a full cohort analysis. The variance 
formula by Rosner et al. can then be re-expressed in terms of an "effective" 
number of cases, D, and of the amount of variation in true intake level 
2 2 
actually predicted by the questionnaire assessments, Var(E[T|Q]) = p_T<j T: 
1 1 
Var(9) = — [1] 
D Var(E(T|Q]) 
(Appendix A). Here, the effective number of cases D is given by 
+ C [2] 
i 1 2 1 1 - P Q R 
where C = A2 , and A2 = e2Var(E[T|Q]). 
N PQR 
In this equation, N denotes the number of participants in the calibration 
sub-study; and p ™ is the correlation between questionnaire and reference 
measurements. The quantity A indicates the strength of the association 
between questionnaire measurements and disease risk, and can be directly 
related to an expected relative risk between quantile levels of the 
distribution of questionnaire assessments. For instance, the relative risk 
for the upper versus the lower quintile of the questionnaire assessments 
9 on A 
approximately equals e * (9), which corresponds to a relative risk of 
about 1.5 when the association A equals 0.15, or a relative risk of 4.0 when 
the association equals 0.50. 
The quantity C in equation [2] will be called the statistical "cost" of 
the calibration (not to be confounded with the financial cost of the 
calibration study). A cost equal to zero corresponds to estimation of the 
calibration factor X without error and, therefore, to no increase in the 
variance of the calibrated estimate of the log-relative risk. In this 
hypothetical situation, the effective number of cases is equal to the number 
actually observed in the study (i.e., D=D). In practical situations, 
however, the calibration factor will be estimated with some level of 
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imprecision. In this case, the ratio D/D expresses the relative efficiency 
of the calibration study, as compared to the situation where the calibration 
is perfect. The loss of efficiency can be defined as D-D. 
To illustrate the potential magnitude of such efficiency losses, Table 1 
shows the effective numbers of cases at selected values of the association 
between questionnaire assessments and disease risk (A), and of the observed 
number of cases (D). The relative efficiency improves with an increasing 
number of subjects in the calibration study, or with increasing values for 
the correlation between questionnaire and reference measurements. The latter 
two parameters determine the precision with which the calibration factor X 
is estimated. On the other hand, the relative efficiency decreases with 
increasing values of the association A, or of the observed number of cases 
D, which both determine the precision of the crude log-relative risk 
estimate before calibration. 
An additional parameter of interest (shown between parentheses in Table 
1) is the expected value of the calibrated estimate of log-relative risk 
divided by its standard error - that is, the expected t-value. This expected 
t-value is determined by the association between questionnaire assessments 
and disease risk, as well as by the effective number of cases, and can be 
computed as E(t)=AVD (see Appendix B). If the 95 percent confidence interval 
of the calibrated log-relative risk estimate is expressed as a fraction f of 
the estimate itself, it can be shown that f=1.96/E(t) (Appendix B)). Thus, 
an expected t-value of 3.92 (=4.0) corresponds to a confidence interval of 
[1±0.50]9. 
Efficient design of calibration studies; number of repeat reference 
measurements 
In practice, the statistical cost of calibration, C, can be reduced in two 
ways: increasing the number of subjects in the calibration study, or taking 
the average of multiple reference measurements per subject (e.g., multiple 
food records, or 24-hour recalls) to strengthen their correlation (prtl>) with 
the questionnaire measurements. The question is which of these two 
approaches will reduce the cost of calibration most efficiently. 
The statistical cost for a calibration study of N=n study participants 
with reference measurements repeated over k days (Cuvi)» relative to that 
for a study of N=nxk participants with only a single reference measurement 
(Cj.), can be computed as: 
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Table 1. Effective numbers of cases, and (between parentheses) expected t-
values after calibration. 
a) The expected odds ratio for the upper versus the lower quintile of the 
measured exposure distribution equals 1.50 (i.e., A=0.15). 
Number of participants in calibration study, N 
1000 2000 3000 4000 5000 
Nr. observed cases, 
D = 100 
P Q R=0.1 
PQR = 0.2 
PQR = °-3 
PQR = 0.4 
PQR = 0.5 
Nr. observed cases, 
D = 500 
P Q R=0.1 
PQR = 0.2 
PQR = 0.3 
PQR = 0.4 
PQR = °-5 
81.8 
(1.36) 
94.9 
(1.46) 
97.8 
(1.48) 
98.8 
(1.49) 
99.3 
(1.49) 
237 
(2.31) 
394 
(2.98) 
449 
(3.18) 
472 
(3.25) 
484 
(3.30) 
90.0 
(1.42) 
97.4 
(1.48) 
98.9 
(1.49) 
99.4 
(1.50) 
99.7 
(1.50) 
321 
(2.69) 
441 
(3.15) 
473 
(3.26) 
486 
(3.31) 
492 
(3.33) 
93.1 
(1.45) 
98.2 
(1.49) 
99.2 
(1.49) 
99.6 
(1.50) 
99.8 
(1.50) 
365 
(2.87) 
459 
(3.21) 
482 
(3.29) 
490 
(3.32) 
494 
(3.33) 
94.7 
(1.46) 
98.7 
(1.49) 
99.4 
(1.50) 
99.7 
(1.50) 
99.8 
(1.50) 
391 
(2.97) 
468 
(3.24) 
486 
(3.31) 
492 
(3.33) 
496 
(3.34) 
95.7 
(1.47) 
98.9 
(1.49) 
99.5 
(1.50) 
99.8 
(1.50) 
99.9 
(1.50) 
409 
(3.03) 
474 
(3.27) 
489 
(3.32) 
494 
(3.33) 
497 
(3.34) 
100 
(1.50) 
100 
(1.50) 
100 
(1.50) 
100 
(1.50) 
100 
(1.50) 
500 
(3.35) 
500 
(3.35) 
500 
(3.35) 
500 
(3.35) 
500 
(3.35) 
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Table 1 (continued) 
b) The expected odds ratio for the upper versus the lower quintile of 
questionnaire measurements equals 4.00 (i.e., A=0.50). 
Number of participants in calibration study, N 
1000 2000 3000 4000 5000 
Nr. observed cases, 
D = 100 
"QR- 0- 1 
PQR = 0.2 
»OR • °-3 
PQR = 0.4 
PQR = 0.5 
Nr. observed cases, 
D = 500 
P Q R=0.1 
PQR = 0.2 
PQR = 0.3 
PQR = 0.4 
PQR = 0.5 
28.8 
(2.68) 
62.5 
(3.95) 
79.8 
(4.47) 
88.4 
(4.70) 
93.0 
(4.82) 
37.4 
(3.06) 
125 
(5.59) 
221 
(7.43) 
302 
(8.69) 
364 
(9.54) 
44.7 
(3.34) 
76.9 
(4.38) 
88.8 
(4.71) 
93.8 
(4.84) 
96.4 
(4.91) 
69.6 
(4.17) 
200 
(7.07) 
306 
(8.75) 
376 
(9.69) 
421 
(10.3) 
54.8 
(3.70) 
83.3 
(4.56) 
92.2 
(4.80) 
95.8 
(4.89) 
97.6 
(4.93) 
97.6 
(4.94) 
250 
(7.91) 
352 
(9.38) 
410 
(10.1) 
444 
(10.5) 
61.8 
(3.93) 
87.0 
(4.66) 
94.06 
(4.85) 
96.8 
(4.92) 
98.2 
(4.95) 
122 
(5.52) 
286 
(8.46) 
380 
(9.75) 
430 
(10.4) 
457 
(10.7) 
66.9 
(4.09) 
89.3 
(4.72) 
95.2 
(4.88) 
97.4 
(4.93) 
98.5 
(4.96) 
144 
(6.00) 
313 
(8.85) 
399 
(9.99) 
442 
(10.5) 
465 
(10.8) 
100 
(5.00) 
100 
(5.00) 
100 
(5.00) 
100 
(5.00) 
100 
(5.00) 
500 
(11.2) 
500 
(11.2) 
500 
(11.2) 
500 
(11.2) 
500 
(11.2) 
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ck>i k K^PJT^ + (^ r)«^ ] 
"Relative Cost" = = [3] 
Ck=l (^ QT* + u 
where o> = [l-p__]/p__, and where y is the correlation between random errors 
of repeat reference measurements taken on the same individual (Appendix C). 
It can be immediately seen from this equation that, unless there is a 
perfect correlation between questionnaire assessments and true intake values 
2 (i.e., unless (l-pnT)=0), the "relative cost" of calibration is always 
greater than 1.0. Thus, for a given total number of reference measurements, 
the calibration study will be most efficient if it includes a maximum number 
of subjects with only a single measurement each (i.e, k=l). 
Table 2.a shows the relative cost of calibration for different numbers of 
repeat reference measurements per subject, at selected values of the 
correlations pQ_, and p R T, assuming that errors of repeat reference 
measurements are uncorrelated. Likewise, table 2.b shows the relative cost 
when there is a 0.10 correlation between the random errors of repeat 
reference measurements. From the two tables it can be seen that, with 14 or 
more repeats (which is a common number in dietary validity studies (10,11)), 
the relative cost can be higher than 2.0, in particular when random errors 
of repeat reference measurements are not fully independent. A relative cost 
of 2.0 means that a similar precision of calibration can be attained with 
half the total number of reference measurements if, instead of taking 
replicate measurements, more subjects are included in the study. 
Precision of calibration studies; sample size requirements 
Given our conclusion that the cost for calibration C is more efficiently 
reduced by increasing the total sample size N, rather than by taking 
replicate reference measurements, the main question to be answered is which 
sample size will be needed for the calibration study to reach a desired 
level of precision. 
Ideally, the calibration study should be as large as to maintain a 
minimum level of relative efficiency D/D of, say, 80 percent. From equation 
[2] we can derive, 
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TABLE 2. "Relative Cost" for calibration with k repeat reference 
measurements, or only a one reference measurement per participant, assuming 
a 0.50 correlation between questionnaire assessments and true intake values 
(i.e., pQT=0.50). 
a) Zero correlation between errors of replicate reference measurements. 
correlation between reference measurements and 
true intake level, p, 
0.10 0.20 
"RT 
0.30 0.40 0.50 
Nr of repeat 
measurements, k 
2 
7 
14 
1.01 
1.05 
1.10 
1.03 
1.18 
1.39 
1.07 
1.41 
1.90 
1.13 
1.75 
2.62 
1.20 
2.20 
3.60 
b) Correlation (y) between errors of replicate reference measurements 
equals 0.10. 
correlation between reference measurements and 
true intake level, p. 
0.10 0.20 
JRT 
0.30 0.40 0.50 
Nr of repeat 
measurements, k 
2 
7 
14 
1.10 1.13 1.16 
1.64 1.76 1.97 
2.39 2.65 3.11 
1.21 1.28 
2.28 2.68 
3.76 4.64 
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D l
 - PQR D 
= 1 + A2 [4] 
5
 <>QR N 
2 
Thus, at any given value of the association A and of the correlation p-._ 
between questionnaire assessments and reference measurements, there is a 
positive relation between the relative efficiency D/D and the ratio N/D 
which is the size of the calibration study relative to the observed number 
of cases. For example, assume that the correlation between questionnaire and 
reference measurements equals p__=0.20. (This was the level of correlation 
between intake assessments obtained by a questionnaire, and reference 
measurements obtained by a single 24-hour recall, as observed for most 
nutrients during the pilot phase of the EPIC study (personal 
communication).) In addition, assume that the relative risk between the 
extreme quintiles of questionnaire assessments equals 1.50 (i.e., A=0.15). 
It then follows that the calibration study should be about 2.2 times as 
large as the number of cases observed. 
Unfortunately, using the relative efficiency D/D as the main criterion, 
sample size requirements for the calibration study may become excessively 
large when the association between questionnaire assessments and disease 
risk is comparatively strong. For example, if the relative risk between the 
extreme quintiles equals 4.0 (i.e., A=0.50), the calibration study should be 
24 times larger than the number of cases observed. Thus, if 500 cases with 
disease are expected within the cohort, the calibration study should include 
12,000 participants! One may argue however that, when the unadjusted log-
relative risk estimate has very narrow confidence limits, the confidence 
interval can still have an acceptable width even in situations where the 
relative efficiency of calibration is less than 80 percent. Thus, when there 
is a strong association between questionnaire assessments and disease risk, 
an alternative may be to use the expected t-value for the calibrated log-
relative risk estimate as a criterion for sample size calculations . 
From equation [2], we can derive an inverse relation between the expected 
t-value of the calibrated log-relative risk estimate, and the relative 
efficiency of the calibration study: 
E(t) = V{ (1 - D/D) N PQR/II-PJR] } [5]. 
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Using this relationship, and making an assumption only about the correlation 
between questionnaire and reference measurements, a minimum sample size for 
the calibration study can be computed so that either 
A. a minimum level of relative efficiency will be attained (e.g., D/D > 
0.80), in which case the expected t-value would be only marginally 
greater even if the calibration was perfect, or 
B. the expected value of the calibrated log-relative risk estimate divided 
by its standard error (i.e., the expected t-value) reaches a desired 
minimum value. 
For example, assuming that the correlation p__ is greater than or equal to 
0.20, it follows from equation [5] that the calibration study should include 
at least 1920 (=2000) subjects to obtain that either the expected t-value is 
greater than 4.0, or the relative efficiency D/D is greater than 0.80. 
Discussion. 
An advantage of multi-centre cohort studies on diet is that these allow the 
consistency of relative risk estimates across populations to be evaluated. 
Moreover, by combining relative risk estimates across cohorts, a more 
powerful summary estimate can be obtained to test for specific diet-disease 
associations. A complication, however, is that errors in the baseline 
questionnaire assessments of dietary intake levels may lead to different 
degrees of bias in each of the cohort-specific estimates of relative risk. 
Adjustments for such divergent biases can be made by means of dietary 
calibration studies, using well standardized reference measurements 
collected within a sub-sample of each cohort. In this paper we have 
evaluated the potential loss in precision of relative risk estimates, within 
a single cohort study, as a result of such calibration adjustments. 
Vithin a single study population (i.e., within each cohort separately), a 
test for association between a given dietary factor and disease risk (i.e., 
a test for the null hypothesis that 6=0) has been shown to have optimal 
power if it is based on the unadjusted log-relative risk estimate (12). On 
the other hand, when multiple relative risk values are combined into a 
single summary value, calibration can remove error by adjusting for 
heterogeneity caused by dietary assessment errors. In a multi-centre study, 
therefore, calibration can in principle also improve the precision of a 
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combined log-relative risk estimate, provided that this potential gain in 
precision is larger than the intra-cohort losses of efficiency (D/D). Ve 
have shown how minimum sample size requirements for calibration studies can 
be computed so that 
1) the relative loss in efficiency will be small; this will be the case 
mainly if the association between questionnaire assessments and disease 
risk is relatively weak or if the number of cases is small; or 
2) the expected t-value of the calibrated log-relative risk estimate 
reaches a minimum predefined value; this will occur only if the 
unadjusted estimate reaches a certain level of precision - that is, 
when the association between questionnaire assessments and disease risk 
is relatively strong, or when there is a large number of cases. 
It is in particular in the first type of situation, when there are only weak 
associations between questionnaire assessments and disease risk, that the 
benefit of reducing error due to unequal biases in relative risk estimates 
may be relevant, to optimize the statistical power. 
Our calculations were based on Rosner et al.'s variance formula for the 
calibrated log-relative risk estimate (4). Using computer simulations, 
Rosner et al. have shown that the linear approximation method results in a 
satisfactory reduction of bias, as long as true relative risks are 
relatively low (as is the case in most studies on diet and cancer). In 
addition, it was shown that confidence intervals for the corrected log-
relative risk estimate will have a probability of covering the true log-
relative risk value that is very close, although not identical, to the 
nominal (95 percent) level. The variance formula for the calibrated log-
relative risk estimate was derived by Rosner et al. on the assumption that 
the calibration study would be conducted externally from the main 
epidemiological study population. In prospective cohort studies, however, 
calibration studies can be conducted on a random sub-sample of study 
participants. Thus, for a small proportion of the cohort (e.g., in 2000 out 
of 50,000 participants), reference measurements of dietary exposure will be 
available, which provide some additional information on the subjects' 
classification by habitual intake level. Since some cases with disease may 
arise in this sub-sample, the calibration studies may actually provide some 
supplementary information about the exposure-disease relationship. By 
ignoring this supplementary information, efficiency losses and sample size 
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requirements may have been somewhat overestimated. Nevertheless, this 
overestimation will be negligible as long as the expected number of cases in 
the sub-sample is low and, in addition, if the reference measurements (e.g., 
based on only a single 24-hour recall) have a comparatively low reliability 
as assessments of the individuals' long-term, habitual intake levels. 
Mathematically more exact, likelihood-based approaches for the 
calculation of the sample size requirements of dietary calibration studies 
have been developed, which do take account of additional exposure 
information for cases and controls within the calibration sub-sample 
(13,14). These approaches allow a simultaneous evaluation of sample size 
requirements of the main cohort, as well as of the proportion of the cohort 
that to be allocated to a calibration sub-study. The relative efficiencies 
of calibration, and expected t-values as presented in this paper are based 
on simplified formulas. In situations where the size of the main study 
cohort has already been decided, however, these parameters can provide 
simple and practical criteria for the estimation of sample size requirements 
for dietary calibration studies. 
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Appendix A 
It was shown by Rosner, Willet and Spiegelman (4) that the variance of the 
calibrated 9-estimate, Var(9), will be approximately equal to: 
i e*2 
Var(6) = Var(6*) + Var(X) [A.l] 
X2 A4 
Assuming that intake levels are Normally distributed, and that cases are 
compared to a much larger number of controls (as in a full cohort analysis), 
the variance of the unadjusted 9-estimate (9 ) is equal to 
1 
Var(9*) = [A.2] 
D Var(Q) 
Furthermore, 
Var(R) [1-p2 ] 
Var(X) = y^— [A.3] 
N Var(Q) 
E(X) = P^T [A.4] 
ßQ 
Substitution of [A.2], [A.3], and [A.4] into equation [A.l], and 
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reexpressing 
Var(R) = <4/pj[T and Var(Q) = ßj o2/p2T yields: 
Var(9) 
2 2 
1 
D 
ft2 n 2 
T 2 
N p RT 
2 2 
PQT oT 
4.-1- a2 „2 „2 1 - PQ R + — e oT p. 
"T HQT
 2 
'QR ' 
2 2 ' 
PQT oT D Var(E[T|Q]) D 
[A.5] 
Appendix B 
The expected t-statistic for a test whether the calibrated 6-estimate 
significantly differs from 0 equals: 
E(t) 
E(6) 
VVar(e) 
E(6) 
1/V(D Var(E[T|Q]) 
e VVar(E[T|Q]) ^ D 
A VD [B.l], 
Suppose the expected 95% confidence interval for the calibrated 6-estimate 
equals (l±f)6. Then, fe = 1.96 VVar(6), and thus f=1.96 VVar(6)/6 = 
1.96/E(t), where 1.96 is the 0.95 point of the standard Normal distribution. 
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Appendix C. 
The relative cost R.C, for a calibration study of N=n subjects each with k 
repeat reference measurements, relative to that for a study of N=nxk 
subjects with only a single reference measurement each, equals 
R.C. = 
[C.l]. 
1/n A2 [l-PQRtk]/PQR>k 
l/(nk) A2 [1-P2R]/P2R 
k
 '
 1/pRT,k - PQT I 
2 2 l/pRT - P QT 
Here, P O R is the correlation between the questionnaire, and (single) 
reference measurements, which can be rewritten as 
PQR = PQTPRT = PQT 1/^{1+(°} [C.2]. 
2 2 
where w is the variance ratio <o=o
 R/o_,. 
Likewise, p n R , is the correlation between questionnaire measurements and 
the average of k repeat reference measurements, and can be rewritten as 
pQR,k = pQTpRT,k = l/fi+YO+ü-YWk) [C.3], 
where y is the correlation between random errors of replicate reference 
measurements. 
Substitution of [C.2] and [C.3] into [C.l] yields 
k [ (1-pL) + Y<o + (l-Y)<o/k ] 
R.C. = *± [C.4]. 
(1 - P Q T ) + «> 
Chapter 6 
Efficient use of biological banks for biochemical epidemiology: 
exploratory hypothesis testing by means of a sequential t-test. 
This chapter has been published by the authors R. Kaaks, I. van der Tweel, 
P.A.H. van Noord, and E. Riboli, in Epidemiology 1994;5:429-38. 
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Abstract 
In view of recent advances in molecular and biochemical epidemiology, there 
is growing interest in the creation of biological banks of blood, urine, 
tissue or other biological specimens collected from participants in 
prospective cohort studies. The existence of biological banks may make it 
possible to study a multitude of etiological hypotheses, by comparing 
biochemical parameters measured in the biological specimens of subjects who 
will eventually develop the disease of interest ("cases") and of control 
subjects, using a nested case-control or a case-cohort design. In practice, 
however, the amount of biological material available per subject (in 
particular that of cases) will limit the number of hypotheses that can be 
tested. The present paper discusses the use of a sequential t-test, which, 
compared to an analogous fixed-sample procedure, will on average require 
fewer biological specimens to accept or reject a given study hypothesis. The 
sequential test may thus facilitate an early decision on whether a new 
hypothesis is worth further investigation, while avoiding to use too much 
biological material on testing hypotheses that would eventually prove 
unfruitful. If the test reveals an exposure difference of interest, the 
study may be extended so as to allow more accurate estimation of relevant 
epidemiological effect measures. 
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Introduction 
Following recent developments in "biochemical" and "molecular" epidemiology 
there is growing interest in the creation of banks of biological samples of 
material, such as blood or urine specimens, collected from participants in 
prospective cohort studies (1,2). After detection of a sufficient number of 
cases of a given disease (during a given follow-up period), parameters 
measured in their biological specimens can be compared with those of 
controls in order to study specific etiological hypotheses. Since new 
laboratory techniques are constantly being developed for the assessment of 
specific biochemical or molecular parameters, the number of new hypotheses 
that can be tested is also increasing rapidly. In practice, however, the 
amount of biological material stored (in particular that of cases) will 
limit the number of possible studies (3). It would therefore be useful to 
have a statistical method which, at the expense of as little biological 
material as possible, allows a distinction between promising hypotheses, 
which may be worth further investigation, and less promising ones. Such a 
method may be particularly useful in exploratory investigations, when there 
is only limited prior evidence to justify a study based on a large number of 
biological specimens. 
Using sequential statistical designs (4,5), it is theoretically possible 
to terminate an investigation on a specific hypothesis as soon as sufficient 
evidence has accumulated for it to be accepted or rejected. On average, 
sequential analysis will arrive at a decision after substantially fewer 
observations than equally reliable test procedures based on a fixed sample 
size. The first sequential procedures were developed during the Second World 
War (6), when Wald described the theoretical basis for a sequential 
probability ratio test (SPRT), and it almost immediately became an important 
tool for efficient quality control in wartime factories. Nowadays, 
sequential methods have also been adopted for use in medical research, in 
particular for the design and analysis of clinical trials (7,8). So far, 
however, sequential methods have not been much used in epidemiological 
studies, outside clinical trials. 
The present paper discusses exploratory hypothesis testing by means of a 
sequential t-test, in cohort-nested case-control studies where the exposure 
assessment is based on a biochemical marker, obtained by laboratory analysis 
of stored biological specimens. (To simplify, we shall refer to the 
biological marker as a measurement of an internal or external "exposure", 
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although it is clear that markers can also be a measure of individual 
susceptibility or of intermediate endpoints (9,10) ). The application of the 
sequential t-test will be illustrated using data from a study conducted to 
examine whether selenium is a potentially protective agent against breast 
cancer (11). 
The sequential t-test 
Ve shall assume that the biomarker measurements, H, can be considered as 
values drawn from two normal distributions, for cases and for controls, 
respectively. We also assume that both distributions have an equal variance, 
2 
o , but that their means may be different; that is: 
. 2 
M|case = N(u.,o ), and 
M|control = N(u0,a ). 
The null hypothesis to be tested is that the mean exposures of cases and 
controls are equal; that is, 
H0 : Ul=u0, or uru0=0. 
If o is not known a priori, but must be estimated, the magnitude of the mean 
difference Vi-Un which can be detected with a given power is unknown. 
However, the null hypothesis can be re-defined in terms of a standardized 
difference, 9=(u.-u0)/o, between the mean exposures of cases and of 
controls: 
HQ : 9 = (uru0)/o = 0. 
If the standard deviation a is high, then for a given number of observations 
only very large differences will be detectable with sufficient statistical 
power. Inversely, the power will be higher if o is small. 
A t-test can be used to evaluate the null hypothesis against an 
alternative. In the case of a well defined biological hypothesis, a one-
sided alternative may be reasonable; that is, 
H. : e > 6_. 
Here, 6R is the minimum standardized difference (u..-uft)/o v ' that one would 
find relevant enough to be detected, with a power of at least 1-ß and a 
significance level a. A two-sided alternative can be specified as 
H X : |e| > eR. 
Most epidemiologists are familiar with the traditional, fixed sample t-test, 
* ' Note: If the exposure is expected to be higher for controls than for 
cases, the standardized difference can also be defined as 6 - (p^-u-J/o . 
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based on the comparison of the mean exposures of predetermined numbers 
of cases and controls. The procedure described here, however, uses a 
sequential sampling of cases and controls within the cohort. This sequential 
sampling may follow the detection of cases over time. Alternatively, if a 
large number of cases has already accrued, the sequential sampling can also 
be performed retrospectively. In the latter situation, the order in which 
cases are selected does not need to follow the chronological order in which 
they were detected, but can also be based on a random selection process. For 
each case selected, a random subset of k controls is drawn from the disease-
free subjects in the cohort. If there are many cases, and if the major 
concern is to limit the additional costs for laboratory analyses, 1:1 
matching (k=l) will give optimal statistical power at a given total cost. 
However, when disease incidence rates are low (e.g., for a given type of 
cancer), cohort studies must be very large to observe a sufficient number of 
cases. Additional costs for laboratory assessments - even though 
considerable - may then still be low in comparison to the initial 
investments in the study, and priority may be given to the possibility of 
studying as many hypotheses as possible with the biological material 
available. In this case, a higher matching ratio will be more efficient 
(k>l), as this will increase the power of the test keeping the number of 
specimens from cases constant. A matching ratio greater than 5 will seldom 
be worthwile, however (12). After every new set of one case plus 
corresponding controls is sampled, the biochemical measurements are compared 
for all cases and controls processed up to that point to determine whether 
there is sufficient evidence to either reject or accept the null hypothesis 
H0. 
The earliest theory for sequential test procedures (that of the 
sequential probability ratio test), was initially developed by Wald (6). 
According to this theory, a sequential test was based on the logarithm of 
the following likelihood ratio, L , which can be computed after every new 
case-control set is being sampled: 
the probability of observing the case and control measurements if H. 
is true (i.e., if 6>6R) 
L = . 
n 
the probability of observing the case and control measurements if H» 
is true (i.e., if 9=0) 
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(where n is the number of case-control sets processed so far). A high value 
of the logarithm of the likelihood ratio, 1 , indicates that, given the 
measurements observed, the alternative hypothesis H. is more likely to be 
true than the null hypothesis H-, vhereas a low value of 1 indicates that 
the null hypothesis is more likely to be true. The testing process will 
continue until one of the following arises: 
1. The log-likelihood ratio 1 becomes smaller than a critical minimum 
value A. In this case, the conclusion is that the standardized 
difference 6 is unlikely to be as large as 6R, and the null 
hypothesis H« will not be rejected. 
2. The log-likelihood ratio 1 becomes larger than a critical maximum 
value B. In this case it will be concluded that there is a 
standardized difference between the average exposures of cases and 
controls as large as or larger than 8_, and the null hypothesis is 
rejected in favor of the alternative hypothesis. 
Whitehead (8) developed a more general approach to sequential test 
procedures, which includes procedures that are equivalent to Wald's 
sequential probability ratio tests, and which is based on a log-likelihood 
function (with unknown parameter 8) rather than on a log-likelihood ratio. 
The log-likelihood function can be expressed in terms of the parameter 8 
(for our comparison of two mean exposures still defined as 8=(p.-p0)/o ), as 
well as of two test statistics, Z and V, which are both computed at each 
stage of the sequential test procedure. Formulae for the computation of Z 
and V are given in Appendix I. Z is the so-called "efficient score for 8" 
and, for the comparison between quantitative exposures of cases and controls 
discussed here, is computed as the cumulative difference in exposure divided 
by an estimate of the unknown standard deviation o. V is a measure of the 
amount of information about 8 contained in Z, also referred to as "Fisher's 
information", and increases as the sequential test procedure progresses. 
Whitehead has shown that, when 8 is small and samples are large, then, at 
any stage in the sampling process, Z follows approximately a normal 
distribution with mean 8V and variance V (8; pp. 60). 
In practice, the sequential testing process can be conveniently presented 
in the form of a graph, plotting Z against V. The testing process then 
continues until: 
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1. Z becomes smaller than the critical value A = -a+bV, in which case H. 
cannot be rejected, or 
2. Z becomes larger than the critical value B = a+bV, in which case KL 
will be rejected. 
The critical values A and B are both linear functions of V. The slope (b) 
and intercepts (± a) of these linear functions depend on the values chosen 
for a, ß, and 9„ (see Appendix I). An example of the graphic presentation of 
the sequential t-test is shown in Figure 1 (further discussed in the next 
section). The computations for this example, including those for 
determination of the critical values A and B , were performed using the 
computer program "PEST", developed by Whitehead and Brünier (13). 
An example 
Within a cohort of participants in the "DOM"-project, a population-based 
breast cancer screening programme at Utrecht (the Netherlands), toenail 
clippings were collected and stored in a biological bank. After an average 
follow up of 25.7 months, a total of 61 cases of pre-menopausal breast 
cancer were detected. Results were reanalysed using a sequential t-test. 
The null hypothesis of an equal selenium content in toenails of cases and of 
controls (HQ: (u0-u.)/o=0) was tested against the one-sided alternative of a 
higher selenium content in the control group (H. : (n^-u^/o > 6 R). The 6_ 
value was chosen equal to 0.25. The significance level and the statistical 
power were fixed at oc=0.05 (one-sided) and l-ß=0.80, respectively. Case-
control subsets consisted of one case and five controls each, and were 
analysed in the chronological order in which the cases had been diagnosed. 
The results of the sequential testing procedure are shown in Figure 1. 
After a total number of 31 case-control sets (i.e., 31 cases and 155 
controls), the sample path of the efficient score Z plotted against V 
crossed the critical boundary corresponding to no rejection of the null 
hypothesis. 
Gain in efficiency: the expected sample size 
The advantage of sequential procedures is that the expected number of 
observations (average sample size) needed to reject a given study 
hypothesis, or not, is smaller than when the test is based on a fixed 
sampling procedure (i.e., with predetermined sample size). Indeed, it has 
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Figure 1. Sample path and critical boundaries for the Selenium and Breast 
Cancer data (one-sided sequential t-test without matching; a=0.05? l-ß=0.8 
and 9R=0.25). 
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A and B are the critical boundaries of the test; Z is the so-called 
"efficient score" for 8, computed as the cumulative standardized difference 
between the exposures of cases and controls; V is a measure of theamount of 
information about 9 contained in Z, also referred to as "Fisher's 
information" statistic. 
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been shown that, when either the null hypothesis Hft or the alternative 
hypothesis H. is true, the sequential probability ratio test is a more 
efficient test (4). 
Table 1 shows, for different values of 6_, the expected sample size for 
the sequential t-test used in the previous example, as compared to that for 
a test with a fixed sample size (these expected sample size values can be 
computed by the PEST program). 
Table 1. Expected number of case-control sets N in a sequential test for a 
standardized exposure difference 9, when in reality 6=0, 9=9_, or 9=0.759... 
Test without matching; <x=0.05, l-ß=0.80. 
one control 
per case 
(k=l) 
five controls 
per case 
(k=5) 
9R 
0.15 
0.25 
0.35 
0.15 
0.25 
0.35 
6=0 
255 
92 
47 
153 
55 
28 
sequential 
e=eR 
361 
130 
67 
216 
78 
40 
test 
9=0.756R 
414 
149 
76 
249 
90 
46 
fixed sample 
test 
550 
198 
101 
330 
119 
61 
It can be seen from this table that, for a sequential t-test with the given 
specifications (one-sided a=0.05, and l-ß=0.80), the expected sample size 
under HQ is approximately 0.46 times the fixed sample size at all values of 
e„. The expected sample size under H. is approximately 0.66 times the fixed 
sample size. For the open sequential test procedure described here, the 
expected sample size of the sequential t-test reaches its maximum in 
situations where the true 9-value is approximately equal to 0.75 9_, but 
even then remains below the sample size for a classical, fixed sample test 
of equal reliability. 
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Choice of the alternative hypothesis 
In sequential test procedures, an explicit definition of the alternative 
hypothesis H. is required, specifying the minimum standardized exposure 
difference 9R high enough to be detected with a given statistical power. 
Specification of the alternative hypothesis, in addition to the null 
hypothesis H«, results in a rule which defines at which stage there is 
sufficient evidence for not rejecting Hn or for rejecting H« in favor of H.. 
If there were no such a rule for stopping a sequential test procedure 
without rejection of H», the sampling of cases and controls could continue 
infinitely in those situations where no difference in exposure between cases 
and controls exists, without ever reaching a conclusion. 
The probability that, at a given stage in the sequential testing process, 
sufficient evidence will have accumulated on whether or not to reject the 
null hypothesis, H«, depends on the specific alternative hypothesis against 
which H0 is tested. For example, imagine a situation in which, at a given 
number of observations, there appears to be little difference between the 
mean exposures of cases and of controls. In such situations, the log-
likelihood ratio 1 would tend to be small if the alternative hypothesis 
were defined by a relatively extreme 9„-value, and H. would appear less 
likely to be true than H0 given the case and control observations. At a 
small value of 9_ specified, however, the same set of case- and control-
observations would have led to a higher log-likelihood ratio. The 
probability of concluding the test procedure with no rejection of the null 
hypothesis would therefore be higher in the first case (high value of 9_) 
than in the second (small value of 9_). Of course, this phenomenon is not 
specific for sequential tests in particular, but occurs also in statistical 
procedures based on a fixed sample size. The example does underline, 
however, that the choice of the alternative hypothesis (i.e., the value for 
9R) should be well motivated, in terms of potential public health impact or 
strength of the biological relation to disease. 
For the sequential t-test discussed here, 9_ is specified as a 
standardized difference between the mean exposures of cases and of controls. 
For epidemiologists, who are more familiar with the definition of study 
hypotheses in terms of measuring disease risk, this specification of the 
alternative hypothesis may be difficult to interpret. However, if the 
disease incidence is low over the entire range of exposures (i.e., the "rare 
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disease" assumption), and assuming that the alternative hypothesis is true, 
it is possible to compute a minimum expected odds ratio value, 0R_, for 
different quantile levels of the distribution of exposure measurements 
within the cohort (from which cases and controls were drawn). For instance, 
the expected odds ratio for the highest versus the lowest quintile of the 
exposure distribution equals: 
01^ (05-0.1) = e 2-80eR (see Appendix II.A). 
Thus, for an alternative hypothesis defined as 8>0.25, the minimum expected 
odds ratio of disease for the highest versus the lowest quintile of exposure 
measurements approximately equals 2.0. An extended list of expected odds 
ratio estimates, for different values of 6R, is given in Table 2. 
Table 2. Expected odds ratio, 0R_[Q5-Q1], for the highest versus the lowest 
quintile of the exposure distribution in the cohort, under the alternative 
hypothesis 0=6R. Study without matching. 
0RR[Q5-Q1] 
0.15 
0.20 
0.25 
0.30 
0.35 
0.40 
1.5 
1.8 
2.0 
2.3 
2.7 
3.1 
Analysis of matched studies: the pairwise sequential t-test 
The sequential test procedure described so far did not take account of any 
potential confounding factors. In many situations, however, it may be 
necessary to adjust for potential confounding factors such as age, duration 
of follow up, or additional risk factors such as body weight and menopausal 
status. Using the sequential procedure described here, adjustments for 
confounding can be made by matching cases and controls for such additional 
risk factors. In case-control studies nested within a cohort this may not be 
too complicated, since there will be a vast pool of disease-free subjects in 
which to find matched controls (unless there are many matching criteria). 
Whenever a matched study design is used, however, the matching should be 
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reflected in the analysis in order to obtain unbiased results. 
A matched sequential t-test can be based on the pairwise differences 
between the exposure measurement of a case, and the exposure measurement of 
each of k controls belonging to the same matched subset. We shall assume 
that these differences, D. . (where j=l, ,k indicates the j-th control 
subject in the i-th case-control set; i=l,...,n), will be normally 
distributed: 
D = N(6,T2), 
2 
where & is the mean, and x the variance of the differences D... As in the 
unmatched situation, the hypotheses H. and H. can then be defined in terms 
of a standardized difference 6 : 
HQ : e = 6/T = 0, 
and, for the one-sided alternative of a higher exposure for cases than for 
controls, 
H X : e = 6/T > eR (1). 
The computation of the statistics Z and V is slightly different from that 
for the unmatched situation (see Appendix I.B). However, the formulae for 
the critical boundaries of the test, A and B , remain the same (since these 
depend only on the values chosen for a, ß, and 8R). Also, with respect to a 
fixed-sample test, efficiency gains will be made similar to those in the 
unmatched situation, in terms of a decrease in the expected sample size. 
Again, with some additional assumptions it is possible to compute 
expected odds ratio values under the alternative hypothesis, 6=9R> for 
quantile levels of the within-stratum exposure distribution (strata being 
defined by the matching variables). As before, it will be assumed that for 
2 
cases and controls the exposure measurements have an equal variance, o , and 
that the overall incidence of disease is low. In addition, it will be 
assumed that, after matching, exposure measurements are equally correlated 
between controls or between cases and controls. The variance of the exposure 
differences D., between a case and k matched controls, can then be written 
as: 
2 2 2 
T = 2 (</-Y) = 2 o'Z , 
where y is the covariance between the exposure measurements of cases and 
2 
controls (due to the matching), and o' is the average variance of exposure 
v
 ' Note: If the exposure is expected to be higher for controls, the 
alternative hypothesis may be defined as H, : 6=6/x < - 8R. A two-sided 
alternative may be specified as H1 : |e| > €T. 
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among controls (and thus, approximately, in the full cohort) within strata 
defined by the matching variables. The expected odds ratio for the within-
stratum difference between the upper and the lower quintiles of the exposure 
distribution will be approximately equal to: 
0RR(Q5-Q1) = e 2'80 ^ 6 R , 
with 9_=6/T (see Appendix II.B). In Table 3, some expected odds ratio values 
are given for different values of 6 R" 
Table 3. Expected odds ratios, 0R_[Q5-Q1], for the highest versus the 
lowest quintile of the exposure distribution of the cohort within strata of 
the matching variables, under the alternative hypothesis that 6=8_ (l:k 
matching). 
9R 
0.15 
0.20 
0.25 
0.30 
0.35 
0.40 
0RR[Q5-Q1] 
k=l 
1.8 
2.2 
2.7 
3.3 
4.0 
4.9 
k=2 
1.7 
2.0 
2.4 
2.8 
3.3 
3.9 
k=3 
1.6 
1.9 
2.2 
2.6 
3.1 
3.6 
k=4 
1.6 
1.9 
2.2 
2.6 
3.0 
3.5 
k=5 
1.6 
1.8 
2.2 
2.5 
2.9 
3.4 
Discussion 
We have shown how a sequential t-test can be applied in case-control studies 
where the exposure measurement is a continuous variable. The use of the 
sequential probability ratio method in epidemiologic studies has been 
suggested before by O'Neill and Anello (14), who described a sequential test 
for analysing (matched pair) case-control studies, with a dichotomous 
exposure variable. So far, however, this has not been put into practice 
widely. An explanation may be that the advantage of a smaller expected 
sample size does not outweigh certain drawbacks in the use of an SPRT 
procedure, particularly in studies where (dichotomous) exposure assessments 
are based on information derived from questionnaires. One such drawback may 
have been the fact that epidemiologists are not familiar enough with 
sequential statistical methods and, until recently, no simple computer 
software for sequential analysis was widely available. Another drawback may 
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be that the sequential probability ratio procedure does not allow flexible, 
multivariate data modelling for the control of varying sets of confounding 
factors. In spite of these various drawbacks, however, a strong argument in 
favor of the use of sequential methods is the desire to make optimal use of 
material from biological banks, reducing the number of biological samples 
needed to test a given hypothesis. 
In a sequential design, the number of case-control sets that will be 
sampled before a conclusion is reached is a random variable, the mean of 
which is smaller than the size of an equivalent fixed-sample test (as 
illustrated in Table 1). Occasionally, however, larger numbers of case-
control sets may be needed for the test to come to a conclusion. This may 
introduce some uncertainty to the process of setting a budget for grant 
requests. However, budgets can be reasonably planned on the basis of the 
90th percentiles, rather than the means, of the possible sample size 
distributions (assuming 6=0, 6=6R, or 8=0.759_). The PEST programme contains 
a sub-routine for the computation of these percentiles, at the planning 
stage of a study. Further details about these computations can be found in 
Whitehead's textbook on sequential medical trials (8). 
The sequential t-tests described in this paper can be useful especially 
in exploratory studies, to decide, at the expense of as little biological 
material as possible, whether a new hypothesis seems worth further 
investigation, or whether it is more likely that it would eventually be 
proven unfruitful. It is generally agreed, however, that the use of 
hypothesis testing is an unsatisfactory way of assessing and presenting 
epidemiological findings, and that results should rather be presented as 
estimates of relevant measures of exposure-disease association, and their 
confidence intervals (15,16). Therefore, after terminating the sequential 
test, and irrespective of whether the null hypothesis is rejected or not, a 
presentation of final results should always include such point and interval 
estimates, describing the association between the marker values and disease 
risk (for instance, in terms of relative risks for different quantiles of 
the marker assessments). Since, on average, a sequential test will terminate 
at a smaller sample size than an equivalent fixed-sample procedure, 
estimates of epidemiological effect measures may be relatively imprecise. 
Once a given hypothesis has been proven of interest, however, (i.e., in case 
of rejection of the null hypothesis of "no difference" in exposure), the 
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investigator may decide to extend the number of laboratory assessments, so 
as to increase the precision of the study. The number of additional 
assessments needed to reach sufficient precision can then be determined from 
the standard error of effect estimates at the end of the sequential test, 
similarly as in a double sampling design (17). 
The combination of sequential testing and subsequent estimation of 
epidemiologic effect measures - with or without further extension of the 
study - can be seen as a two-step estimation procedure, which will tend to 
result in effect estimates with a desired precision if there is a clear 
difference in exposure, or in less precise estimates if no exposure 
difference of interest exists. In the latter case, on average more 
biological samples will be saved for the investigation of other hypotheses. 
O'Neill and Anello (14) have described how, for a dichotomous exposure 
variable and for matched case-control pairs, the critical values of a 
sequential test can be interpreted in terms of odds ratio values. He have 
shown that, under the rare disease assumption, and for a matched or an 
unmatched case-control design, similar interpretations can be given to the 
critical 6_-value of a sequential t-test for comparison of cases and 
controls by a continuous exposure variable. However, due care must be taken 
to avoid mis-interpretation. The sequential procedures described in this 
paper essentially provide a test for a difference between the mean exposures 
of cases and of controls, and are not a substitute for a test of statistical 
significance for odds ratios at different quantile levels of exposure. It is 
possible to compute expected odds ratio values for different quantile 
categories of exposure, such as quartiles or quintiles, under the assumption 
that the alternative hypothesis 9=6R is true (i.e., that a certain 
standardized difference in mean exposure actually exists). The relation 
between a 6R-value chosen and expected odds ratio values for different 
quantile levels of exposure is of interest only as far as it may help define 
a reasonable 6R-value for the alternative hypothesis. Within this context, 
the choice of quintile levels of exposure was of course quite arbitrary; 
computation of expected odds ratio values for tertiles or quartiles could be 
equally informative. 
The exact value which should be chosen as a reference odds ratio value 
0R_ (as defined for instance for quintiles) may depend on the specific 
hypothesis to be tested, as well as on the potential relevance of the 
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exposure in terms of attributable risk (i.e., also taking into acount the 
prevalence of exposure within a population). O'Neill and Anello recommend 
specifying that the alternative hypothesis should correspond to an odds 
ratio not greater than about 2.0 for exposed versus non-exposed subjects 
(the exposure in their paper being defined as a dichotomous variable). Ve 
agree that the value of 8R should always correspond to relatively small 
expected odds ratio values, so that a failure to reject the null hypothesis 
can be interpreted as the absence of any relevant association between 
exposure and disease risk. Of course it should also be kept in mind that, 
due to intra-individual variation over time, many biochemical markers will 
provide only an approximate estimate of the true risk factor of interest, 
and that the observed association with disease risk (also in terms of a 
standardized difference between mean exposures) may therefore be attenuated. 
In this paper, it was assumed that the sequential testing process 
proceeds in steps corresponding to case-control sets consisting of only one 
case and its k controls. It will often be more practical, however, to run 
laboratory analyses in batches of more than only one case-control set at a 
time. It is possible to perform the sequential probability ratio test on 
case-control sets each comprising multiple cases. The only disadvantage of 
such larger inspection intervals is that there can be some "over-running" of 
the critical boundary, by the sample path of Z plotted against V. The number 
of observations may thus exceed the number that was actually required to 
reach a conclusion, and part of the advantage of sequential methods, in 
terms of a reduction in expected sample size, will be lost. However, this 
loss of efficiency resulting from over-running can be limited by including 
only a relatively small number of cases in each group of observations. 
We have discussed only so-called "open" or "non-truncated" procedures, in 
which no upper limit has been set to the number of observations needed 
before a conclusion is reached. Therefore, although sequential procedures 
will on average require fewer case-control comparisons than equivalent tests 
based on a fixed sample size, there may be occasions on which the sequential 
procedure terminates after a much larger number of observations than would 
have been required for a classical, fixed sample test. In "closed", or 
"truncated" sequential procedures, an upper limit is fixed for the actual 
number of observations that may be needed in order to reach a conclusion. 
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For instance, it may be decided that the null hypothesis will not be 
rejected if the number of case-control comparisons becomes larger than twice 
the normal sample size for a fixed sample test without reaching the critical 
boundaries, A or B . Such an additional stopping rule will then affect a 
and ß to some extent. If the maximum number of observations chosen is 
sufficiently large, however, the effects on these error probabilities will 
be relatively small. Whitehead's computer programme "PEST" (13) provides an 
option for the analysis of sequential studies with a truncated design. More 
extensive discussions of truncated sequential procedures are given in his 
textbook on sequential clinical trials (8), as well as by Wetherill and 
Glazebrook (5), and Armitage (7). 
Aliquots of biological specimens such as blood serum cannot be thawed and 
refrozen too frequently without potentially causing changes in the 
biochemical parameters of interest. However, the volume of aliquots may 
often be sufficiently large to allow more than one type of biochemical 
analysis within the same laboratory. It would thus be possible to study 
several etiological hypotheses in parallel, based on different biochemical 
markers measured in the same aliquot. The simple sequential tests described 
in this paper are based on the concept of studying only one type of exposure 
measurement in relation to a single type of disease. Further development of 
sequential statistical methods is needed, so that such multiple, parallel 
hypotheses can be evaluated simultaneously with minimal loss of biological 
material. 
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Appendix I. Computation of the statistics Z and V, and formulae for critical 
boundaries A and B . 
I.A Analysis without matching: After the n-th case-control subset, the 
following sample statistics will be available: 
Cases Controls All 
Number of observations n nk n(k+l) 
Sum of observed exposures S. Sn S 
Sum of squares Q. Qn Q 
The statistics Z and V are computed from the cumulative sums, S. and S«, and 
cumulative sums of squares, Q. and Q«, of the exposure measurements of cases 
and controls, respectively (see Whitehead (7) pp. 57-62). The efficient 
score statistic Z is computed as: 
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z = • 
where 
c2 = 
n k S. - n S» 
n (k+1) C 
Q 
n(k+l) 
• 
n(k+l) 
2 2 
It is to be noted that C is a maximum likelihood estimate of o , under the 
null hypothesis 6=0. Thus, Z is equivalent to the cumulative difference 
between the exposure measurements of cases and of controls, divided by a 
maximum likelihood estimate of the standard deviation o. Fisher's 
information statistic V is computed as: 
n nk Z2 
n (k+1) 2 n(k+l) 
Coefficients for critical boundaries A and B are computed as: 
In 
1-ß 
l ß 
a = 
( i i 1-a 
+ In 
and 
2 6„ 
In 
f 1-ß 1 
l ß 
1-a 
+ In 
( 1 A 1-a 
In 
For a=0.05, ß=0.2 and 9R=0.25 this leads to a=8.661 and b=0.17. 
( A continuity correction is calculated as ± 0.583 •/(V. - V. . ) , 
independently of values of a, ß, and 8_; in this paper continuity 
corrections were of negligible magnitude, and have been ignored for the sake 
of simplicity. ) 
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I.B Matched analysis: The following sample statistics can be computed after 
each new case-control subset : 
Number of case-control sets n 
Sum of exposure differences D. S 
2 
Sum of squared differences D. Q 
The efficient score statistic Z is computed as : 
S 
Z = 
C 
where 
Q 
n 
C2 
2 
Again, C corresponds with a maximum likelihood estimate of the variance of 
the exposure differences D., under the null hypothesis (6=0). Fisher's 
information statistic is computed as : 
Z2 
2n 
(See whitehead (8), pp. 67-68.) 
Appendix II. Relation between 6_ and the expected odds ratio for the upper 
versus the lower quintile of exposure. 
II.A Analysis without matching: Suppose that, both among cases and among 
controls, exposure measurements M have normal distributions with different 
means but with an equal variance: 
M|case = N(p.,o ), and 
M|control = N(u0,o ). 
If the probability density functions of both exposure distributions are 
given by <fr,(M) = Pr(M|case) and <t>0(M) = Pr(M | control), respectively, then, 
for a given difference in exposure, A=m.-m0, the odds ratio of disease can 
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be written as : 
0R(A) _ •1C1)/»0C1) _ ^ - ^ ( . ^ / o 2 __ e8A/a _ 
<
*
>it n ,o ) /*o ( mo ) 
Here, the standard deviation o is unknown. If the disease incidence in the 
cohort is low, however, the distribution of exposure measurements of the 
controls will be approximately identical to the exposure distribution in the 
entire cohort. Then, for subjects belonging to different quantile categories 
of this distribution, the expected difference in exposure A can be expressed 
as a number of unknown standard deviations o. The expected exposure 
measurement above a given cutpoint value L can be computed as the mean of a 
truncated normal distribution: 
E(M|M>L) = u0 + a 
•I(L-u0)/o] 
1 - *[(L-u0)/o] J 
where <(>[u] is the probability density function, and $[u] is the cumulative 
distribution function of the standard normal distribution at the point u. If 
L is chosen to be the cutpoint for the highest quintile of exposure, we find 
from the normal distribution table that (L-uft)/o = 0.84. The average 
exposure in the highest quintile is thus expected to be equal to: 
E(M|M>L) = u + o 
<H0.84] 
0.80 
H0 + 1.40 a. 
Likewise, the average exposure in the lowest quintile is expected to be 
equal to E(M|M<-L) = uQ - 1.40 o. Thus, the difference between the average 
exposures in the highest and lowest quintiles will be equal to A = 2.80a. 
The expected odds ratio for the highest versus the lowest quintile of 
exposure can now be written as a function of 6: 
OBjIQS-Ql] = e 6 A / o = e2"809. 
Inversely, this function can be used to compute the value for 8_ that 
corresponds with a minimal expected odds ratio, 0R„[Q5-Q1] for the upper 
versus the lower quintile of exposure. For instance, an expected odds ratio 
of 2.00 corresponds with a standardized difference between the mean 
exposures of cases and controls equal to 6„ = ln(2.00)/2.80 = 0.25. 
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II.B Matched analysis 
Suppose that, in a matched pairs study, D. is the difference between the 
exposure measurement for the i-th case and its matched control, and let the 
2 
distribution of such differences be given by D. = N(&,T, ). Then, as was 
previously derived by Rosner & Hennekens (18), the odds ratio for a 
difference D.=A can be computed as : 
e-fc(A-6)2/tJ 
0R(A) = Pr(D.=A)/Pr(D.=-A) = = e29l A/tl , 
1
 2 2 
e-*(-A-8)VTf 
with 61=6/T1. 
Assume, moreover, that for unmatched cases and controls the exposure 
distributions have an equal variance, and that, after matching, the exposure 
measurements are equally correlated between controls (if more than one 
control is matched per case), or between cases and controls. The variance of 
the exposure differences, D., between a case and a single matched control 
will then be equal to 
2 
ll 
where y is the covariance between the exposures of cases and of controls 
2 2 (due to the matching). In this case, o' = o -y can be interpreted as the 
average variance of exposure measurements among controls (and thus, 
approximately, in the full cohort) within strata defined by the matching 
variables. The expected difference between the top and bottom quintiles of 
the within-stratum exposure distribution can then be written as 
A = 2.80 o' = 2.80 
^2 
The odds ratio corresponding with this difference in exposure equals 
0RR(Q5-Q1) = e26lA/Tl = e2'80 V 2 61 
with 
e1=6/t1. 
If k>l controls are matched per case, the variance of the exposure 
differences D. becomes smaller: 
xk
2
 = (k+l)/k o'2 , 
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and we can write 
9X = 6/x1 = 7((k+l)/2k) 6/tk = \/((k+l)/2k) ek. 
Thus, with k controls per case, 
OHRCQS-Q!) - e2"80 ^  ei = e2'80 « W * ) ek. 
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Prospective cohort studies provide an ideal epidemiological approach to 
investigating the relation between dietary intake patterns, indicators of 
nutritional status, and the risk of developing chronic diseases such as 
cancer. To obtain sufficient numbers of cases with a specific form of 
disease, however, such studies must be very large (1-3), and thus require 
important investment for the collection of exposure assessments (the costs 
of follow up and statistical data analysis are much lower when passive 
follow-up is possible through routinely collected data). It is therefore 
fundamental to use an efficient study design, to optimize the amount of 
information obtained for a given investment of time and resources. Three 
main arguments can be identified, around which the efficiency aspects 
discussed in this thesis can be grouped: 
1) approaches to maximize the amount of variation in true exposure level 
that is actually distinguished - or "predicted" - by exposure 
measurements collected at baseline; this is a way to increase the power 
of a cohort study (to test for the presence of diet-disease 
associations) while keeping its size constant; 
2) approaches for the precise estimation of the distribution of predicted 
exposure levels; this is essential for accurate estimation of 
statistical power or sample size requirements for the cohort, as well 
as for the adjustement for biases in estimates of the (log) relative 
risk; and 
3) the optimal balance between, on the one hand, a minimum study size to 
allow a minimum power for a statistical test on whether there is an 
association between exposure and disease risk, and, on the other hand, 
the number of different exposures measured. 
Chapters 2 to 5 of this thesis are mainly related to the first two 
arguments, and discuss efficiency aspects related to the assessment of the 
habitual, long-term dietary intake levels of individual participants in a 
prospective cohort study. Chapter 6 is more related to the third argument, 
addressing the aspect of optimizing the number of relevant etiological 
hypotheses that can be evaluated when exposure assessments are based on 
biochemical markers measured in urine, blood, or (other) tissue specimen. 
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I. The assessment of dietary intake levels 
Maximizing the variation in predicted dietary intake level 
Two possible approaches have been discussed to maximize the amount of 
variation in true dietary exposure level predicted by the dietary 
questionnaire assessments collected at baseline. 
First, one may select a dietary questionnaire method by which individuals 
can be ranked as precisely as possible by their true, habitual intake 
levels. This selection can be based on a validity study, conducted even 
before the cohort study is started, in which the correlation between 
questionnaire measurements and true intake level is estimated. In Chapter 2 
it is concluded that this estimation requires a comparison of questionnaire 
assessments with at least two additional intake measurements, based on 
repeat food intake records, or on an intake record plus a biochemical 
marker. A crucial assumption is that the three measurements should have 
mutually independent random errors. As discussed in Chapter 3, it will often 
be difficult to conduct a validity study within a truly representative sub-
group of the (planned) main study population. This may not be a major 
problem, however, as long as the validity study is used only to develop or 
select an optimal dietary questionnaire instrument, assuming that the 
selected method will also be the optimal one for use in the main study 
cohort. 
A second method to increase the amount of predicted variation is to 
broaden the range of true dietary intake levels covered, by combining the 
data from multiple cohort studies conducted in populations with 
heterogeneous life styles and dietary habits. The analysis of such multi-
cohort studies entails some specific problems, however. Stratifying the 
analysis by the factor "cohort" would restrict comparisons of dietary intake 
levels and disease outcome to those between subjects belonging to the same, 
restricted study population. Stratification would therefore defeat the main 
purpose of multi-cohort studies, which is to increase power by augmenting 
the range of dietary exposure levels. An alternative, "naive" approach would 
be to treat the data of all the cohorts combined as if they had been 
collected within a single study population, and to perform an analysis 
without stratification by cohort. This alternative approach would ignore, 
however, whether there is sufficient concordance between the cohort-specific 
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relative risk estimates for these to be combined into a single summary 
estimate. Likewise, no evaluation would be made of the presence of any 
confounding by "cohort", as a potential source of "ecological bias" (4). In 
Chapter 4 it is shown that the overall relative risk estimate obtained in a 
pooled, unstratified analysis is approximately equivalent to a weighted 
average of several component estimates based on 
a) within-cohort variations in exposure level and disease risk of 
individuals, and 
b) the between-cohort variation in the exposure and disease risk as 
measured at an aggregate level. 
Only if there is sufficient concordance between the various component 
estimates is it valid to compute an overall, combined summary estimate of 
relative risk. 
Estimating the predicted amount of variation in true intake level 
Having taken all possible measures to maximize the amount of variation in 
true intake level predicted by questionnaire assessments collected at 
baseline (to optimize the power of tests for a diet-disease association), 
additional reference measurements are needed, at least in a representative 
sub-group to estimate the magnitude of this predicted variation. An 
important conclusion reached in this thesis is that, for a fixed total 
number of daily intake records taken as reference measurements in a 
calibration sub-study, the variance of predicted intake levels will be 
estimated most precisely when a calibration sub-study includes a maximum 
number of participants with only a single record each. A major additional 
advantage of this calibration study design is that it allows such sub-
studies to be conducted more easily on a truly representative sample of 
cohort participants. In contrast to preliminary validity studies for the 
development and selection of a dietary questionnaire instrument, the 
representativeness of calibration studies is strictly required for the valid 
evaluation of study power or biases in relative risk estimates. 
In multi-cohort studies, the calibration approach can be used to adjust 
for heterogeneity in cohort-specific relative risk estimates resulting from 
divergent biases due to dietary assessment errors. If the calibration is 
perfect, this will improve the precision of a pooled summary estimate, by a 
more optimal weighting of cohort-specific estimates (the weights being 
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inversely proportional to the variances of the predicted intake 
distributions, rather than to the variances of baseline dietary intake 
assessments). On the other hand, calibration increases the width of 
confidence intervals of relative risks as estimated within cohorts 
separately, due to imprecision in the estimation of the calibration factor. 
No quantitative evaluation has been made of the potential gains in power 
by a more optimal weighting of cohort-specific evidence, against the losses 
in power that will be incurred within each cohort separately. The outcome of 
such evaluation will, among other things, depend on what we would assume to 
be the sources of heterogeneity between log relative estimates obtained in 
different cohorts (5,6). Assuming that true relative risks are the same in 
cohorts, the most precise summary estimate of (log) relative risk is 
obtained by weighting each cohort-specific estimate by the inverse of its 
variance, as described in Chapter 4. This approach is based on a so-called 
"fixed effect model" (6). When there is important heterogeneity between the 
estimates, however, even after calibration adjustments, it may be difficult 
to justify a single summary estimate for all cohorts combined. In this case 
it may be preferable to use a "random effects" model, in which both a 
between-cohort (extra-logistic, or extra-Poisson) variance and the within-
cohort variances of (log) relative risk estimates are accounted for in 
deriving the weighting of the cohort-specific estimates (7,8). This aspect 
may require further research. 
The pragmatic approach chosen in Chapter 5 for the computation of sample 
size requirements for calibration studies, is that the relative efficiency 
of calibration within cohorts should be high when the observed associations 
between questionnaire assessments and disease risk are relatively weak (such 
as for fat intake and breast cancer), because it is especially in this 
situation that even a modest increase in statistical power may be of 
interest. On the other hand, the relative efficiency may be lower in 
situations where the association is more significant even within a single 
cohort. This motivated the use of two alternative criteria to compute sample 
size requirements for dietary calibration studies: 
a. the relative efficiency of the calibration study (which defines to what 
extent the precision of the adjusted estimate of log-relative risk (6) 
is limited by random error in the estimation of the calibration 
factor), or 
b. the ratio of the expected, calibrated 6-estimate divided by its 
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Standard error (i.e., the expected t-value to test whether the 
calibrated 8-estimate differs from zero). 
Using these criteria, the calculation of sample size requirements needs only 
one assumption, about the minimum level of correlation between questionnaire 
and reference measurements. The expected t-value is above all a criterion of 
statistical power more than of precision. The use of a fixed value of the 
expected t-value as a criterion for minimum precision of the estimated log 
relative risk implies that one accepts a larger margin of error when the 
estimate itself is larger. Preferably, precision should be defined by the 
absolute width of the confidence interval, and for estimates of the relative 
risk itself rather than for its logarithm. However, this definition would 
result in much more complicated calculations of sample size requirements, 
based on the separate specifications of an increased number of key 
parameters, such as the strength of the association between true dietary 
intake levels and disease risk, and of the expected number of cases. 
Stratified sampling of calibration studies, and definition of "cohorts" 
When planning the sampling scheme for a calibration sub-study, nested within 
a prospective study cohort, it must be anticipated that, during the analysis 
of the cohort study, statistical adjustments will be made for potential 
confounding factors such as age and sex. This has two implications for the 
design of calibration studies. First, the variance of a given exposure 
variable of interest will on average be smaller within confounder strata 
than in the non-stratified cohort. Consequently, the correlation between 
questionnaire and reference measurements adjusted for the confounding effect 
will tend to be weaker (9). To account for this effect, the estimation of 
sample size requirements for calibration studies should be based on the 
partial correlation between questionnaire assessments and reference 
measurements, adjusted for age and sex, and possibly also for other 
potential confounding factors. Second, the variation in true intake levels 
can vary across strata of main confounding factors such as age or sex or 
demographic sub-groups (10), whereas the magnitude of random errors may also 
show some variation. Thus, true intake differences may not be predicted in a 
uniform manner by questionnaire assessments, and, between strata, there may 
be different amounts of bias in relative risk estimates in the same way as 
this may happen between "cohorts" (which in fact can also be considered as 
strata, in a multi-cohort study). Perfect calibration can therefore also 
130 Chapter 7 
result in an improved weighting of log relative risk estimates across strata 
defined by age, sex, or other potential confounding factors, the relative 
weights being proportional to the predicted intake variance in each stratum. 
In an optimally designed calibration study, the relative efficiency of 
calibration (as defined by the ratio D/D in Chapter 5) should be of equal 
magnitude across confounder strata. Assuming that the true log relative risk 
does not vary between strata, the relative efficiency will be constant if 
the numbers of subjects sampled for the calibration study are a fixed 
multiple of the expected numbers of cases (Chapter 5, equation 4). This 
underlines that, ideally, sample size requirements for calibration studies 
should be based on a relative efficiency criterion alone. The use of a high 
relative efficiency as the only criterion may however lead to excessively 
high sample size requirements in situations where there is a relatively 
strong association between baseline questionnaire assessments of intake 
level and disease risk (i.e., unadjusted relative risk estimates are 
relatively high), or where the number of cases is large. It was therefore 
proposed that, at the level of "cohorts", the sample size requirements for 
calibration studies would be truncated to a maximum level, using the 
expected t-value for the calibrated log relative risk estimate as an 
alternative criterion. This raises the question: At which sub-group level 
the truncation rule should be applied; that is, at what level do we wish to 
consider certain sub-groups to be separate "cohorts"? A guiding principle is 
that the true relation between diet and disease risk within cohorts is 
expected to be relatively homogeneous across strata of other potential 
confounding factors, whereas between cohorts this assumption remains to be 
verified. On the other hand, there are also practical considerations, such 
as the financial resources available. For the EPIC project, it was decided 
to define cohorts by country. One of the objectives of this project is to 
evaluate the consistency of relative risk estimates between countries, as 
life-style and dietary intake patterns vary considerably in different 
countries. An additional, more pragmatic consideration was that cohorts 
should be relatively independent within each country, and reach a sufficient 
level of power and precision at a national level. It was thus estimated that 
within each participating country in the EPIC project, the calibration 
sample will include about 4000 subjects (assuming a minimum correlation of 
0.2 between questionnaire and reference measurements, this corresponds to a 
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relative efficiency of calibration of at least 0.90 or, alternatively, an 
expected t-value for the calibrated log relative risk greater than 4.0). 
Financial resources would have been insufficient, however, to conduct 
calibration studies of this size (i.e., including up to 4000 individuals) at 
a smaller sub-group level defined for example by regional study centre, 
ethnic group, or sex. 
Further aspects related to validation and calibration, and topics for 
future research 
Relative risks, and attributable fractions 
A condition for using the calibration approach is that relative risks must 
be estimated for scaled quantitative intake differences, rather than for 
quantiles of the measured intake distribution. In the discussion of Chapter 
3, several arguments are given as to why the first type of relative risk 
estimate should be preferred to that for quantiles. Nevertheless, an 
attractive aspect of relative risk estimates for quantiles is that these can 
be easily interpreted in terms of attributable fractions (11) if the 
quantile cutpoints are determined for the full cohort population (or for the 
control population in a nested case-control study). This may also explain 
why, in nutritional epidemiology, it has become customary to estimate 
relative risks for quantile categories. 
For unbiased estimation of the attributable fraction from relative risks 
defined for quantile levels, the relative risk estimates should be adjusted 
for attenuation bias, which, for this form of relative risk estimate, 
requires an estimate of the correlation between questionnaire assessments 
and true intake values (12,13). This remains a valid reason for conducting a 
dietary validity study within a cohort, based on at least two reference 
measurements per person (e.g., daily intake records), or combining one 
reference measurement with a biochemical marker, as described in Chapter 2. 
In this context, it may be of interest to note that a validity study is also 
needed for the unbiased estimation of the attributable fraction for subjects 
with true intake levels above or below a given absolute cutpoint value T». 
Under the model assumptions of Chapters 3 to 5 - i.e., an exponential risk 
model, and a normally distributed intake variable - the attributable 
fraction F can be computed as (14) 
F=l-exp[9(T0-uT- % 9o£)] . 
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A calibration study allows an unbiased estimation of only two of the three 
unknown parameters in this equation: the log relative risk 9, and the mean 
true intake value uT. A validity study will be required, however, to 
2 
estimate the variance of the true intake distribution o_, which, together 
with the mean intake value u-, defines the proportions of individuals with 
true intake levels above or below the cutpoint value T... 
Multivariate validation and calibration 
"Validation" is usually defined as the evaluation of whether a given method 
actually measures what it purports to measure (15,16). In practice, one of 
the objectives of conducting a dietary validity study is to estimate the 
amounts of "noise" and "signal" in measured intake levels of foods or 
nutrients; that is, to separate variation due to error, from variation due 
to true between-subject intake differences. Throughout this thesis, 
validation has been considered only in terms of a univariate measurement 
error model, considering the intake level of only one food or nutrient. This 
univariate approach does not address the question whether the "signal" 
represents differences specifically in the type of intake variable that one 
purports to measure. For example, there can be high correlations between 
intake measurements of animal protein and saturated fat, or between vitamin 
C and beta-carotene, even when the two variables are measured by different 
methods. Partly, this correlation may be explained by the fact that, 
depending on body size and physical activity, some individuals consume more 
food than others, and that generally the intake levels of most nutrients are 
positively correlated with total energy intake (17). An additional 
explanation is that specific nutrients tend to be found in similar types of 
food. For example, fruits and vegetables are by far the main sources of 
vitamin C and beta-carotene, while meat or dairy products provide only 
negligible amounts of these compounds. More research is needed on the use of 
validity studies to estimate how much variation exists in the true intake 
level of one nutrient independently from that of another, using a multi-
variate measurement error model similar to that in Chapter 2, but with 
intake levels of different nutrients represented by multiple (correlated) 
latent variables. 
The presence of multiple correlations between the many different chemical 
constituents of foods also form a problem for the calibration approach. For 
example, questionnaire assessments of animal protein intake will not only 
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predict true intake differences for animal protein itself, as a main factor 
of interest, but also for saturated fat or other constituents that may be 
particularly abundant in meat, eggs, or dairy products. To account for the 
multivariate correlations between the intakes of different nutrients as 
potential predictors of disease risk, these variables can be treated as 
mutually confounding factors, by including them simultaneously in a relative 
risk estimating model. A complication, however, is that each intake variable 
will be measured with substantial amounts of random error. When errors are 
independent, inclusion of one variable as a potential confounder of the 
effect of another will result in only a partial adjustment, leaving residual 
confounding (9,18-20). The situation becomes even more complex when one 
considers that errors in questionnaire assessments are likely to be 
correlated for nutrients that tend to be present in the same types of food 
(19-21). As a possible solution to this problem, Rosner et al. (22) have 
extended the linear approximation approach to the situation with multiple, 
correlated exposure factors each measured with error. This multi-variate 
calibration approach estimates the variation in the intake levels of 
multiple nutrients (measured by a reference method) as predicted by a 
similar number of baseline questionnaire assessments, and provides valid, 
mutually adjusted relative risk estimates. The major requirement remains 
that, for each nutrient, errors in the reference measurents must be 
independent of those of the baseline questionnaire assessments. More 
research is needed for the evaluation of sample size requirements for 
calibration studies with multiple covariates. 
Robust statistical methods for validation and calibration 
The approach for validation of dietary questionnaire assessments, as 
described in terms of structural equation models in Chapter 2, depends on 
the assumptions that the relations between different types of measurements 
are linear, and that distributions of the latent, true intake variable as 
well as of measured intake values are approximately normal. These have been 
the underlying assumptions for the analyses of most validity studies 
published so far, although this has not always been made very explicit. 
Similar assumptions are needed for the calibration approach described in 
Chapter 3. 
In practice, the assumptions of normal distributions and of measurements 
having homoscedastic random errors do not always appear to be valid. 
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Distributions of nutrient intake assessments often show a negative skewness, 
reflecting a larger variance of random errors at the higher intake levels. 
In Chapter 2, transformations were used to improve the normality of the 
measured intake distributions. It is unclear, however, whether the 
assumption of linear relations between different types of intake 
measurement, or between intake levels and the logarithm of disease risk, can 
reasonably be made after such transformations. Future work should explore 
the use of more robust statistical methods for validation and calibration of 
dietary intake assessments, which depend less on assumptions of normality 
the intake distribution, and homoscedasticity of measurement errors. 
II. The use of sequential study designs 
An important approach to reducing the cost of a prospective cohort study is 
to bank "raw material" collected at baseline and to complete the exposure 
assessment when it is known which individuals have developed a specific form 
of disease, and who are suitable control subjects. This approach may in 
principle apply to all types of information obtained, whether collected by 
questionnaires or by means of biochemical markers. Coding and entry of 
questionnaire data into the computer may be too expensive to complete for 
all participants in a prospective cohort study. It may therefore be decided 
to complete coding and data entry only for cases with disease, as soon as 
these have been identified, and for a subset of disease-free subjects used 
as controls in a nested case-control, or case-cohort design (3). For similar 
reasons - in particular, the high cost of laboratory analyses - biological 
specimens such as blood or urine may be frozen and stored in a biological 
bank until it is known who has developed a specific form of disease and who 
are suitable control subjects. An additional reason for creating a 
biological bank, however, is that only a limited amount of biological 
specimens (e.g., blood, or urine) can be taken from each individual. To some 
extent, an analogous problem exists when using questionnaires for the 
collection of exposure information (about diet, as well as about many 
potential confounding factors), since including too many questions may 
reduce the quality of response, or may decrease rates of participation in 
the study. Nevertheless, an obvious difference between questionnaires and 
biological specimens is that a choice of questions to be included in a 
questionnaire must be made at the beginning of the study, whereas it can be 
decided later what types of biochemical markers will be assessed, once cases 
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and controls have been identified. Thus, the banking of biological material 
is used not only to reduce the costs of exposure assessment, restricting the 
assessments to cases and a subset of disease-free individuals, but also to 
postpone the decision on which hypothesis will be tested (and which 
corresponding markers of exposure will be assessed) depending on the type of 
disease outcome observed. 
In the case of a well established biological hypothesis, which has long 
been waiting for a more definite answer (e.g., free estrogens and breast 
cancer risk), a precise estimation of the association between the marker and 
disease risk is of interest not only when this association is clearly 
present, but also when, after careful evaluation, the association appears to 
be very weak or even absent. In the case of a more tentative hypothesis, 
however, related to a new type of marker, one will generally be more 
interested in such precise estimation when a clear association does exist, 
whereas in the absence of a clear association one would rather save the 
biological samples to search for stronger predictors of disease risk. The 
sequential t-test discussed in Chapter 6 presents a simple approach to 
deciding whether a new hypothesis is worth further investigation, while 
avoiding wasting too much biological material in testing a hypothesis which 
is not strongly supported by the emprical data at hand. 
The sequential probability ratio procedure presented in Chapter 6 has the 
advantage that on average it requires fewer observations to test for the 
presence of an association than a traditional, fixed sample test procedure, 
not only in situations where the null hypothesis is to be rejected, but also 
in situations where the null hypothesis is true. The latter is not true of 
all sequential procedures, however. For example, Pasternak and Shore (23) 
have proposed the use of repeat significance tests on the accumulating data 
in prospective studies, with adjustment of the nominal significance (i.e., 
a- ) levels for planned interim tests, to avoid an increase in the overall 
probability of falsely rejecting the null hypothesis (24). The appeal of 
Pasternack and Shore's sequential procedure is that it uses standard 
statistical test methods common in epidemiology. However, although the 
expected numbers of observation required in repeat significance tests are 
smaller than in fixed-sample test procedures when the alternative hypothesis 
is true (and the null hypothesis is to be rejected), the average number of 
observations needed is actually larger when the null hypothesis is true. 
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Chapter 6 is an extension of a previous paper which discusses two 
different versions of a sequential t-test, based on alternative 
approximations of the log likelihood ratio, and using a self-written 
computer programme. A copy of this paper is included in the Annex of this 
thesis. Computer simulations were carried out to evaluate the operating 
characteristics of the two alternative tests, in terms of their true levels 
of statistical significance and power. Similar simulations have been done to 
evaluate the sequential t-test by Whitehead's approach discussed in Chapter 
6 (i.e., using the "PEST" programme), and it was found that generally this 
approach is superior to the methods used in the previous paper (van der 
Tweel, personal communication). An additional aspect, which had not been 
addressed in the previous paper, is to find a reasonable definition of the 
alternative hypothesis expressed as a standardized exposure difference. In 
Chapter 6 it is shown that this standardized difference can be related to an 
expected odds ratio of disease, for quantile categories of the exposure 
distribution. 
As already mentioned in Chapter 6, a potential shortcoming of the 
proposed sequential t-test is that it allows an evaluation of only one type 
of exposure at a time, whereas in practice it is often possible to measure 
several markers in the same aliquot of a biological specimen. More work is 
therefore needed on the use of sequential methods in which the stopping rule 
is based on case-control differences in more than one type of exposure. 
III. Conclusions 
A basic approach to improving the statistical power of a cohort study 
without increasing its size is to maximize the amount of variation in true 
intake level predicted by measurements collected at baseline. Preliminary 
validity studies, based on multiple, additional measurements with 
independent sources of error, can help select an optimal questionnaire 
instrument to measure dietary intake. Additional, unbiased ("reference") 
measurements are also needed to evaluate the statistical power and sample 
size requirements of a cohort study, and to obtain unbiased relative risk 
estimates. For the latter two objectives, however, it is more efficient to 
conduct "calibration" sub-studies based on only a single reference 
measurement per subject (but on a larger number of individuals). Calibration 
studies should always be conducted on a representative sub-sample of cohort 
participants. In multi-cohort studies, calibration of intake assessments can 
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help decrease between-study heterogeneity in relative risk estimates due to 
bias, and can thus improve the precision of a pooled summary estimate. 
Sample size requirements of calibration sub-studies can be determined on the 
basis of a trade-off between relative efficiency criterion or, 
alternatively, a minimum absolute level of statistical power for a test on 
diet-disease association after calibration. For optimal efficiency, the 
number of participants in calibration sub-studies within cohorts should be 
proportional to the numbers of cases expected within strata of main 
confounding factors. 
An important aspect of the planning of prospective studies is to find an 
optimal balance between the cohort size required to attain a minimum level 
of power and precision, and the number of different exposures measured. When 
exposure measurements are based on the chemical analysis of biological 
specimens, stored in a biological bank, a sequential statistical design can 
be used to minimize the average number of specimens required for the 
preliminary evaluation of a scientific hypothesis. Thus, a maximum number of 
scientific hypotheses can be addressed with a given total amount of 
biological material available. A commercially available computer programme, 
"PEST", can be used for the analysis of such sequential studies. 
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Abstract—Application of sequential analysis may avoid unnecessary experimentation 
and achieve economical use of available biomaterial stored in biological banks. When, 
as often happens in cohort case-control studies, cases are scarce, it may be possible to 
use multiple control observations per case to increase the power of a test for detecting 
differences between cases and controls. Samples from a biological data bank were 
analysed. We compared results of a non-sequential analysis with results of sequential 
/-tests for 1 to 5 controls matched per case in a cohort nested case-control study. 
Simulations are performed to get an idea of the unreliability and the power of the 
sequential test. In general the sequential /-tests are too conservative with respect to the 
achieved power. Average sample numbers are lower for the sequential tests and decrease 
with multiple controls. More than 3 or 4 controls per case does not give a meaningful 
increase in efficiency. 
Sequential /-test Multiple controls 
Cohort nested studies 
Simulations Efficiency Biobanking 
INTRODUCTION 
Sequential analysis of quantitative data has 
never found wide application in clinical trial 
practice, even though considering its use 
might be worthwhile. For ethical reasons 
alone one may wish to minimize the expected 
number of exposed patients. From an exper-
imental point of view, one may wish to avoid 
unnecessary experimentation. In cohort nested 
case-control studies exposures may be assessed 
in biological samples stored in a biological 
bank. In this situation, economy with material 
from the biological bank may be a reason to 
choose a sequential type of analysis. In a 
prospective study, cases are often detected 
sequentially during follow-up. A sequential 
analysis could then limit the total duration of 
the study. 
In a sequential case-control analysis, the re-
sponse of a case is compared with the response 
of a single control. O'Neill describes in a de-
tailed way a sequential analysis of a matched 
pair case-control study with a dichotomous 
response [1]. 
In a cohort study, usually there is only a 
limited amount of biological material per sub-
ject, and there are far more controls in the bio-
bank for which such material can be analyzed 
than cases. Therefore it may be desirable to com-
pensate for the loss of statistical power by com-
paring each case with more than one control [2], 
Ury [3] showed that, for non-sequential 
case-control studies with continuously dis-
tributed data, the efficiency of multiple {k > \) 
controls relative to matched pairs (k = 1) is 
equal to 2k j(k + 1) for equal case and control 
variability. 
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Gail et al. [4] show that in (non-sequential) 
situations with a limited number of cases, more 
than four controls per case (or vice versa) does 
not give a meaningful power increase. 
We are unaware of literature about the 
efficiency of multiple controls per case in 
sequential analyses. Therefore, we compared the 
effect of more controls per case in a sequential 
design with the results of a non-sequential 
analysis. 
MATERIALS AND PATIENTS 
We performed retrospective analyses on data 
from a cohort nested case-referent (control) 
study on breast cancer and the selenium content 
in ppm of toenails (Van Noord [5]). The aim of 
the study was to determine whether selenium, as 
available in the body, is already decreased be-
fore tumour occurrence. 
Nail clippings had been collected since 1982 
in a cohort of 8760 premenopausal (i.e. without 
menopausal signs) women (42-52 years of age), 
who attended a breast cancer screening pro-
gram. A total number of 64 premenopausal 
breast cancer cases were detected in this cohort. 
Controls were matched to cases for age. For 
57 cases 5 controls per case were available; for 
7 cases 3 or 4 controls could be matched per 
case. 
Selenium content in the nails did not depend 
on age, probably due to the relatively small 
age-range in our data. No seasonal or other time 
trends were found in nail selenium contents 
during 3 years of investigation (unpublished 
results). 
The data were analysed in the order the cases 
became available over time. 
STATISTICAL ANALYSIS 
Non-sequential analysis 
For matched case-control observations the 
minimal sample size n, (i.e. the number of 
case-control pairs necessary) for detecting a 
true difference between case and control obser-
vations of at least fi with a (two-sided) type I 
probability (or unreliability) a and a type II 
probability ß (i.e. power 1 — )S) is [6] 
«I = ('a + h?*o\ln\ 
where 
a] is the variance of the difference be-
tween a case and a control obser-
vation, 
ta and tß are values from the two-tailed t-
table with «, - 1 ^"corresponding to 
probabilities of a and ß respectively. 
The type I probability a is the risk one wants 
to accept that the null hypothesis of no differ-
ence between case and control observations is 
falsely rejected; the type II probability ß is the 
risk of falsely not rejecting the null hypothesis 
when a true difference of at least n exists 
between case and control observations. 
In case of multiple (say k) control obser-
vations per case, assuming equal variances for 
cases and controls and, for the sake of argu-
ment, a negligible correlation between case and 
control observations, the variance of the differ-
ence between a case observation and the mean 
of the k control observations becomes 
a
2
 = {(* + \)/k}*a2 = {(* + \)l2k}*a\, 
{a] = 2a2, where a2 is the variance of a single 
case or control observation). 
The minimal number of case-control sets for 
detecting the same difference ft then becomes 
»* = ('. + tpvllv1 = «••{(* + 0/2*}. 
N.B. We assumed (near) independence of case 
and control observations. In case of a positive 
correlation between case and control obser-
vations, the result will be a smaller a] and a\ 
and a smaller sample size needed to detect the 
same difference p. 
Sequential analysis 
Wald [7] developed the theory for the 
"sequential probability ratio test" (SPRT). 
Rushton [8] further developed this theory to the 
one-sample, two-sided sequential Mest. This 
test is based on the probability ratio 
_ probability of observed results given H, true 
" probability of observed results given H0 true ' 
for n observations processed so far. For our 
situation with case-control sets, we pose as null 
hypothesis H0: 
<5 =/i/ffk = 0 
and as alternative hypothesis H,: 
l* l>0 
where \i is the minimal mean difference to ! e 
detected and <rk is the theoretical standard devi-
ation of the differences between the case and 
control observations. Because in most practical 
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situations ak will be unknown and needs to be 
estimated from the data, the parameter ô = \i\ov 
is used in the test. The test operates as follows: 
—continue sampling as long as B <1„<A 
—stop sampling and decide for 
H0 as soon as /„ < B 
—stop sampling and decide for 
H, as soon as /„ > A 
To obtain approximately the a priori specified 
error probabilities a (two-sided type I error) and 
ß (type II error), Wald stated the theorem that 
Acz(l-ß)/a and A ~ 0 / ( l - a ) . The logar-
ithm of the probability or likelihood ratio /„ can 
be calculated exactly using the series expansion 
of Kummer's function [9]. 
Rushton [8] obtained a practical approxi-
mation to the logarithm of the likelihood 
ratio. 
See Appendix A for more details on 
Kummer's function, Rushton's approximation 
and our adaptation of the test statistic for k 
control observations per case. 
Simulations 
To examine the effect of multiple controls per 
case in a sequential f-test on its overall type I 
and type II error, simulation studies were per-
formed. A simulation program was written in 
Turbo Pascal Version 5.0 (Borland). Random 
case and control observations were generated 
following a normal distribution with expec-
tation Ho or fit and theoretical standard devi-
ation a. The values chosen for p^, /*,, a and 5 
under H, are based on population values and a 
desirable shift in ppm of the selenium content 
(see Van Noord [10]). Both for case and control 
observations a was chosen equal to 0.15. Under 
H0: Ô = 0, rt, was chosen equal to 0.8. Under H,: | c51 = Ô, Hx was equal to 0.8 + Ô*a*yj2. 
Both under H0: Ö = 0 and under H,: |<51 = ô 
(<5 = 0.3, 0.4 and 0.5 respectively), and with 1 to 
5 controls per case, we ran 1000 simulation runs 
(a = 0.05, 1 - ß = 0.80). 
Per run, the resulting decision ("accept H0" or 
"reject H0 in favour of H,") and the number of 
case-control sets necessary to come to that 
decision were recorded. 
Simulations were performed using both 
Rushton's approximation to the logarithm of 
the likelihood ratio and the series expansion of 
Kummer's function. 
RESULTS 
Non-sequential analysis 
The results of a randomized block analysis of 
variance on the "selenium and breast cancer" 
data for n = 57 cases and 5 control observations 
per case are shown in Table 1. 
Table 1. "Selenium and breast cancer" study; descriptive statistics and 
ANOVA table for 57 cases with 5 controls per case 
Cases 
Controls 
Source 
Between matched sets 
Within matched sets 
Case-controls* 
Between controls 
Residual 
mean 
(ppm) 
0.790 
0.772 
SD 
(ppm) 
0.156 
0.207 
ANOVA table 
Sum of 
squares 
2.20 
0.16 
0.02 
0.14 
11.24 
Degrees of 
freedom 
56 
5 
1 
4 
280 
Mean 
squares 
0.04 
0.03 
0.02 
0.03 
0.04 
n 
57 
285 
F p 
<1 NS 
•Due to the difference between cases and the mean of the matched control 
observations. 
Means, standard deviations and a randomized-block analysis of variance 
(ANOVA) table for n = 57 cases with 5 controls per case. Data are the 
selenium content in ppm in toenails from the "selenium and breast 
cancer" study. 
Within matched sets the sum of squares, degrees of freedom and mean 
square are subdivided into two components: one that measures the 
variation because of a difference between cases and the mean of the 
matched control observations, and one that measures variation be-
tween controls. If we assume no differences between control obser-
vations, this last component can be combined with the residual sum 
of squares to give a (slightly) improved estimate of the residual mean 
square or error variance. 
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The mean difference between a case and the 
mean of the corresponding 5 control obser-
vations was 0.018 ppm with a SE = 0.029 ppm 
(NS). 
Sequential analysis 
Sequential t -tests were performed on the 
"selenium and breast cancer" data, using the 
available cases and a random sample of k 
(k = 1 , . . . 5) control observations available in 
the matched set. (For each sequential test 
performed, control observations were replaced.) 
Both Kummer's function and Rushton's 
approximation were applied. 
The number of cases (n) at which the decision 
"H0 cannot be rejected" was reached, is tabu-
lated in Table 2 for several alternative hypoth-
eses (|<5| = 0.3, 0.4, 0.5). 
N.B. None of the tests led to rejection of H0; 
in the case of H,:|<5| =0.3, for some tests no 
conclusion could be reached with the available 
number of case-control sets. 
Simulations 
The relative efficiency of more (k) controls 
per case is depicted graphically in Figs 1 and 
2 for Ô = 0.4. (For ,5 = 0.3 and Ô = 0.5 the 
course of the relative efficiency is similar.) 
There the relative sample size nk/w, is plotted 
against k for the median, mean and 95th-
percentile number of cases required to reject 
H0 in favour of H,. The theoretical expected 
efficiency (k + l)/2/c is plotted as a com-
parison. 
Appendix B shows data and calculations of 
one of the simulations as an example. 
Rel. sample size (delta = 0.4) 
(Rushton's approximation) 
Fig. 1. Relative sample size (njn,) for mean (A), median 
( • ) and 95th percentile ( • ) number of cases necessary 
to reject H„ in favour of H,:|51 = 0.4 compared to the 
theoretical expected value (k + 1)/2A (X), using Rushton's 
approximation. 
DISCUSSION 
Biological data banks contain valuable 
material that can be analysed to explore 
new hypotheses with possible important pub-
lic health consequences. But, with most 
chemical analyses, these unique biological 
samples are destroyed and thus economical 
tests are preferable [11]. 
While in case-control studies, cases are 
mostly scarce, but control samples abundant, 
statistical efficiency of non-sequential tests can 
be increased by including multiple controls per 
case. If the power using equal allocation (k = 1) 
is greater than 0.9, this is of no practical import-
ance. If the equal allocation power is less than 
0.9, meaningful power increases may be ob-
tained, but more than 4 controls per case are 
seldom worthwhile [4]. 
Table 2. "Selenium and breast cancer" study; 
results of sequential /-tests for k controls per case 
k 
1 
1 
1 
1 
1 
2 
3 
4 
5 
l<5| 
R 
21 
25 
27 
22 
26 
25 
22 
22 
22 
= 0.3 
K 
— 
— 
62 
48 
50 
50 
— 
— 
— 
1-51 
R 
12 
30 
21 
23 
13 
17 
18 
12 
13 
H, 
= 0.4 
K 
23 
30 
21 
24 
25 
21 
21 
21 
21 
1*1 = 
R 
9 
11 
10 
10 
8 
9 
12 
8 
9 
= 0.5 
K 
13 
15 
13 
14 
18 
14 
16 
13 
13 
Results of the sequential t -tests, given 57-64 cases 
and random samples of, : controls per case, on 
the "selenium and breast cancer" study 
(a = 0.05 and 1 - ß = 0.80); R, Rushton's 
approximation; K. Kummer's function. 
Rel. sample size (delta = 0.4) 
(Kummer's function) 
Fig. 2. Relative sample size (njn,) for mean (A), median 
( • ) and 95th percentile ( • ) number of cases necessary 
to reject H„ in favour of H, : | S | = 0.4 compared to the 
theoretical expected value (k + l)/2k (X), using Kummer's 
function. 
A Sequential /-Test with Multiple Controls per Case 
Retrospective analyses as well as prospective 
studies justify the use of sequential investigation 
to avoid unnecessary destruction of the biologi-
cal material and to limit the total duration of the 
study. In prospective clinical trials ethical as-
pects may play a role. For example when 
chemotherapy is one of the trial arms in a trial 
comparing two cancer therapies, one wishes to 
expose as few patients as necessary in coming to 
a decision. 
From an economical point of view we per-
formed sequential /-tests with multiple control 
observations per case and compared the results 
with those of a non-sequential analysis and of 
simulation studies. 
The expected average sample numbers (ASN) 
for a sequential /-test with one control obser-
vation per case are already smaller than the 
minimal sample size required for a correspond-
ing non-sequential ( = fixed sample size) paired 
/-test (Table 3). (See Appendix C for the calcu-
lation of the ASN according to Cox' approxi-
mation [12].) Notable in Table 3 is the fact that 
both the mean number of case-control pairs 
required to reject H0 using Rushton's approxi-
mation and the median number using Rum-
mer's function almost equal Cox' approximated 
ASN. Only the median number of cases necess-
ary to accept H0 using Rushton's approximation 
resembles the corresponding ASN according to 
Cox. Our simulations indicate that Cox' ap-
proximation probably underestimates the aver-
age sample size, especially the expected ASN 
needed to accept H0. 
Table 3. Comparison of expected and observed sample size 
for one control matched per case (k = 1) 
H, 
IS| =0.3 |<51 = 0.4 |(5| = 0.5 
Fixed 
Paired /-test 88 50 32 
Sequential 
Expected: 
Cox' approximation 57/34 34/20 22/14 
Observed: 
Simulation results 
Rushton 
Mean 57/44 36/27 25/18 
Median 50/33 31/20 21/13 
Kummer 
Mean 64/54 39/31 26/21 
Median 57/43 35/25 23/17 
Sequential sample sizes are expressed as "number of 
case-control pairs neccesary to reject H0/number of 
case-control pairs neccesary to accept H0". 
Expected sample size for a non-sequential paired /-test and 
expected and observed sample sizes for sequential /-tests 
with matched pairs (i.e. 1 control per case). 
Most sequential <-tests of our "selenium and 
breast cancer" data (Table 2) resulted in accep-
tance of H0 at a considerably smaller number of 
case-control sets than necessary for a non-
sequential analysis. 
The simulations confirm these results even 
better. The largest gain in efficiency as com-
pared to matched pairs is reached with 2 con-
trols per case, when H0 is rejected. When H0 
cannot be rejected, the gain in efficiency is 
smaller. The simulated power values are closer 
to each other for different values of <5 using the 
exact Kummer function than they are using 
Rushton's approximation. 
Rushton's approximation, on the other hand, 
is less conservative with respect to the simulated 
power and thus more economical in its use of 
case-control sets. Only with the matched-pairs 
simulations Rushton's approximation yields a 
simulated power significantly less than the 
theoretical power of 0.80. In general, the simu-
lated unreliability using Rushton's approxi-
mation is larger than that using Kummer's 
function and more often even larger than the 
theoretical unreliability of 0.05. 
Skovlund and Wallae [13] already drew atten-
tion to the conservatism of the sequential /-test 
when applied as a two-sample sequential test. 
Their smallest value for <5 studied was 0.5, 
however. Neither did they simulate with more 
than 1 control matched per case. 
In theory it is possible that a sequential test 
continues infinitely. To warrant that a decision 
is reached, albeit "no decision can be made", it 
is recommended to set a restriction (e.g. once or 
twice the fixed sample size) to the total number 
of cases available for the test. 
Our simulations illustrate that there is hardly 
any effect on the simulated power and unreli-
ability when the sequential test procedure is 
truncated at twice the fixed sample size. 
Truncating the procedure at a fixed sample 
size results in a simulated power that is still too 
large, except for the matched-pairs situation 
using Rushton's approximation where it is too 
small. The unreliability resulting from the simu-
lations using Rushton's approximation with 
more than one control per case is often (signifi-
cantly) too large. 
When a sequential test is terminated after a 
small number of observations, point and inter-
val estimates of the case-control difference are 
.ather imprecise. We hold the view that these 
objections play a less important role when, as in 
our experimental set-up, a rather "qualitative" 
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answer ("H0 can/cannot be rejected") suffices to 
distinguish promising new hypotheses from un-
fruitful ones (see for an example Van Noord 
[10]). 
Group sequential procedures (for matched 
case-control sets) [15-18] also have the advan-
tage of a reduction in the average sample size as 
compared to fixed-sample-size plans. There are 
some differences between group sequential pro-
cedures and a one-at-a-time SPRT, however. 
A one-at-a-time sequential approach can be 
stopped after every new case-control set, while 
a group sequential procedure can only be 
stopped after the next planned inspection. Fur-
thermore, a group sequential procedure cannot 
come to a decision to accept the null hypothesis 
until after the last planned inspection. A SPRT 
can be stopped the very moment that evidence 
exists that the null hypothesis cannot be rejected 
anymore. 
Therefore, the authors prefer a one-at-a-time 
SPRT over the group sequential procedure 
when ethical and/or economical motives play a 
role. Promising hypotheses as well as unfruitful 
ones can be distinguished with as little as poss-
ible biological material destroyed or, for that 
matter, time and/or money spent. 
Following Skovlund and Wallae [14], we hold 
the view that a sequential design might be 
considered more often in prospective clinical 
trials as well as in (cohort-nested) case-control 
studies. 
Furthermore, we are of opinion that a 
sequential /-test with 2-4 controls per case is 
appropriate in case-control studies and other 
experimental designs where the case material 
must be used economically, and the response is 
available (almost) immediately. In general the 
investigation can then be stopped at a lower 
average sample size as compared to one control 
per case or a non-sequential test. 
The use of exact calculations (the series 
expansion of Kummer's function) is rec-
ommended, although less conservative pro-
cedures are to be developed. 
Tables and figures summarizing the results 
from the computer simulations are available 
from the authors by written request. 
CONCLUSIONS 
(1) A seq-iential /-test with 2-4 controls 
matched per case in general leads to lower 
average sample sizes than a matched-pairs 
sequential /-test or a non-sequential analy-
sis. The largest gain in efficiency as com-
pared to matched pairs is reached with 2 
controls per case. 
(2) Rushton's approximation to the logarithm 
of the likelihood ratio is rather inaccurate 
and leads to a power that is significantly too 
small in case of a matched-pairs analysis. 
(3) The use of Kummer's function (the exact 
calculation) results in power values which 
are too conservative. 
(4) Cox' approximation to the expected average 
sample number probably underestimates the 
expected sample size needed to accept Hj. 
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A Sequential (-Test with Multiple Controls per Case 
APPENDIX A 
The logarithm of the likelihood ratio /„ is a function of S, 
n ands u2 and equal to 
L = ln(/„) = In M(n/2; 1/2; \ • S2 • u2) - j (Al) 
For the nth case-control pair (n = 1, 2, 3 , . . . successively 
and one control observation per case) u2 is equal to 
where 
= (Zd,)2II.d2 = n • t2l(n - 1 + t2), i = l. 
t2 = n • mean(rf)2/var(</), 
d: is the difference between the observation for the case and 
the control observation, and mean(rf) and var(</) stand for 
the mean and variance of these differences. For every n L 
is compared to ln(/?/(l — a)) and ln((l — /J)/a). M(a;b;x) is 
the confluent hypergeometric function, which can be calcu-
lated using Rummer's function [9], a series expansion: 
M(a;b;x) = 1 + ax/b + a(a + \)x2/{b(b + 1)2!} 
+ a(a + l)(a + 2)*3/{6(6 + 1)(* + 2)3!} + . . . 
We involved 30 terms of this expansion. Rushton's approxi-
mation [8] to L is equal to 
/, = \ • S • « 3 / > + V(" à2u2)-Crn-S2 + ln(2)). (A2) 
For k control observations per case the variance of the 
difference between the case observation and the mean of the 
k control observations is estimated using the cumulating 
case-control variance-covariance matrix. This estimate is 
then substituted as s2 in the equations mentioned below. 
(The variance-covariance matrix takes the correlations 
among cases and controls into account. If we assume 
negligible correlations among control observations, equal 
variance for the control observations and equal correlations 
between the case and each of the controls, s2 can be 
approximated by the variance of the differences between the 
case and the mean of the control observations.) Then 
Rushton's approximation to L can be calculated by 
/, = H • V/V" + V(" • &1 • "*2) - (5 ' " • -52 + '"(2)) (A3) 
with 
and 
tk2 = n- mean(dY/s2. 
N.B. For matched case-control observations (k = 1) 
equation (A3) is equal to equation (A2). 
APPENDIX B 
Data and calculations of one of the simulations with 
a = 0.05, 1 - ß = 0.80, S = 0.5, /i„ = f, = 0.8, a = 0.15 and 
2 controls per case are presented in Table Bl (see Appendix 
A for the notation used). 
After 13 case-control sets are evaluated, M equals 1.002 
and therefore L = — 1.623 becomes smaller than the lower 
boundary, ln(j3/(l - a ) ) = -1.558, and thus H0 cannot be 
rejected. 
When Rushton's approximation to L is applied, the 
sequential analysis can be stopped after the 10th 
case-control set, where /, = —1.719. 
APPENDIX C 
For matched case-control observations, the average sample 
number (ASN) for a sequential (-test with unknown vari-
ance is approxiamtely (1 +S2/2) times the ASN for a test 
with known variance (Cox' approximation, Wetherill and 
Glazebrook [12]). 
Under H0 this ASN (unknown variance) is about 
-2/a2 .{a' • ln((l -/?)/«')+ 0 -<x') • ln((0)/l -a'))}, 
and under H, this ASN is about 
(1 + 2la2)*{ß • ln((/?)/(l - a')) + (1 - ß) • ln((l - /?)/(«'))} 
(with a' = a/2). We recognize that Cox' approximation is an 
asymptotic result and that it is currently unknown how 
accurate it is. 
Table Bl 
n 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
Case 
0.911 
0.919 
0.628 
0.781 
0.947 
0.527 
0.814 
0.784 
0.908 
0.745 
0.846 
0.650 
0.898 
Control 
0.912 
1.044 
0.867 
0.759 
0.740 
0.728 
1.053 
0.730 
0.860 
0.637 
0.659 
0.762 
0.896 
Control 
0.891 
0.518 
1.029 
0.861 
0.600 
0.791 
0.771 
0.877 
0.826 
0.580 
0.672 
0.919 
0.778 
s2 
0.008 
0.056 
0.037 
0.049 
0.050 
0.042 
0.036 
0.033 
0.032 
0.032 
0.032 
0.030 
h2 
1.312 
0.180 
0.273 
0.022 
0.084 
0.223 
0.263 
0.151 
0.018 
0.032 
0.019 
0.001 
«i1 
1.135 
0.248 
0.334 
0.028 
0.099 
0.250 
0.290 
0.167 
0.020 
0.035 
0.020 
0.002 
M 
1.312 
1.095 
1.174 
1.018 
1.075 
1.230 
1.308 
1.195 
1.025 
1.048 
1.031 
1.002 
L 
0.022 
-0.284 
-0.340 
-0.608 
-0.677 
-0.668 
-0.731 
-0.947 
-1.226 
-1.328 
-1.470 
-1.623 
Summary I Samenvatting I Résumé 
151 
Summary 
Prospective cohort studies provide an ideal epidemiological approach to 
investigating the relation between diet, nutritional status, and cancer. For 
sufficient statistical power, however, which requires the observation of a 
minimum number of "cases" with disease, such prospective studies must 
usually comprise a very large number of individuals. As the costs of this 
type of study can be high, it is fundamental that an efficient design be 
used so that the study will be as informative as possible for a given 
investment of time and resources. 
This thesis includes a series of methodological papers which present and 
analyse approaches that may improve the design and analysis of prospective 
cohort studies on diet, nutrition and chronic disease risk. The first 
chapters (2 to 5) examine methods of optimizing the assessment of the 
habitual, long-term dietary intake of cohort members, focusing on: 
1. methods to maximize the amount of variation in true intake level of 
foods and nutrients that is actually distinguished - or "predicted" -
by dietary questionnaire assessments collected at baseline; this is a 
means to increasing the power of a cohort study without increasing the 
number of study participants; 
2. methods for the precise estimation of the distribution of predicted 
intake levels; this is essential for the accurate estimation of the 
statistical power or sample size requirements of the cohort, as well as 
for the unbiased estimation relative risks describing diet-disease 
associations. 
Chapter 6, on the other hand, discusses the use of a sequential study 
design, to optimize the number of specific study hypotheses that can be 
evaluated when exposure assessments are based on a biochemical marker 
measured in urine, blood, or other tissue samples. 
A first basic approach to maximize the predicted variation in true intake 
level is to select a dietary questionnaire method that allows an optimal 
classification of individuals by their respective intakes of foods and 
nutrients. Traditionally, the method is selected on the basis of the 
estimated correlation between questionnaire assessments and the individuals' 
true dietary intake levels. Chapter 2 reviews, in terms of latent variable 
models, how this correlation can be estimated in a preliminary validity 
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study, by comparison with at least two additional intake measurements. A 
vital assumption is that all measurements must have mutually independent 
errors, so that correlations between the measurements are entirely due to 
their relations with the same (latent) true intake variable. In practice, 
the additional measurements are most often obtained by means of repeated 
food intake records, using either a weighing method or 24-hour recalls. An 
alternative design of validity studies is presented, where the correlation 
between questionnaire assessments and true intake levels of nutrients is 
estimated by comparison with food intake records as well as with a 
biochemical marker. The advantage of this alternative approach is that 
measurement errors are more likely to be independent when all three 
measurements are taken with different methods (i.e., questionnaire, records, 
and biochemical marker). 
The estimated coefficient of correlation between questionnaire 
assessments and the individuals' true habitual intakes is also seen as 
essential information for the subsequent planning of epidemiological studies 
on diet: 
a) to evaluate the sample size requirements of a cohort study with 
correction for power losses due to random errors in the dietary 
exposure assessments; and 
b) to estimate the magnitude of attenuation bias in relative risks. 
In Chapter 3 it is shown that, if relative risks are estimated for scaled, 
absolute differences in intake level (expressed in standard units), sample 
size requirements for a cohort study can be computed from the variance of 
the distribution of true dietary intake levels predicted by the 
questionnaire assessments collected at baseline. Likewise, bias in relative 
risk estimates can be shown to be equal to the variance of the predicted 
intake distribution divided by the variance of the questionnaire 
assessments. To estimate the variance of the predicted intake distribution, 
it is not necessary to know the correlation between questionnaire 
assessments and true dietary intake values. Thus, a validity study based on 
multiple additional measurements is not essential. Instead, a calibration 
study can be used, based on only a single day's food intake record per 
person as a reference measurement. It is shown that, for a given total 
number of daily intake records taken, the estimation of the variation in 
predicted intake levels is most precise when the calibration is based on a 
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maximum number of participants, with only a single record each. An 
additional major advantage is that a calibration study can be conducted more 
easily on a representative sample of the study population (when nested 
within a prospective cohort study). Representativeness is an important 
condition for accurate estimation of the power of cohort studies, or of 
biases in relative risk estimates. 
A second approach to increase the magnitude of the predicted variation in 
intake values is to broaden the range of true dietary intake levels covered. 
This can be achieved by combining the data from multiple cohort studies, 
conducted in different geographical areas with heterogeneous life styles and 
dietary habits. An example of this multi-cohort approach is the EPIC study 
(European Prospective Investigation on Cancer and Nutrition), which is 
coordinated by the International Agency for Research on Cancer at Lyon 
(France). In Chapter 4 it is shown that in such multi-cohort projects, 
relative risks indicating associations between dietary intake level and 
disease incidence can be estimated from: 
1. within-cohort differences in the measured dietary intake levels and 
disease outcomes of individuals; and 
2. between-cohort ("ecological") variation, between mean intake 
measurements and mean incidence rates of disease at a population level. 
If there is sufficient concordance between the various component estimates, 
these can be combined into an overall, more powerful summary value. A 
complication, however, is that relative risk estimates within different 
cohorts can be biased to various degrees as a result of dietary assessment 
errors, while the between-cohort ("ecological") relation may also be 
distorted by differences in systematic over- or under-estimation of mean 
intake levels. This may be particularly true when it is impossible to use an 
identical method for dietary intake assessment in all cohorts. The second 
part of Chapter 4 proposes the use of sub-studies for the calibration of 
dietary intake assessments to adjust for possible heterogeneity in relative 
risk estimates due to such divergent biases. This reduction in heterogeneity 
may improve the power of a statistical test for diet-disease association 
based on a pooled estimate of relative risk. 
Calibration adjustments for biases in relative risk estimates will only 
be adequate if the calibration factors used for such corrections are 
themselves estimated with sufficient precision. This aspect is discussed in 
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Chapter 5, which presents a simplified approach to the estimation of 
approximate sample size requirements for dietary calibration studies nested 
within a cohort. These sample size estimations are based on two alternative 
criteria, requiring either a minimum relative efficiency of calibration (so 
that there is little loss of precision in the estimation of relative risk), 
or a minimum statistical power of a test for diet-disease association based 
on the corrected relative risk estimate (i.e., after calibration). The 
required size of a calibration study then depends only on the correlation 
between questionnaire assessments and reference measurements. 
In studies where the exposure assessments are based on a biochemical 
marker, measured in blood, urine, or other biological specimens, a simple 
efficiency measure is to store the biological specimens in a "biobank", and 
to postpone the exposure measurement until it is known which individuals 
develop a given type of disease, and which will be suitable control 
subjects. Nevertheless, the number of scientific hypotheses potentially of 
interest is usually much larger than the number of biomarkers that can be 
actually assessed with a limited amount of blood or other biological 
specimens available. It would thus be useful to have a statistical method 
which, at the expense of as little biological material as possible, 
distinguishes between promising or less promising hypotheses. For this 
purpose, Chapter 6 proposes the use of a sequential study design, in which 
laboratory analyses of the biological specimens of cases and controls are 
conducted until sufficient data have accumulated to either reject or not a 
null hypothesis of "no association" between marker and disease risk. On 
average, as compared to an equivalent fixed-sample test procedure, a 
sequential test may require less than half the number of biological 
specimens to reach a conclusion. If the null hypothesis is rejected, 
additional biological specimens may be analyzed to improve the precision of 
relative risk estimates; if not, biological specimens can be spared for the 
evaluation of different hypotheses. 
In conclusion, preliminary validity studies in which the correlation 
between questionnaire assessments and true dietary intake levels is 
estimated, may be used to select an optimal questionnaire instrument to be 
employed in a prospective cohort study. On the other hand, calibration 
studies using only one reference measurement per person are more efficient 
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when the objective is to estimate the power of prospective cohort studies, 
accounting for the effects of random dietary assessment errors, or to 
correct for biases in relative risk estimates. A main advantage of 
calibration studies is that these can be conducted more easily on a 
representative sample of the study population. In multi-cohort projects, 
calibration studies can be used to improve the comparability of cohort-
specific relative risk estimates, and to obtain a more precise estimate of 
the between-cohort, "ecological" relation between dief.Ty intake levels and 
disease incidence. In studies where the exposure assessments are based on a 
biochemical marker, a simple efficiency measure is to store biological 
specimens in a biobank, and to postpone laboratory analyses until cases with 
disease have been identified. Sequential study designs can then be used to 
allow the evaluation of an maximum number of scientific hypotheses with a 
given amount of biological material available. 
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Samenvatting 
Prospectieve cohort studies bieden een ideale epidemiologische benadering om 
relaties tussen voeding, voedingstoestand and kanker te bestuderen. Echter, 
om een voldoende groot statistisch onderscheidingsvermogen te ontwikkelen -
hetgeen vereist dat een minimum aantal ziektegevallen wordt waargenomen -
moeten prospectieve studies over het algemeen een groot aantal individuen 
omvatten. De kosten van dit type studie kunnen daarom hoog oplopen, en het 
is dus van fundamenteel belang de studie efficient op te zetten, zodat 
zoveel mogelijk informatie wordt verkregen voor een gegeven investering in 
tijd en middelen. 
Dit proefschrift bevat een reeks methodologische artikelen waarin een 
aantal benaderingen worden gepresenteerd en besproken om de opzet en analyse 
van prospectieve cohort studies over voeding, voedingstoestand en chronische 
ziekten te verbeteren. In de eerste hoofdstukken (2 tot 5) worden methoden 
onderzocht om een optimale meting te verkrijgen van de gebruikelijke 
voedings inname op langere termijn van individuen in de cohort study. 
Hierbij wordt de nadruk gelegd op: 
1. methoden om de variatie in innameniveau van voedingsmiddelen of 
nutriënten die werkelijk wordt onderscheiden - ofwel "voorspeld" - door 
metingen aan het begin van de studie zo groot mogelijk te maken; dit is 
een manier om het onderscheidingsvermogen van een cohort study te doen 
toenemen zonder het aantal deelnemers in de studie te vergroten; 
2. methoden voor een nauwkeurige schatting van de werkelijk gemeten 
variatie in innameniveaus; dit is essentieel voor een nauwkeurige 
schatting van het onderscheidingsvermogen of de vereiste 
steekproefgrootte van het cohort, zoel als voor de zuivere schatting 
van relatief risiko's die verbanden tussen voeding en ziekte 
beschrijven. 
Hoofdstuk 6 bespreekt de toepassing van een sequentiële studie-opzet om een 
optimaal aantal specifieke hypothesen te kunnen toetsen wanneer potentiële 
risikofactoren worden gemeten in urine, bloed, of biologische 
weefselmonsters. 
Een eerste basisbenadering om de werkelijk gemeten ("voorspelde") 
variatie in innameniveau zo groot mogelijk te maken is het selecteren van 
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een vragenlijst methode die leidt tot een tot een optimale classificatie van 
individuen naar hun gebruikelijke inname van voedingsmiddelen of nutriënten. 
Deze selectie wordt traditioneel gemaakt op basis van de geschatte 
correlatie tussen inname-metingen verkregen via de vragenlijst en werkelijke 
inname-niveaus. Hoofdstuk 2 geeft een overzicht, in termen van "latent 
variable" modellen, van benaderingen om deze correlatie te schatten in een 
voorafgaande validatie-studie. Dit vereist een door vergelijking met 
tenminste twee extra innamemetingen. Daarbij is het een essentiële aanname 
dat fouten in de verschillende metingen wederzijds onafhankelijk zijn, zodat 
correlaties tussen de metingen uitsluitend het gevolg zijn van hun relaties 
met dezelfde (latente) inname variabele. In de praktijk worden de extra 
metingen meestal verkregen met behulp van een meerdaagse gewogen 
opschrijfmethode, of door middel van herhaalde 24-uurs recalls. In hoodstuk 
2 wordt ook een alternatieve opzet van validatie-studies gepresenteerd 
waarin de correlatie tussen vragenlijstmetingen en werkelijke innameniveaus 
van nutriënten wordt geschat door vergelijking met metingen verkregen via 
een opschrijfmethode zowel als met metingen gebaseerd op een biochemische 
parameter. Het voordeel van deze laatste benadering is dat de aanname van 
onafkankelijke meetfouten gemakkelijker kan worden gemaakt als alle drie 
metingen worden verkregen via verschillende methoden (d.w.z., vragenlijst, 
opschrijfmethode of 24-uurs recall, en biochemische parameter). 
De geschatte correlatie tussen vragenlijst-metingen en werkelijke inname-
niveaus wordt ook gezien als essentiële informatie voor de verdere planning 
van epidemiologische studies met betrekking tot de voeding: 
a) om de vereiste steekproefgrootte van een cohort studie te schatten, 
daarbij rekening houdend met het verlies aan onderscheidingsvermogen 
als een gevolg van toevallige (d.w.z., "random") fouten in de 
voedingsinname-metingen; en 
b) om de grootte van attenuatie bias in relatieve risiko's te schatten 
In hoofdstuk 3 wordt getoond dat, als relatieve risiko's worden geschat voor 
absolute verschillen in inname-niveau, uitgedrukt in standaard eenheden, de 
vereiste steekproefgrootte voor een cohort studie kan worden berekend uit de 
variantie van de verdeling van werkelijke innamewaarden zoals die worden 
voorspeld door vragenlijst-metingen verkregen aan het begin van de studie. 
Bovendien blijkt de de bias in relatief risiko-schattingen gelijk te zijn 
aan de variantie van de verdeling van voorspelde innamewaarden gedeeld door 
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de variantie van vragenlijstmetingen. Om de variantie van de voorspelde 
innamewaarden te schatten is het niet noodzakelijk de correlatie tussen 
vragenlijstmetingen en werkelijke innamewaarden te kennen. Een validatie-
studie gebaseerd op meer dan één aanvullende innamemeting is dus niet echt 
vereist. In plaats daarvan kan een calibratiestudie worden opgezet, 
gebaseerd op een slechts eendaagse gewogen opschrijfmethode, of een enkele 
24-uurs recall. Het wordt getoond dat, voor een gegeven totaal aantal 
dagelijkse innamemetingen, de schatting van de voorspelde variatie in 
innameniveaus het meest nauwkeurig is wanneer de calibratiestudie een 
maximum aantal deelnemers omvat, met ieder slechts één enkele innamemeting. 
Een groot voordeel van deze benadering is dat een caliebratie-studie 
gemakkelijker kan worden uitgevoerd in een representatieve steekproef van de 
onderzoekspopulatie (indien genest in een prospectief cohort onderzoek). 
Representativiteit is een belangrijke voorwaarde voor een correcte schatting 
van het onderscheidingsvermogen van een cohort-studie, of van bias in 
schattingen van relatieve risiko's. 
Een tweede benadering om de voorspelde variatie in de innamewaarden van 
individuen te vergroten is het bereik van werkelijke innameniveaus te 
verbreden. Dit kan worden bereikt door het combineren van gegevens verkregen 
in meerdere cohort-onderzoeken, uitgevoerd in geografische gebieden met 
verschillende leefstijlen en voedingsgewoonten. Een voorbeeld van deze 
multi-cohort benadering is de EPIC-studie (European Prospective 
Investigation on Cancer), die wordt gecoördineerd door de International 
Agency for Research on Cancer in Lyon (Frankrijk). Hoodstuk 4 laat zien dat 
in dit type onderzoek relatieve risiko's die het verband aangeven tussen 
voedingsinname-niveaus en de incidentie van ziekte kunnen worden geschat 
uit: 
1. binnen-cohort variatie in gemeten innameniveaus en ziekte-uitkomst van 
afzonderlijke individuen; en 
2. tussen-cohort variatie in de gemiddelde innamemetingen en ziekte-
incidenties op populatie-niveau. 
Als er voldoende overeenkomst is tussen deze verschillende relatief risiko-
schattingen dan kunnen deze worden verenigd in een samenvattende waarde met 
een grotere precisie. Een complicatie hierbij is echter dat fouten in de 
voedingsinname-metingen in ongelijke mate bias kunnen geven aan relatief 
rissiko-schattingen verkregen in verchillende cohorten, terwijl ook de 
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tussen-cohort ("ecologische") relatie tussen voedingsinname en ziekterisiko 
kan worden verstoord door systematische over- en onder-schattingen van 
innameniveaus. Dit kan met name het geval zijn wanneer het niet mogelijk 
eenzelfde methode te gebruiken voor het meten van de voedingsinname in alle 
cohorten. In het tweede deel van hoofdstuk 4 wordt voorgesteld om sub-
studies voor de calibratie van voedingsinname-metingen te gebruiken voor de 
correctie van variatie in relatief risiko-schattingen als gevolg van 
verschillen in bias. De reductie in de bias in de verschillende relatief 
risiko-schattingen kan zo het onderscheidingsvermogen van een statistische 
toets voor een verband tussen voeding en ziekte vergroten, wanneer deze 
toets is gebaseerd op een samenvattende relatief risiko-schatting in een 
multi-cohort onderzoek. 
Calibratie-correcties voor bias in relatief risiko-schattingen zullen 
alleen doeltreffend zijn als de gebruikte calibratie-factoren zelf met 
voldoende precisie worden geschat. Dit aspect wordt besproken in hoofdstuk 
5, waarin een eenvoudige methode wordt gepresenteerd voor het schatten van 
de vereiste steekproefgrootte van calibratie-studies binnen een cohort. Deze 
steekproefgrootte-schattingen zijn gebaseerd op twee alternatieve criteria. 
Deze criteria vereisen een minimale relatieve efficiëntie van calibratie 
(d.w.z., zodat er slechts weinig verlies in precisie in relatief 
risikoschattingen optreedt), ofwel een minimum onderscheidingsvermogen van 
een statistische toets voor een verband tussen voeding en ziekte, als deze 
toets is gebaseerd op de gecorrigeerde (d.w.z. "gecalibreerde") relatief 
risiko-schatting. De benodigde steekproefgrootte van een calibratiestudie 
hangt dan uitsluitend af van de correlatie tussen vragenlijst- en 
referentie-metingen. 
In studies waar een potentiële risiko-factor wordt gemeten in urine, 
bloed, of andere biologische monsters (d.w.z., in de vorm van een 
"biomarker"), kan de efficiëntie van de studie op eenvoudige wijze worden 
verbeterd door de biologische monsters op te slaan in een "biobank", en door 
meting van de risikofactor uit te stellen tot het bekend is welke individuen 
een bepaald type ziekte hebben ontwikkeld, en wie daarbij als controle-
personen kunnen worden geselecteerd. Desondanks is het aantal te toetsen 
hypothesen meestal veel groter dan het aantal biomarkers dat kan worden 
gemeten in de beschikbare hoeveelheid bloed, of andere biologische monsters. 
Het is daarom van belang over een statistische methode te beschikken om, met 
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gebruik van zo weinig mogelijk biologisch materiaal, onderscheid te maken 
tussen veelbelovende en minder interessante hypothesen. Voor dit doel wordt 
in hoofdstuk 6 een sequentiële onderzoeksopzet voorgesteld, waarin 
laboratoriumanalyses van biologische monsters van cases met ziekte en 
controlepersonen net zolang worden uitgevoerd tot er voldoende gegevens zijn 
om de nulhypothese van "geen verband" tussen biomarker en ziekterisiko al of 
niet te verwerpen. Vergeleken met een statistische toets gebaseerd op een 
vaste steekproefomvang, kan via deze sequentiële benadering minder dan de 
helft van het aantal laboratoriumanalyses volstaan om tot een conclusie te 
komen. Als de nulhypothese wordt verworpen kunnen extra biologische monsters 
worden geanalyseerd om de precisie van relatief risiko-schattingen te 
verbeteren; zo niet, dan kunnen biologische monsters worden gespaard voor 
het toetsen van andere hypothesen. 
Tot besluit, validatiestudies waarin de correlatie tussen vragenlijst-
metingen en werkelijke voedingsinname-niveaus worden geschat kunnen worden 
gebruikt om een optimale vragenlijstmethode te selecteren voor toepassing in 
een prospectief cohortonderzoek. Aan de andere kant zijn calibratiestudies 
met slechts één referentiemeting per persoon efficiënter voor het schatten 
van het statistisch onderscheidingsvermogen van een cohortonderzoek -
daarbij rekening houdend met de effecten van toevalsfouten in innamemetingen 
- of voor de correctie van bias in relatief risiko-schattingen. Een 
belangrijk voordeel van calibratiestudies is dat deze gemakkelijker kunnen 
worden uitgevoerd in a representatieve steekproef van de 
onderzoekspopulatie. In multi-cohort projecten kunnen calibratiestudies 
worden gebruikt om de vergelijkbaarheid van relatief risiko-schattingen te 
verbeteren, en om een nauwkeurigere schatting the verkrijgen van de 
"ecologische" relatie tussen gemiddelde voedingsinnamen en ziekterisiko's in 
verschillende cohorten. In studies waar een risikofactor wordt gemeten met 
behulp van een biomarker, kan de efficiëntie eenvoudig worden vergroot door 
biologische monsters op te slaan in een biobank, en laboratorium-analyses 
uit te stellen totdat "cases" met ziekte zijn geïdentificeerd. Gebruik van 
een sequentiële studie-opzet maakt het dan mogelijk een optimaal aantal 
wetenschappelijke hypothesen te evalueren. 
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Résumé 
Les études prospectives de cohorte constituent une approche idéale pour 
étudier les relations entre le régime, le statut nutritionnel et le cancer. 
Toutefois, pour obtenir une puissance statistique suffisante, ce qui exige 
l'observation d'un minimum de "cas" atteints de la maladie, de telles études 
prospectives doivent en général englober un très grand nombre d'individus. 
Le coût d'une telle étude peut donc être élevé. C'est pourquoi il est 
capital de choisir un protocole efficace qui rende l'étude aussi informative 
que possible pour un investissement temps/ argent donné. 
La présente thèse contient une série de conseils méthodologiques qui 
proposent et analysent des démarches qui pourraient améliorer la conception 
et l'analyse des études prospectives de cohorte sur l'alimentation, la 
nutrition et le risque de maladie chronique. Les premiers chapitres (2 à 5) 
passent en revue des méthodes qui pourraient optimiser l'évaluation de la 
consommation alimentaire habituelle à long-terme des membres de la cohorte 
en attirant l'attention sur : 
1. les moyens de maximaliser la quantité de variations dans la consommation 
réelle d'aliments et de nutriments qui est en fait évaluée -ou "prédite"-
par le biais des bilans alimentaires recueillis à la base. Ceci est une 
des méthodes permettant d'augmenter la puissance d'une étude de cohorte 
sans pour autant augmenter le nombre des participants à cette étude ; 
2. les méthodes permettant d'estimer la distribution des niveaux de 
consommation prédits de façon précise ; ceci est indispensable pour 
obtenir une évaluation exacte de la puissance statistique ou de la taille 
nécessaire de l'échantillon de la cohorte ainsi que pour une estimation 
objective des risques relatifs décrivant les associations entre la 
maladie et les habitudes alimentaires. 
Quant au Chapitre 6, il traite de l'utilisation d'un protocole d'étude 
séquentielle dans le but d'optimiser le nombre d'hypothèses d'études 
spécifiques qui peuvent être obtenues lorsque l'on évalue l'exposition à 
partir de marqueurs biochimiques mesurés dans les urines, le sang ou 
d'autres échantillons de tissu. 
Une première approche simple permettant de maximaliser la variation 
prédite en niveau réel de consommation consiste en la selection d'un type 
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de questionnaire alimentaire qui autorise la classification optimale des 
individus en fonction de leur consommation respective d'aliments et de 
nutriments. Traditionnellement, on fait cette sélection en se basant sur les 
corrélations estimées entre les bilans alimentaires et le niveau de 
consommation réel des individus. Le Chapitre 2 examine, en termes de modèles 
de variable latente, comment estimer cette corrélation au cours d'une étude 
préliminaire de validité, en comparaison avec au moins deux mesures de 
consommation. Il est primordial que toutes les mesures comportent des 
erreurs indépendantes les unes des autres afin que la corrélation entre les 
mesures soient uniquement due à leur relation avec la même variable de 
consommation réelle (latente). En pratique, les mesures complémentaires sont 
le plus souvent obtenues au moyen d'enregistrements de consommation répétés 
qui utilisent soit une méthode de pesée, soit un rappel de 24 heures. On 
peut aussi concevoir des études de validité où la corrélation entre le 
questionnaire d'évaluation et les niveaux de consommation réels de 
nutriments seraient estimés en les comparant aux enregistrements de 
consommation alimentaire et aux marqueurs biochimiques. Cette alternative 
présente l'avantage que les erreurs de mesures ont plus de chances d'être 
indépendantes quand les trois mesures sont obtenues par des méthodes 
différentes (c'est à dire, questionnaire, enregistrement, et marqueurs 
biochimiques). 
Les coefficients de corrélation estimés entre les évaluations obtenues 
par questionnaire et la consommation habituelle réelle de l'individu 
constituent aussi une information essentielle pour la plannification 
ultérieure d'études épidémiologiques sur l'alimentation : 
a) pour évaluer la taille nécessaire de l'échantillon d'une étude de cohorte 
avec les corrections pour les pertes de puissance dues aux erreurs 
alléatoires dans l'évaluation de l'exposition alimentaire ; et 
b) pour calculer une estimation de l'amplitude du biais d'atténuation dans 
le risque relatif. 
Dans le Chapitre 3, on démontre que si les risques relatifs sont calculés 
pour des différences échelonnées et absolues dans le niveau de consommation 
alimentaire (exprimées en unités standard), on peut calculer la taille 
requise de l'échantillon à partir de la variance de distribution des niveaux 
de consommation réels prédits par les questionnaires d'évaluation recueillis 
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au départ. De même, on peut démontrer que le biais des risques relatifs 
estimés est égal à la variance de la distribution de la consommation prévue 
divisée par la variance du questionnaire d'évaluation. Il n'est pas 
nécessaire de connaître la corrélation entre les questionnaires d'évaluation 
et les valeurs de consommation réelle pour évaluer la variance de la 
distribution de la consommation prédite. C'est pourquoi une étude de 
validité basée sur de multiples mesures complémentaires n'est pas 
indispensable. On peut utiliser à la place une étude de calibrage qui 
utilise comme mesure de référence la consommation en aliments d'un seul jour 
pour une seule personne. On sait que pour un nombre donné d'enregistrements 
sur la consommation journalière, l'estimation de la variation des niveaux de 
consommation prédits est la plus précise quand le calibrage est basé sur un 
nombre maximum de participants, avec seulement un enregistrement chacun. 
Autre avantage important : l'étude de calibrage peut être mise en place plus 
facilement sur un échantillon représentatif de la population de l'étude 
(quand il est inclus dans une étude prospective de cohorte). La 
représentativité est une condition importante pour une estimation exacte de 
la puissance des études de cohorte, ou des biais d'estimation du risque 
relatif. 
La deuxième démarche permettant d'augmenter l'amplitude des variations 
prédites des valeurs de consommation est d'élargir la gamme de consommation 
alimentaire réelle couverte. On peut obtenir cela en combinant les données 
de différentes études de cohorte, réalisées dans des régions du monde 
différentes et recouvrant des styles de vie et des habitudes alimentaires 
différents. Le programme EPIC (étude prospective de recherche sur le cancer 
en Europe, coordonnée par le Centre International de Recherche sur le Cancer 
(Lyon, France)) est un exemple de cette approche multi-cohortes. Le Chapitre 
4 montre que dans les projets multi-cohortes de ce genre, le risque relatif 
indiquant des associations entre le niveau de consommation alimentaire et 
l'incidence de la maladie peut être estimé à partir : 
1. des différences internes aux cohortes dans les niveaux de consommation 
alimentaires mesurés et les pronostics de la maladie chez les individus ; 
2. des variations ("écologiques") inter-cohortes, entre les mesures de 
consommation moyenne et les taux moyens d'incidence de la maladie au 
niveau de la population. 
Si la cohérence entre les diverses estimations des composés est suffisante, 
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on peut les rassembler dans un résumé des valeurs générales plus puissant. 
Il est toutefois préférable de rester prudent puisque, à l'intérieur des 
différentes cohortes, les estimations des risques relatifs peuvent être 
biaisées à différents degrés à la suite d'erreurs dans les bilans 
alimentaires, de même que les relations inter-cohortes ("écologiques") 
peuvent aussi être faussées par des différences entre les inévitables "sur" 
ou "sous-évaluations" des niveaux de consommation moyens. Ceci est 
particulièrement vrai lorsqu'il est impossible d'utiliser des méthodes 
identiques pour évaluer la consommation alimentaire dans toutes les 
cohortes. La deuxième partie du Chapitre 4 propose d'utiliser des 
mini-études pour le calibrage des bilans alimentaires permettant un 
ajustement pour l'hétérogénéité possible dans les risques relatifs estimés, 
dont les biais de divergeance sont responsables. Cette diminution de 
l'hétérogénéité dans les risques relatifs estimés pourrait augmenter la 
puissance d'un test statistique basé sur les risques relatifs estimés 
groupés et permettant d'établir la relation entre alimentation et maladie. 
Les ajustements de calibrage pour les biais de risques relatifs ne seront 
appropriés que si les facteurs de calibrage utilisés pour ces corrections 
ont eux-mêmes été établis avec suffisamment de précision. Cet aspect du 
problème est abordé dans le Chapitre 5 qui présente une approche simplifiée 
de l'estimation de la taille approximative nécessaire à un échantillon au 
sein d'une cohorte. Ces estimations de la taille d'un échantillon sont 
basées sur deux critères alternatifs, qui exigent soit une capacité de 
rendement relative minimum du calibrage (pour qu'il n'y ait qu'une perte 
minime de précision dans l'estimation du risque relatif), soit un test doté 
d'un minimum de puissance statistique pour établir une relation entre 
l'alimentation et la maladie basée sur les estimations corrigées des risques 
relatifs (c'est à dire, après calibrage). La taille nécessaire d'une étude 
de calibrage ne dépend alors plus que de la corrélation entre les 
évaluations obtenues par questionnaires et les mesures de référence. 
Dans les études où les évaluations de l'exposition sont basées sur des 
marqueurs biochimiques mesurés dans le sang, les urines ou d'autres 
spécimens biologiques, une mesure performante et simple est de stocker les 
échantillons biologiques dans une "biobanque", et de repousser la mesure de 
l'exposition jusqu'à ce qu'on sache quels sont les individus qui ont eu un 
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type donné de maladie et qui fera un contrôle approprié. Il n'en reste pas 
moins que le nombre d'hypothèses scientifiques qui présentent un intérêt 
potentiel est généralement bien plus grand que le nombre de marqueurs 
biologiques que l'on peut effectivement mesurer avec une quantité limitée de 
sang ou d'un autre échantillon biologique disponible. Il serait donc utile 
de disposer d'une méthode statistique qui, avec le moins de matériau 
biologique possible, permette de distinguer les hypothèses les plus 
interessantes des moins intéressantes. C'est dans ce but que le Chapitre 6 
propose d'utiliser un plan d'étude séquentiel dans lequel les analyses des 
laboratoires des échantillons biologiques provenant des cas et des contrôles 
seraient effectuées jusqu'à ce que l'on dispose de suffisamment de données 
pour rejeter ou conserver une hypothèse nulle de "non association" entre 
marqueur et risque de maladie. En moyenne, et en comparaison à une procédure 
équivalente de test sur échantillon fixe, un test séquentiel demande moins 
de la moitié des échantillons biologiques pour aboutir à une conclusion. Si 
l'hypothèse nulle est rejetée, on peut analyser des échantillons biologiques 
suplémentaires pour améliorer la précision des risques relatifs estimés ; 
sinon, on peut garder les échantillons biologiques pour évaluer les 
différentes hypothèses. 
On peut donc conclure que les études préliminaires de validité qui 
évaluent la corrélation entre les bilans et la consommation alimentaire 
réelle, peuvent servir à sélectionner le type de questionnaire optimal qui 
pourra être utilisé dans une étude prospective de cohorte. D'autre part, les 
études de calibrage qui n'utilisent qu'une mesure de référence par personne 
sont plus efficaces quand leur objectif est d'estimer la puissance des 
études prospectives de cohortes en rendant compte des effets causés par les 
erreurs d'évaluation aléatoires ou de corriger des biais dans les risques 
relatifs estimés. Le principal avantage des études de calibrage est qu'elles 
peuvent être effectuées plus facilement sur un échantillon représentatif de 
la population de l'étude. Dans le cadre des projets multi-cohortes, les 
études de calibrage peuvent être utilisées pour améliorer la qualité de 
comparaison entre les risques relatifs estimés de chaque cohorte et pour 
obtenir une estimation plus précise de la relation inter-cohorte, 
"écologique" entre les niveaux de consommation alimentaires et l'incidence 
de la maladie. Dans les études où les évaluations de l'exposition sont 
basées sur les marqueurs biochimiques, une mesure simple et efficace est de 
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stocker les échantillons biologiques dans une "biobanque" et de repousser 
les analyses de laboratoire jusqu'à ce qu'on ait rencontré des cas de 
maladie. On peut ensuite utiliser les plans d'études séquentielles pour 
permettre l'évaluation d'un nombre optimal d'hypothèses scientifiques avec 
une quantité donnée de matériau biologique disponible. 
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